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Three turkey rhinotracheitis virus-like (TRTV-like) isolates were 
isolated from chickens with swollen heads. All grew well via the 
yolk sac (y/s) , chorioallantoic membrane (CAM), tracheal organ 
culture (TOC) , chicken embryo fibroblast (CEF) , and Vero cell 
routes. Affected embryos were stunted and severely congested. No 
pathological alterations were detected in allantoic sac (a/s) 
inoculated embryos. The CEF and Vero cells required 
trypsinisation for five consecutive passages before any visible 
cytopathic effects (CPE) were observed. Intra-cytoplasmic 
eosinophilic inclusions were observed in Vero and CEF monolayers . 
Only isolate 652/93 caused 100% ciliostasis in TOC. The other two 
isolates were able to cause a maximum of only 70-80% ciliostasis. 
The isolates were inactivated by chloroform treatment and 
exposure to 56°C for 1 h. Long term storage could be achieved at 
-70°C or in liquid nitrogen but not at 4°C or at -20°C. The 
isolates did not agglutinate chicken red blood cells and were 
found to contain genomes of RNA. They were able to elicit TRTV 
antibodies in specific pathogen free (SPF) birds as measured with 
the Pathasure enzyme linked immunosorbent assay (ELISA) kit. They 
could also be neutralised by TRTV-specific antisera. 
Electron microscopy of infective allantoic fluid (A/F) revealed 
particles of 100-300 nm in diameter with a helical nucleocapsid 
component approximately 15 nm in diameter and a fringe of 
approximately 12 nm long spikes. The processes of VLP development 
and maturation in TOC's and Vero cells were similar with 
x 
accumulations of virus-like nucleoprotein close to the plasma 
membrane, forming the nucleocapsid. Virus-specified spikes were 
then inserted into the plasma membrane after which the VLP budded 
from the plasma membrane, incorporating this membrane with spikes 
as its own. 
Nine viral polypeptides with molecular weights of 200kDa, 83kDa, 
53kDa, 40kDa, 37kDa, 28kDa, 19kDa and 15kDa were detected by SDS-
PAGE in samples of the three isolates. The 83kDa and 53kDa 
polypeptides were al·so detected by western blotting using TRTV-
specific antisera. Both, a TRTV and a 652/93 isolate non-
radioactive DNA probe, appeared specific for TRTV and TRTV-like 
isolates. The 652/93 probe detected 652/93 virus in SPF chickens 
for 19 days post-inoculation. 
A vaccine produced in SPF eggs using the attenuated 652/93 
isolate, was able to protect vaccinates against virulent virus 
in laboratory challenge studies. In field trials, birds 
vaccinated at day-old or at day-old and again at 14 days, showed 
slightly improved performance compared to non-vaccinated birds. 
However, this benefit was not statistically significant. It is 
suggested that other environmental and disease factors mask the 
benefit provided by the vaccine in field trials. 
The three TRTV-like isolates appear to be chicken strains of TRTV 
and vaccination with an autogenous vaccine appears to afford some 
benefit to vaccinates. 
xi 
CHAPTER 1 
REVIEW OF TURKEY RHINOTRACHEITIS AND SWOLLEN HEAD SYNDROME 
1.1. The Poultry Industry in South Africa 
Chicken meat is a relatively inexpensive source of protein for 
millions of South Africans and the country's broiler industry is 
well geared to adequately supply the increasing demand for 
chicken meat. The demand for white meat is further stimulated by 
the increasing awareness of consumers that red meat as a staple 
food, is unhealthy. 
South Africa has an extensive poultry industry responsible for 
approximately 1% of the world poultry production and is the 
largest poultry meat producer in Africa, producing approximately 
394 000 metric tons per annum, which comprises 22% of Africa's 
~otal production (FAO, 1992). The production of poultry in South 
Africa has steadily increased at an estimated rate of 10 000 
metric tons per annum from 1989 to 1991 (FAO, 1992). World 
production of poultry meat represented 21.3% of all meat in 1986 
and, in the United States of America (USA), chicken consumption 
had overtaken that of pork by 1986 and of beef in 1988 (Jordan, 
1990) . To maintain the continued growth of the poultry industry, 
it is essential that successful disease control be achieved by 
recognition, treatment and prevention of the diseases. 
The only poultry production of economic significance in South 
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Africa, is chicken. Production of other poultry is mainly at an 
informal level. 
1.2. Symptoms and Pathology caused by Turkey Rhinotracheitis 
Virus and the Swollen Head Syndrome Virus 
The Afrikaans word for swollen head syndrome (SHS) , IIdikkopll, 
aptly describes the condition frequently seen .in turkeys and 
.' 
chickens suffering from a severe respiratory disease. 
II Dikkop II , or SHS, was first described in turkeys by Buys and Du 
Preez (1980) in South Africa, and later in Great Britain by many 
researchers (Anon, 1985; McDougall and Cook, 1986; Naylor and 
Jones, 1993; Wilding, Baxter-Jones and Grant, 1986; Wyeth, Gough, 
Chettle and Eddy, 1986). However, Morley and Thomson (1984), 
described a swollen head condition in broilers in South Africa 
that was seen from as early as 1972. According to Box (1989), 
turkey rhinotracheitis (TRT) was present in Europe from 1981 but 
was not linked to the disease previously described in South 
Africa. Initially, outbreaks of the disease were sporadic, but 
later became epidemic (Box, 1989). 
Various names had been used to describe the disease in turkeys, 
including TRT, turkey coryza and acute respiratory syndrome 
(Wyeth, 1990). The names IITRTII and IISHSII are currently used to 
describe the disease in turkeys and chickens respectively. 
The symptoms of TRT are consistent irrespective of the geographi-
2 
cal region of the disease outbreak. Symptoms associated with TRT 
are sneezing, coughing, snicking, rales and a watery nasal 
discharge which thickens with progression of the disease and 
becomes turbid and purulent, eventually blocking the nares (Buys, 
Du Preez and Els, 1989a; Collins, Gough, Lister, Chettle and 
Eddy, 1986; Gough, Collins and Hancock, 1988b; Naylor and Jones, 
1993; Wyeth, 1990). Other clinical signs of disease include 
depression, change of voice, gasping, torticollis,. sub-mandibular 
• 
oedema, swollen infra-orbital sinuses, and foamy occular 
discharge (Jordan, 1990; Wyeth and Alexander, 1989). Birds are 
eventually forced to breathe with open mouths (Buys et al., 
1989a) . The clinical symptoms appear to be more severe during the 
colder months of the year (Jordan, 1990). 
Post mortem examinations reveal sinusitis, conjunctivitis, 
rhinitis, tracheitis, and pericarditis (Naylor and Jones, 1993; 
Wyeth, 1990). Jones, Williams, Baxter-Jones, Savage and Wilding 
(1988), found after experimental inoculation of turkeys with a 
TRT virus (TRTV) , abnormalities in the oviducts 2-12 days post-
inoculation (pi) . This included the deposition of inspissated 
albumen and yolk material in the abdominal cavity. The virus did 
not appear to replicate in the lungs or air sacs. However, virus 
was detected in the epithelium of the uterus on day 7 pi and in 
all other regions of the oviduct on day 9 pi. Virus was also 
isolated from the middle magnum and vagina on day 9 pi. 
Microscopic changes may occur in the mucosa of the nares and 
trachea between 4-10 days after infection (Jordan, 1990). The 
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first abnormality is a focal loss of the cilial layer at 2 days 
pi (Jones, Baxter-Jones, Wilding and Kelly, 1986). Jones et al. 
(1986) demonstrated changes in the trachea following experimental 
inoculation of turkeys with virulent virus. There was focal 
discontinuity at day 2 followed by extensive loss of cilia by day 
4 together with extrusion of epithelial cells. Vacuolation and 
cell debris, together with infiltration of heterophils and 
lymphocytes, within the epithelium, were obs~rved. Recovery 
occurred after approximately 10 days pi, and the tracheal 
epithelium returned to normal (Jones et al., 1986). 
TRT infection is confined to the upper respiratory tract (Cook, 
Ellis and Huggins, 1991; Cook, Kinloch and Ellis, 1993b; Jones, 
1993; Jones, Baxter-Jones, Savage, Kelly and Wilding, 1987). 
Jones et al. (1986), and Baxter-Jones, Wilding and Grant (1986), 
detected virus in the tracheas of experimentally infected poults 
2-4 days pi. According to Gough et al . (1988b), no generalised 
viraemia occurs, confirming that replication of the virus is 
localised in the respiratory tract. Cook et al. (1991) recovered 
large amounts of TRTV from the respiratory tract of turkey poul ts 
for 5 days after experimental eyedrop inoculation and they found 
that small amounts of virus could be shed up to 14 days after 
inoculation. 
The disease of TRT is characterised by a rapid onset and very 
rapid spread through a flock. Morbidity is often 100~ within 24 
hrs of the first signs of the disease (Buys et al., 1989a; Wyeth, 
1990) . Mortality may vary from 1-50~, but could reach 90~ in some 
4 
cases (Gough et al., 1988b; Wyeth, 1990). Mortality rates may be 
increased by the presence of other pathogens, poor hygiene or 
ventilation, overstocking, and cold damp weather (Jordan, 1990; 
Naylor and Jones, 1993). Layers often suffer a drop in · egg 
production of up to 70%, which is of sudden onset and lasts for 
10-21 days (Peleteiro, 1991). 
The disease originally occurred in older turkeys b,etween 9 - 2 0 wks ,. 
of age (Wyeth, 1990), but Gough et al. (1988b) showed that TRTV 
could affect flocks from as early as one day of age, despite the 
fact that they had maternal antibodies . It therefore appears that 
maternal antibodies cannot protect poults in the face of a severe 
TRT outbreak. According to Wyeth (1990), mortality is usually 
higher in younger turkeys and affected birds take approximately 
3 weeks to fully recover. 
An outbreak of TRT in South Africa in 1978, completely destroyed 
the country's turkey industry (Stuart, 1986), and there are at 
present no large scale commercial producers of turkeys. There 
were also devastating effects of TRT in the United Kingdom (UK) 
(Gough et al., 1988b). 
The involvement of a TRTV-like virus in SHS, was confirmed by 
histOlogy, electron microscopy, serology and challenge studies 
(Gaudry, 1991; O'Brien, 1985; Picault, Giraud, Guittet, 
Bennejean, Lamande, Toquin and Gueguen, 1987; Vanmarcke, 1989). 
TRTV has been isolated from chickens with clinical SHS {Buys, Du 
Preez and Els, 1989b; Jones, Naylor, Bradbury, Savage, 
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Worthington and Williams, 1991; Wyeth, Chettle, Gough and 
Collins, 1987), and Picault et al. (1987) were able to reproduce 
TRT in turkeys with an isolate from chickens with SHS. Swollen-
head syndrome causes extensive losses in the chicken industry and 
the syndrome appears to be more predominant in broilers, than in 
layers (Gaudry, 1991). According to Shane (1992; 1993), SHS in 
broiler chickens is an emerging condition with a complex 
aetiology. • 
The symptoms of SHS vary from broilers to layers or breeders, the 
last two groups showing a similar picture (Anthony, 1992; 
Peleteiro, 1991). In broiler chickens, SHS may result in only 1-
2% of the birds exhibiting pronounced lesions and symptoms (Buys, 
1990; Cambridge Veterinary Sciences, 1989; Pattison, Chettle, 
Randall and Wyeth, 1989). However, according to Peleteiro (1991), 
morbidity is usually high, ranging from 1-90%, depending on the 
general condition of the flock . Mortality is generally low, 
rarely exceeding 10%. The disease also has a rapid onset 
(Anthony, 1992). 
SHS in broilers usually occurs between 20-30 days, but it has 
been observed in birds 15 days of age (Naylor and Jones, 1993; 
Shane, 1992). Flocks initially appear depressed, with mild 
sneezing and coughing, followed by a nasal discharge (Anthony, 
1992; Buys et al., 1989b; Peleteiro, 1991; Shane, 1992). The 
first symptoms of SHS in broilers are often disregarded, as they 
appear as mild respiratory distress mainly at night. However, 
within 48 hours, the birds show hyperlacrimation, congestive 
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conjunctivitis, oedema of the eyelids and perioccular oedema. The 
oedema extends to the base of the head and the inter-mandibular 
space and wattles. Affected birds show an abnormal "almond eye" 
appearance (Anthony, 1992; Peleteiro, 1991; Shane, 1992). A nasal 
discharge that may last for 4 days, often occurs (Dr S.S. Buys, 
Early Bird, 1992 pers. comm. ). Pericarditis, perihepatitis, 
rhinitis, and tracheitis, are common features (Cambridge 
Veterinary Sciences, 1989; Peleteiro, 1991). 
In the acute form of the disease, birds with nervous symptoms 
such as torticollis, incoordination and opistotonus, are observed 
(Anthony, 1992). The main problem in broilers, is that there is 
a decrease in food intake, resulting in poor growth performance 
(Buys, 1990; Naylor and Jones, 1993; Peleteiro, 1991). Birds that 
do not eat or drink, die of dehydration and exhaustion (Shane, 
1992). Recovered birds often have airsacculitis, due mainly to 
Escherichia coli (Anthony, 1992; Buys, 1990). The disease in 
broilers, runs its course in 7-10 days (Peleteiro, 1991). 
In commercial layers and broiler breeders, SHS mainly affects the 
birds at the peak of production, or just before they enter the 
production stage (Naylor and Jones, 1993; Peleteiro, 1991). 
According to Vanmarcke (1989), floor reared broiler breeders show 
the most clear and intensive symptoms. Prior to the appearance 
of the obvious clinical signs, birds appear depressed, and there 
is a slight increase in mortality. A decrease in food intake may 
occur. Morbidity at this stage is generally low between 1 and 5% 
(Anthony, 1992). The disease has a rapid onset and can cause a 
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drop in egg production of between 5-40% (Peleteiro, 1991; Shane, 
1992). There may be a drop in the percentage hatchability 
(Cambridge Veterinary Sciences, 1989). Chicks from eggs laid 
during this period also perform poorly (Peleteiro, 1991). Egg 
production returns to normal after 2-3 wks of the onset of SHS. 
Apart from oedema of the head, pin-point haemorrhagic lesions 
occur in the palatine cleft and mucosae of the upper respiratQry 
tract. From these lesions, bacterial complications occur with 
inflammation of the surrounding tissue. These cause the head and 
sinus swelling (Pattison et al., 1989). The secondary bacterial 
infections in the brain are responsible for the nervous disorders 
(Vanmarcke, 1989). 
Haemorrhages may occasionally occur in the pericardial fat 
(Eleazer, 1991). According to Peleteiro (1991), the kidneys 
occasionally become inflamed and congested, and disturbances of 
the ovaries also occur. Involution of the ovaries with 
surrounding moist inflammatory lesions and released yolk free in 
the peritoneum, were found (Pattison et al., 1989; Peleteiro, 
1991). Some birds have a foul smelling greenish diarrhoea with 
nervous symptoms similar to that of affected broilers (Eleazer, 
1991; Naylor and Jones, 1993) . 
The disease runs its course in layers and breeders in 4-6 wks but 
although the mortality and morbidity may be low, affected birds 
often die (Anthony, 1992). 
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1.3. Global Distribution of TRT and SHS 
TRT and SHS have been reported from many countries where 
intensive rearing of turkeys and chickens for meat occurs (Lister 
and Alexander, 1986). Although SHS was initially observed in 
turkey producing areas, it was recently found in areas where no 
turkeys were grown (Anthony, 1992). 
TRT was first seen in turkeys in South Africa in 1978 by Buys and 
Du Preez (1980). In 1978, a virulent outbreak of a similar 
disease occurred in Israel (Weisman, Strengel, Blumenkranz and 
Segal, 1988), and spread to Germany in 1980 (Stuart, 1986). The 
disease was then seen in The Netherlands and France in 1981 
(Alexander, Borland, Bracewell, Chettle, Gough and Lister, 1986a; 
Alexander, Gough, Wyeth, Lister and Chettle, 1986b; Giraud, 
Bennejean, Guittet and Toquin, 1986; Giraud, Le Gros, Guittet, 
Bouquet, Toquin and Bennejean, 1987; Wyeth, 1990). In June 1985, 
an acute, highly contagious respiratory disease of turkeys was 
reported in England and Wales (Anon, 1985). Many subsequent 
reports on the occurrence of the virus have been made from the 
UK (Gough et al., 1988b; McDougall and Cook, 1986; Wilding et 
al., 1986; Wyeth et al., 1986). However, according to Baxter-
Jones (1992), TRT could have been present in Europe since the 
early 1970's. According to Andral, Louazis, Trap, Newman, 
Bennejean and Gaumont (1985), all European countries experienced 
a similar type of disease. TRT has also been reported from 
Hungary, Italy, Northern Ireland, Greece, Spain and Mexico 
(Eleazer, 1991; O'Loan, Allan, McNair, Mackie and McNulty, 1990; 
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Wyeth, 1990). An extensive study of Australian turkey flocks 
failed to find any positive sera (Bell and Alexander, 1990). 
Strict quarantine procedures enforced by the USA, prevented the 
early occurrence of TRT in that country (Pearson, Senne, 
Panigrahy and Mixson, 1993). However, Grow (1992) confirmed the 
presence of TRT in North Carolina . 
• 
; " 
SHS has been reported from many countries including England, 
France, Portugal, Spain, Germany, Belgium, Italy, Saudi Arabia, 
Kuwait, South Africa, Taiwan, Mexico, Mauritius, Argentina, 
Canada, The Netherlands, Israel and Peru (Buys et al., 1989b; 
Eleazer, 1991; Goren, 1985; Lu, Shien, Tsai, Tseng, Lee and Lin, 
1994; O'Brien, 1985; Pages, Ramis and Majo, 1992; Perelman, Meroz 
and Samberg, 1988; Picault et al . , 1987; Shane, 1992; Zellen, 
1988) . Chicken sera from Hungary, Morocco, Malaysia, Philippines 
and the Dominican Republic, tested at Rhone Merieux in France, 
confirmed the presence of SHS in these countries (Gaudry and Le 
Gros, 1993; Vanmarcke, 1989). The syndrome was first observed in 
South Africa in the early 1970's by Morley and Thomson (1984). 
The prevalence of the disease increased since then with the 
expansion and intensification of the country's broiler industry. 
SHS remains a problem in most countries, especially in areas of 
high poultry density (Shane, 1992). As is evident, TRT and SHS 
are present virtually throughout the "poultry world". 
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1.4. Isolation and Propagation 
The viruses responsible for TRT and SHS, are very elusive. 
Successful isolation requires that tissues from the upper 
respiratory tract be submitted from early in the course of the 
disease (Jordan, 1990) . Once clinical signs are apparent in the 
flock, the chances of isolation are considerably reduced (Baxter-
Jones, 1992). According to Jordan (1990), it ~s difficult.to 
• 
isolate the virus beyond 6-7 days after infection (3-4 days after 
the onset of clinical signs). 
Some researchers have been successful in the isolation of TRTV 
from chickens with SHS(Buys et al., 1989b; Jones et al., 1991; 
Picault et al., 1987; Wyeth et al . , 1987). However, it is more 
difficult to isolate the virus from chickens, than it is from 
turkeys (Baxter-Jones, 1992). According to Buys (1990), the best 
samples for virus isolations are from birds with a distinct nasal 
discharge. 
TRTV or SHS virus has most consistently been isolated using 
tracheal organ culture (TOC) of chickens or turkeys (Buys et al . , 
1989a; Giraud et al., 1986; Gough et al., 1988b; Jones et al., 
1986; McDougall and Cook, 1986; Wyeth et al., 1986). Picault et 
al. (1987) and Jones et al . (1991) used chicken TOC's to isolate 
TRTV from chickens. Ciliostasis usually occurred within 1 wk of 
inoculation. 
Embryonated chicken eggs have also been used for the isolation 
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of TRTV and SHS viruses. The viruses caused congestion and 
haemorrhages on the embryos when the yolk sac (y/s) route of 
inoculation was used (Buys et al., 1989a,b; Gough et al., 1988b; 
Wyeth, 1990). Buys et al. (1989a) were able to grow TRTV on the 
chorio-allantoic membrane of embryonated specific pathogen free 
(SPF) eggs. -However, when the TRTV or SHS virus was inoculated 
via the allantoic sac (a/s) route, there was a lack of embryo 
pathology, but the virus did replicate as evj.denced by the 
; -
visualisation of virus particles with the electron microscope ( 
Buys et al., 1989b; Cook and Ellis, 1990). 
The TRT and SHS viruses were able to grow in Vero cell 
monolayers, where they caused cytopathic effects (CPE) consisting 
of cytoplasmic eosinophilic inclusions and polykaryocytes (Buys 
et al., 1989a,b; Giraud et al., 1986). Gough et al. (1988b) were 
unable to grow the virus in chicken embryo liver cells (CELC), 
but Williams, Savage and Jones (1991a) successfully cultivated 
the TRTV in CELC. TRTV and SHS virus were also adapted to grow 
in chicken embryo fibroblast (CEF) cells where they caused the 
formation of syncytia and eosinophilic inclusions (Naylor and 
Jones, 1993). 
1 . 5. Transmission 
The methods of spread of the virus responsible for TRT and SHS, 
are still uncertain. 
Al though there is no evidence of transovarial transmission of the 
12 
virus, Jones et al. (1988), speculate that the replication of the 
virus in the oviduct, although for a short period, could cause 
some of the virus to be shed in the eggs which develop during 
this period. However, they found the ovary to be free of virus. 
Jones et al. (1988) believed that if transmission did occur by 
this method, then it was most likely a temporary occurrence of 
a low level and of little importance in the spread of the 
infection. It is now generally accepted that the transmission.is 
horizontal (Peleteiro, 1991). 
In the initial TRT outbreak in the UK in 1985, the disease spread 
within 24 h through the entire site, and during the next few 
weeks, it spread to other parts of the UK. Within 4 wks, 9 other 
outbreaks were reported. Within 3 months, 72 outbreaks occurred 
(Gough et al., 1988b; Lister and Alexander, 1986; McDougall and 
Cook, 1986; Wilding et al., 1986; Wyeth, 1990; Wyeth et al., 
1986). The primary wave of infection affected turkey flocks of 
all ages, and the disease became enzootic. Thereafter , successive 
waves of infection occurred, affecting only those farms that had 
been depleted and restocked with susceptible poults. The 
frequency of the secondary waves of infection appeared to be 
dependent upon the density of the turkey population (Jordan, 
1990) . 
In high density areas, most flocks experience disease during the 
first 16 wks of age, and in low density areas, secondary waves 
of infection may only be rarely encountered (Gaudry and Le Gros, 
1993; Jordan, 1990). 
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The rapidity of spread of the virus, suggests that airborne 
transmission is the primary method, followed by the movement of 
vehicles,. personnel, and feed, from contaminated to "clean" sites 
(Jordan, 1990; Shane, 1992). Poor biosecurity practices are 
important factors in the spread of disease (GauQry and Le Gros, 
1993) . 
Cook et al. (1991), showed that TRTV is highl)C contagious. A 
single infected bird within a group was able to rapidly infect 
all others in that group. This only occurred for the first nine 
days after infection. Seronegative sentinel birds placed in a 
flock previously exposed to TRTV, did not develop antibodies to 
TRTV. This suggests that TRTV is rapidly excreted from infected 
birds (Jordan, 1990). This was confirmed by D. K. Thomson (Rainbow 
Farms, 1993 pers. comm.). 
The close relationship between TRTV and SHS virus explains why 
both diseases spread more rapidly in geographic areas with a high 
concentration of turkeys or chickens. Since their first 
appearance, TRT and SHS have evolved in a very irregular fashion 
characterised by periods of persistence in some countries and 
sudden disappearance in others (Peleteiro, 1991). 
1.6. Host Range 
The virus of TRT originally affected turkeys, but has since 
adapted to other avian species (Buys 1990, Gough et al., 1988b; 
Jones et al., 1987; Picault et al., 1987). According to Gaudry 
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and Le Gros (1993) the prevalence of TRT facilitated the adapta-
tion of the virus to hosts different from the initial turkey. 
Picault et al. (1987), showed that the TRTV and SHS virus were 
related, by reproducing TRT in turkeys with a homogenate from 
chickens affected with SHS. They were also able to reproduce the 
disease in guinea fowls. 
Gough, Collins, Cox and Chettle (1988a) , experimentally 
inoculated 
pheasants, 
turkeys, chickens, Pekin 
guinea fowls and pigeons, 
ducklings, 
with a TRTV. 
goslings, 
Only the 
turkeys showed obvious symptoms of infection. No clinical signs 
were detected in the other groups of birds, except for the 
pheasants, which had a transient conjunctivitis. Virus was 
reisolated only from the turkeys and chickens. This is in 
contrast to the results of Picault et al. (1987), who were able 
to reproduce the disease in guinea fowls. However, Gough et al. 
(1988a) detected antibodies against TRTV in sera from the 
turkeys, chickens, pheasants and guinea fowls. All other groups 
were negative for antibodies against TRTV. This suggests that the 
turkeys are the most susceptible to TRTV. However, these results 
were obtained under laboratory conditions, and may not represent 
the situation in the field, where many other factors contribute 
to the severity of the disease. 
Jones et al. (1987), were able to induce mild clinical signs of 
infection in SPF chicks inoculated with TRTV. Cook, Dolby, 
Southee and Mockett (1988), suggest that TRTV could infect 
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chickens without necessarily being responsible for clinical 
disease. 
In South Africa, a difference in clinical pathotypes, has been 
described (Buys et al., 1989b). The chicken SHS virus caused 
symptoms in both chickens and turkeys, but the turkey TRTV 
produced clinical disease only in turkeys (Buys et al., 1989b; 
Cook, 1993; Cook et al., 1993b). This indiGates that the 
• 
pathogenicity of the virus can evolve rapidly (Gaudry and Le 
Gros, 1993). According to Buys (1990), the TRTV from turkeys 
appears to be more host specific than the virus isolated from 
chickens. Further work on the SHS and TRT isolates of Buys et al. 
(1989b) by Cook et al. (1993b), showed that although the SHS 
isolate caused symptoms in both chickens and turkeys, the 
symptoms were more severe in the species from which the isolate 
was made. However, the symptoms observed were often only in a 
small proportion of the inoculates. They also found little 
difference in the clinical signs which the chicken isolate caused 
in seven different inbred chicken lines. Buys et al. (1989b), 
believed that the TRTV from turkeys could adapt itself to infect 
chickens. According to them, the viruses isolated in South Africa 
underwent changes with regard to their growth characteristics. 
f 
Many clinicians initially believed that the two diseases, TRT and 
SHS, were unrelated, but it is now accepted that the virus 
responsible for TRT is also involved in SHS of chickens (Cook et 
al., 1993b) 
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1.7. Interactions with other Agents 
According to Shane (1992; 1993), a complex of factors is required 
to initiate TRT and SHS. This is especially true for SHS in 
broiler flocks. Some of the factors include immunosuppression 
associated with infectious bursal disease, chicken anaemia agent, 
Marek's disease, and reovirus; exposure to respiratory viruses 
or other unidentified agents, the presence of pathogenic bacteria 
• 
such as pathogenic serovars of E. coli, environmental stress 
which exacerbates the incidence and severity of SHS in broilers, 
and the administration of live vaccines like Newcastle disease 
virus and infectious bronchitis virus, especially by the aerosol 
route (Gough et al., 1988b; Jordan, 1990; Shane, 1992; 1993). 
Most specialists stress the importance of environmental factors 
in the onset of the disease ( Anthony, 1992; Gough et al., 1988b; 
Jordan, 1990; Peleteiro, 1991). These include the stocking 
density of birds in the house, aeration of the house, levels of 
ammonia in the air, dust in suspension, poor general hygiene, and 
cold damp weather. In many TRT outbreaks, the respiratory disease 
was attributed to TRTV, but the high mortality which resulted in 
many cases, was attributed to the combination of factors, 
including secondary bacterial invasions, as listed earlier (Gough 
et al., 1988b; Jordan, 1990). 
Cook et al. (1991), were able to recover virulent TRTV from the 
internal organs and intestinal tract of birds only if bacteria 
(Bordetella avium, and a Pasteurella-like organism) were adminis-
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tered simultaneously. They suggest that the bacteria caused 
damage to the upper respiratory tract tissue, thereby permitting 
penetration of the virus. TRTV replication which is limited 
mainly to the ciliated epithelium of the upper respiratory trac;:t, 
causes ciliostasis, resulting in suppression of an important 
mechanical barrier to bacterial and viral infections. The virus 
is in itself not immunosuppressive, but it reduces the capability 
of non-specific immunity (Gaudry and Le Gros, .1993). General .. 
immunity may not be of great help against infection, as compared 
to local immunity (Cook et al., 1991; Gaudry and Le Gros, 1993; 
Williams, Savage, Worthington and Jones, 1991b). 
1.8. Physicochemical Properties 
The agents responsible for TRT and SHS, have been identified as 
extremely pleomorphic viruses ranging in size between 40-1000nm 
(Buys et al., 1989a;b; Collins and Gough, 1988; Gough et al., 
1988b; Picault et al., 1987; Wyeth et al., 1986). Virions were 
either filamentous or spherical; spherical forms ranging in size 
from 40-200nm in diameter, while filamentous forms differed 
widely in length with some as long as 1000nm. The virions possess 
a fringe of closely spaced projections 13-14nm long (Collins and 
Gough, 1988; Giraud et al., 1987; Gough and Collins, 1989; Wyeth, 
1990). The internal helical nucleocapsid has a diameter of 14nm 
with a pitch of 7nm. 
UI tra-thin sections of Vero cells, showed viral material in 
electron-dense accumulations in cytoplasmic inclusions (Giraud 
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et al . , 1987; Buys, 1990). Virions budded from the cell through 
a modified outer-cell membrane . Pages et al. (1992) observed 
numerous spherical virions with diameters ranging from 100 - 200 
nm in Vero cells, but they did not see any filamentous forms. 
The viruses contain lipids and they lack haemagglutinating and 
neuraminidase activity (Buys et al . , 1989a;b; Giraud et al., 
1987; Wyeth, 1990). The viral genome consists of RNA #of 
approximately 15000 bases (Dr D. Cavanagh, Institute for Animal 
Health UK, 1993 pers. conun.) . These properties are characteristic 
of the Pneumovirus genus. Collins and Gough (1988), confirmed, 
using sodiumdodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) analysis of the viral polypeptides and electron 
microscopy, that TRTV is a Pneumovirus. Also, the morphological 
and biological properties of TRTV resembled those of the human 
and bovine respiratory syncytial viruses (RSV), which are 
Pneumoviruses (Cavanagh and Barrett, 1988; Collins and Gough, 
1988; Gough and Collins, 1989; Wyeth et al., 1986). Yu, Davis, 
Barrett, Binns, Boursnell and Cavanagh (1991), sequenced the 
fusion glycoprotein of TRTV and found a close identity with RSV 
while Cavanagh and Barrett (1988) found the mRNA profile to be 
similar to RSV. However, Yu, Davis, Brown and Cavanagh (1992) and 
Yu, Davis, Li and Cavanagh (1992) showed that RSV and TRTV had 
different gene orders. 
Giraud et al. (1987), using SDS-PAGE, detected five viral 
proteins of molecular weights 94kDa, 83kDa, 58kDa 50kDa, and 
35kDa. The 58kDa protein was believed to be a glycoprotein. 
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However, Collins and Gough (1988) and Gough and Collins (1989), 
reported the presence of seven viral polypeptides of 200kDa, 
84kDa, 54kDa, 42kDa, 37kDa, 31kDa, and 14kDa. The 84kDa and 54kDa 
polypeptides were found to be glycosylated, which confirmed their 
viral specificity. The 42kDa and 31kDa polypeptides were 
tentatively designated as the "N" and "M" proteins respectively. 
Ling and Pringle (1988), identified 8-10 TRT-virus-specified 
• 
polypeptides with molecular weights of 129kDa, 83kDa, 57kDa, 
45kDa, 38kDa, 35kDa, 30kDa, 22kDa, 19kDa, and 15kDa. They 
suggested that the 22kDa polypeptide could be a non-structural 
protein or a minor strUctural polypeptide. They also believed 
that the 57kDa polypeptide was a disulphide bonded dimer of the 
45kDa and 15kDa polypeptides. They found that the 57kDa, 45kDa, 
and 15kDa polypeptides were glycosylated. Ling and Pringle (1988) 
attribute the differences in molecular weight estimations between 
their work and that of Collins and Gough (1988), to the different 
gel conditions and the different range of reference marker 
proteins employed. 
The SDS-PAGE profiles of all TRTV isolates tested by Gough and 
Collins (1989), were found to be identical. The buoyant density 
of TRTV was found to be between 1 . 2 - 1. 22g/ml (Collins and 
Gough, 1988; Gough and Collins, 1989). 
1.9. Vaccine Development 
Many researchers have attempted to develop vaccines against TRTV. 
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The methods employed to achieve this goal often differed. Some 
vaccines comprise egg passaged material, while others comprise 
Vero cell passaged material (Cook, Ellis, Dolby, Holmes, Finney, 
and Huggins, 1989a; Cook, Holmes, Finney, Dolby, Ellis and 
Huggins, 1989b; Gaudry, 1991; Gaudry and Le Gros, 1993; Giraud 
et al., 1987; Williams et al., 1991a;b). 
According to Cook et al. (1991), the most urgent need is fo~ a 
• 
vaccine to protect poults against infection during the rearing 
stage when the stocking density is highest and when risk of 
secondary infection with pathogenic bacteria is greatest. This 
. also applies to broilers, where the birds are subj ected to 
enormous stress. 
Buys et al. (1989a) found that their strain of TRTV was 
attenuated within three passages in Vero cells and poults 
vaccinated with this material, resisted subsequent challenge with 
virulent TRTV. They also found that the 17th chorio-allantoic 
membrane (CAM) passaged virus was sufficiently attenuated and 
afforded good protection against challenge with a virulent TRTV. 
Approximately 75% of the birds vaccinated with this material, 
were protected. 
Giraud et al. (1987) used Vero cells to propagate their strain 
of TRTV. They found the 39th Vero cell passaged material to be 
suitable for a live vaccine. This vaccine offered good protection 
against experimental challenge. However , inactivated vaccine 
prepared with the 19th Vero cell passaged virus, was ineffective 
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and offered little or no protection against challenge infection. 
Williams et al. (1991a) tested three preparations of a strain of --
TRTV, passaged differently, for their ability to protect poults 
against challenge with virulent TRTV. They used the 98th turkey-
TOC passage, 28th CEF passage and 17th Vero cell passage 
material. The TOC preparation was still virulent after 98 
passages, while the CEF passage material was over.attenuated and 
failed to protect poults. However, the Vero cell passage material 
was sufficiently attenuated and able to offer protection against 
clinical disease following experimental challenge. The TOC 
passaging is believed to closely simulate the bird to bird 
passage in the field resulting in little or no attenuation of the 
virus. However, birds inoculated with the TOC material were 
refractile to virulent challenge, suggesting that birds become 
inunune to reinfection. Williams et al. (1991aib) found that 
al though birds were protected against virulent virus after 
vaccination, there was a very poor seroconversion against TRTV. 
Further work by Williams et al. (1991b) showed that poults could 
be protected for at least 22 wks post vaccination and the vaccine 
was safe at ten times its normal dose. Attempts to back passage 
the virus from bird to bird, were unsuccessful. 
A TRTV vaccine available from a conunercial vaccine . producer 
(Pittman-Moore), was able to protect turkeys from virulent TRTV 
with marked improvements in the performance of vaccinates 
compared to non-vaccinated control birds (Box, 1989). However, 
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this vaccine is costly, which prevents its widespread application 
for broilers. 
Cook et al. (1989b) found that humoral antibody was not a good 
indicator of protection against TRTV infection, especially in 
older birds. Also, they found that maternally derived antibody 
may limit the effects of virus multiplication in a proportion of 
the birds, and the serological response to an attenuated TRTV.in , 
these birds could be very poor with many birds showing no 
detectable antibodies. They state that cellular immunity may be 
more important than humoral antibodies in the resistance to TRTV 
infection. 
Cook and Ellis (1990) attenuated TRTV for vaccine use by 
alternate passaging in 9-day-old embryonated chicken eggs and 
chicken TOC. After 30 cycles of alternate passages, the virus 
caused only mild transient respiratory signs in turkeys and 
protected birds against challenge with a virulent TRTV 21 days 
later. This attenuated strain was stable with no reversion to 
pathogenicity after 12 turkey-turkey passages. The poult passaged 
and pre-passaged strains caused only mild respiratory signs, even 
when bacteria known to be associated with severe outbreaks of TRT 
in the field, were included in the inoculum (Cook et al., 1989a). 
Cook et al. (1989a) used the severity of damage on the trachea 
as well as clinical signs, to determine the extent of 
attenuation. They found a good correlation between the degree of 
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deciliation of the trachea, and the clinical signs observed. The 
attenuated strain and the tenth poult-passaged virus, induced 
minimal damage to the ciliated epithelium. This attenuated strain 
was shown to be effective in protecting poults against 
experimental challenge with TRTV for up to 14 wks after 
vaccination. Immunity developed within six days of vaccination 
(Cook et al., 1989b). Poults free of TRTV antibodies and those 
hatched from TRTV-immune dams, were both equally. well protec£ed , 
but the serological response of the latter was poor with many 
poul ts showing no detectable serum antibody response. Cook et al. 
(1989b) found that one ciliostatic dose 50% (CD~) of vaccine was 
effective in protecting poults against challenge. 
Gaudry (1991) and Gaudry and Le Gros (1993) found differences in 
the vaccination results obtained in the field and in the 
laboratory. The vaccine response in birds at the laboratory, 
appeared good when evaluated by seroconversion and challenge 
studies, but in the field, there was often no seroconversion even 
after two vaccinations, and when there was a seroconversion, it 
was low and of a shorter duration than that obtained in the 
laboratory. This demonstrates the major role of the farm 
environment in the evolution of the disease (Gaudry, 1991). 
Broiler breeders given a live attenuated vaccine followed by a 
killed oil emulsion vaccine (KOE) , were well protected against 
virulent challenge (Gaudry and Le Gros, 1993). The KOE vaccine 
provided a high level of enzyme linked immunosorbent assay 
(ELISA) and serum neutralisation (SN) antibodies, especially when 
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used as a booster vaccine after live vaccination (Gaudry, 1991). 
However, the quality of live vaccination remains a problem, as 
is the situation for other members of the Pneumovirus genus. 
Although there are a few vaccines licensed for use against TRT 
in turkeys, there are no vaccines currently available, comprising 
a chicken pneumovirus isolate, for use against SHS in chickens. 
Many commercial chicken producers have implemented vaccination 
• 
programs using the turkey TRT vaccine. According to Gaudry 
(1991), the solution to vaccination against TRT and SHS will not 
come from the laboratory, but from extensive field trials. 
1.10. Serology 
Initial attempts to develop a TRTV diagnostic test were hampered 
by the difficulty in growing the virus. The first successful 
tests employed SN (Baxter-Jones et al., 1986) and indirect 
immunofluorescence (IIF) (Baxter-Jones, Cook, Frazier, Grant, 
Jones, Mockett and Wilding, 1987), but ELISA tests were developed 
by Grant, Baxter-Jones and Wilding (1987), Chettle and Wyeth 
(1988), and O'Loan, Allan, Baxter-Jones and McNulty (1989). Cook 
et al. (1988) demonstrated by ELISA and SN, the presence of TRTV 
antibodies in commercial chickens after the initial appearance 
of TRT in turkeys in the UK in 1985. Sera prior to this, were 
negative for TRTV antibodies. Apparently healthy flocks also had 
TRTV antibodies, indicating an infection at some stage. Cook et 
al. (1988) suggested that TRTV could infect chickens without 
necessarily being responsible for clinical disease. 
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Antibodies to TRTV can be detected by ELISA within 6-10 days of 
experimental infection, and it reaches a peak at 14 days post-
infection (Cambridge Veterinary Sciences, 1989). Jones et al . 
(1991) detected antibodies to TRTV in experimentally inoculated 
chicks and poults, 13 and 16 days pi respectively. Antibodies 
could persist for a minimum of 26 wks after initial detection 
(Baxter-Jones, Grant, Jones and Wilding, 1989). 
Baxter-Jones et al. (1989) compared SN, IIF, and ELISA for the 
detection of antibodies against TRTV and found significant 
correlation between the three tests. However, 0' Loan et al. 
(1990) found IIF to be the most sensitive, providing the widest 
range of antigens for antibody detection. The SN tests are type 
specific and the sensitivity of the ELISA, although more 
sensitive than the SN test, depends largely on the conservation 
of different epitopes during antigen production (O'Loan et al., 
1990). Jones et al. (1986) and Baxter-Jones et al. (1986) used 
IIF to demonstrate the presence of TRTV in the ciliated 
epithelium of the tracheal cells. O'Loan and Allan (1990) used 
a streptavidin-biotin-irnmunoperoxidase staining technique to 
detect TRTV in formalin and Bouins-fixed paraffin embedded 
tissue. They believed that this method would enable detailed 
pathological studies of TRT and SHS. 
It has been shown that all TRTV isolates from the UK are 
antigenically related (Collins and Gough, 1988; Gough and 
Collins, 1989; Baxter-Jones et al., 1987). O'Loan, Curran and 
McNulty (1992) demonstrated antigenic relatedness between TRTV 
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isolates from Great Britain, France and South Africa using 
immuno-gold labelling of TRTV. However, Baxter-Jones (1992) found 
antigenic differences between TRTV isolates from different 
geographical locations, but he was unable to distinguish between 
chicken and turkey isolates. He believes that the antigenic 
variation could be due to the different passage histories of the 
isolates following primary isolation, or it may be due to 
separate routes of virus introduction into different countries. 
; 
Cook, Jones, Ellis, Jing and Cavanagh (1993a) examined TRTV 
isolates from various countries and found using polyclonal 
antisera that although there was some diversity between the 
isolates, all the strains belonged to one serotype. The TRTV 
strains isolated in the UK in 1985 were closely related to 
isolates of TRTV made in South Africa in 1978 by Buys and Du 
Preez (1980). They also confirmed the findings of Baxter-Jones 
(1992), that one could not differentiate between chicken and 
turkey isolates of a particular country based on neutralisation 
studies with monoclonal antibodies . However, the chicken and 
turkey isolates from one country could be differentiated from 
that of another country (Cook, 1993). 
Gaudry and Le Gros (1993) were able to differentiate nine 
Pneumovirus isolates from chickens or turkeys of various 
countries, into three groups; SHS strains, related TRT strains, 
and poorly related TRT strains . They found the SHS group to be 
more homologous than the TRT groups. A close antigenic 
relatedness was demonstrated between TRTV and SHS virus in 
Britain (Peleteiro, 1991; Wyeth et al., 1987). Based on the 
27 
serological and physico-chemical data, ~t is now accepted that 
TRT and SHS are induced by the same, or variant strains of the 
same virus. 
1.11. Objectives of the Study 
An attempt will be made to characterise the virus isolated from 
chickens and to determine its relatedness to TRTV from turkeys. 
Due to the difficulty associated with the isolation of the 
rhinotracheitis virus from chickens, a quick, reliable and 
accurate diagnostic test is required for the diagnosis of 
infection with the chicken rhinotracheitis virus. A suitable and 
sensitive test is the peR followed by probing with a non-
radioactive probe. An attempt will be made to develop a DNA probe 
that will be able to detect the virus in chicken tracheas. 
An attempt will also be made to develop a chicken rhinotracheitis 
virus vaccine capable of protecting birds against challenge with 
a field strain of the virus. 
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CHAPTER 2 
ISOLATION AND PROPAGATION OF THE TRTV-LIKE AGENT 
2 . 1. Introduction 
Poultry grown in a high density environment are exposed to many 
potentially virulent and pathogenic organisms. Often, the 
symptoms observed in diseased birds are a result of infection 
with a combination of pathogens which are further complicated by 
environmental factors such as dust, ,ammonia and temperature. It 
is therefore difficult to state precisely the cause of the 
disease based solely on symptoms displayed by the birds. An 
accurate method of diagnosis is by nucleic acid detection using 
the polymerase chain reaction (PCR) (Saiki, Gelfand, Stoffel, 
Scharf, Higuchi, Horn, Mullis, and Ehrlich, 1988) or by isolation 
of the pathogen by conventional methods . These results should be 
used in conjunction with the symptomology and serological results 
(Metselaar and Simpson, 1982) . The diagnosis can be further 
substantiated by inoculation of the isolated pathogen into birds 
and reproduction of the symptoms followed by re-isolation of the 
pathogen (Picault et al . , 1987). However, it is sometimes 
difficult to reproduce the disease symptoms in the absence of 
adverse environmental factors and secondary pathogens (Shane, 
1993) . 
According to Jordan (1990), the diagnosis of TRT or SHS depends 
on the demonstration of the virus or by serological means. The 
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difficulty involved in the isolation of these viruses is well 
documented (Buys, 1990; Naylor and Jones, 1993; Wyeth et al., 
1987). According to Baxter-Jones (1992) it is more difficult to 
isolate the virus from chickens, than it is from turkeys. Many 
host systems have been used for the primary isolation and 
subsequent propagation of the virus. The most commonly used 
routes are the a/s, y/s, Vero cell and TOC routes (Buys et al., 
1989a,b; Cook and Ellis, 1990; Gough et al., 198Bb; Williams.et 
al., 1991a; Wyeth et al., 1986). 
Investigations in determining the most convenient ·and successful 
methods for the isolation of TRTV-like viruses from chickens are 
described in this Chapter. 
2.2. Materials and Methods 
2.2.1. Sample material 
Chickens displaying severe sinusitis with excessive sinus exudate 
and swollen heads, were selected for sampling. The birds were 
humanely euthanased with CO2 gas and the infraorbital sinuses 
exposed by cutting with a sterile No. 22 scalpel blade just below 
the eye. Using a sterile bacterial loop, the sinus was swabbed 
and the loop streaked onto a 90 mm blood agar plate. The plates 
were incubated in 5% CO2 at 37°C for 24 h. The sinus fluid and 
exudate were aseptically removed with a sterile 2 ml syringe 
fitted with a 15 gauge needle and ejected into sterile tryptose 
phosphate broth containing 10% glycerol and antibiotics. The 
sinuses were rinsed with this broth . 
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The sample was centrifuged at approximately 2000 g for 5 min in 
a Hereaus Hettich Universal II benchtop centrifuge to pellet the 
red blood cells and debris. The supernatant was aspirated and 
placed in a sterile Bijou bottle. A total of 37 separate samples 
were prepared in this way. 
2.2.2. Allantoic sac inoculation 
Ten Valo SPF eggs (Lohmann, Germany), incubated at 37°C for 10 
days in a Buckeye egg setter incubator, were candled by holding 
them to a bright light and the air space of the embryonated 
fertile eggs marked with a pencil. Infertile and dead embryonated 
eggs were discarded. 
Using a steel needle, a hole was punched into the shell of each 
of five of the candled embryonated eggs, approximately 2 rnrn above 
the base of the air space. Approximately 0.2 ml of the sample was 
inoculated, without filtration, using a 2 ml syringe fitted with 
a 26 gauge needle, into the a/s of the five 10-day-old 
embryonated eggs. The inoculation holes were sealed with molten 
Paraclean wax (Klinipath) and the eggs incubated at 37°C. 
The eggs were candled after 24 h. Embryos that died within 24 h 
of inoculation, were discarded as traumatics caused by the 
inoculation. The eggs were candled daily for 7 days. After 
incubation at 37°C for 7 days, the eggs were chilled at 4°C for 
2 h. The allantoic fluid was harvested with a sterile disposable 
plastic Pasteur pipette into a sterile 25 ml McCartney bottle and 
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centrifuged at approximately 2000 g for 5 min in a Hereaus 
Hettich Universal II centrifuge. The supernatant was transferred 
to another sterile McCartney bottle. 
The allantoic fluid was checked for haemagglutinating (HA) 
activity (refer to Chapter 3) and further work was done only on 
samples found to be HA negative. The HA activity of the positive 
samples was neutralised with Newcastle disease.virus specific 
antisera. Samples causing stunting, curling or clubbing of the 
embryo were tested for the presence of Infectious Bronchitis 
virus (IBV) by the serum neutralisation (SN) test (see Chapter 
3). Further passaging of IBV positive samples was terminated. 
Approximately 0.2 ml of the HA and IBV negative allantoic fluid 
was re-inoculated into the a/s of each of five 10-day-old 
embryonated SPF eggs. This was repeated for 10 passages per 
sample. 
2.2.3. Yolk sac inoculation 
Six-day-old embryonated SPF eggs were candled and the centre of 
the air space of each of five fertile eggs was marked. 
Approximately 0.2 ml of the 1st a/s material was inoculated into 
the y/s of the five eggs using a 2 ml syringe fitted with a 21 
gauge needle. The inoculation holes were sealed with Paraclean 
wax and the eggs incubated at 37°C for 24 h. The eggs were 
candled the following day and all dead embryos discarded. The 
remainder of the eggs were incubated at 37°C for 10 days or until 
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embryo mortality occurred. Embryos found dead when candling, were 
immediately chilled at 4°C for 2 h. The remainder of the embryos 
were terminated at 10 days post-inoculation by chilling at 4°C 
for 2 h. The 1st y/s passaged material from the dead and live 
embryos, were harvested as described earlier for the a/s 
material, and re-inoculated into the y/s. This was repeated until 
a consistent pattern of embryo mortality was achieved. In cases 
where the virus was unable to cause any consistent pathology~in 
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the embryo after 30 y/s passages, the egg passaging was 
terminated. 
2.2.4. Chorio-allantoic membrane inoculation 
Ten 12-day-old embryonated SPF eggs were candled for viability 
and a mark made on the side of each egg in an area free of blood 
vessels, approximately 1.5 cm below the air space. A hole was 
punched with a needle at this mark without piercing the shell 
membrane. Another hole was punched at the top of the air space 
and the egg placed horizontally in an egg tray with the first 
hole facing up. With the egg in the horizontal position, a rubber 
bulb was used to draw out the air from the air space. The 
negative pressure created, caused an artificial air space to form 
over the first hole. 
Using a 2 ml syringe fitted with a 26 gauge needle, 0.2 ml of the 
3rd y/s material of isolates causing pathology of the y/s-
inoculated embryos (isolates 4916/91, 652/93 and 711/93), were 
inoculated onto the chorio-allantoic membrane (CAM) at the 
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artificial air space. Both the holes were sealed with molten 
Paraclean wax and the embryos incubated at 37°C for 24 h, after 
which they were candled for traumatics. The traumatics were 
discarded and the remaining eggs re-incubated for 7 days. The 
eggs were candled daily and all dead embryos were chilled for 2 
h before harvesting of allantoic fluid (A/F) and CAM's. Embryos 
still alive on day 7 pi, were also chilled for 2 hrs and the A/F 
and CAM's harvested. 
The CAM's and A/F from the dead and live embryos, were pooled and 
homogenised in a Waring blendor . The resulting homogenate was 
centrifuged (2000 g for 5 min). The supernatant was retained and 
filtered through a 0.22~ Sterivex-GS filter unit (Millipore) and 
then re-inoculated onto the CAM's of a further 10 12-day-old SPF 
eggs. This procedure was repeated for 10 passages. 
2.2.5. Growth in chicken embryo fibroblast cell (CEF) monolayers 
The embryos were removed from five 10-day-old SPF eggs and placed 
in a sterile Petri dish. The head and limbs were cut off and the 
embryos homogenised by passing through a 5 ml syringe into a 
sterile beaker. The homogenate was washed three times with Hanks 
balanced salts solution (HBSS) (Flow Laboratories) to remove red 
blood cells. 
Approximately 30 ml of a 0.25* solution of trypsin (Highveld 
Biologicals) was added to the homogenate and the embryonic tissue 
was disrupted into single cells by magnetic stirring at 37°C for 
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15 min. The action of the trypsin was stopped by the addition of 
2 ml bovine foetal calf serum (FCS) (Sterilab). 
The trypsinised tissue was centrifuged at 1000 g for 15 min in 
a Hereaus Hettich Universal II centrifuge. The pelleted cells 
were resuspended in 5-10 ml of growth medium consisting of 
Eagles minimum essential medium (MEM) (Hi ghveld Biologicals) with 
10% FCS. The number of cells were counted in a haemocytometer and 
diluted to achieve a minimum concentration of 2 X 105 ml-1 • The 
cell suspension was dispensed in 5 ml aliquots to 50 cm3 tissue 
culture flasks (Greiner Labortechnik) and incubated at 37°C for 
24 h, by which time a confluent monolayer of cells, viewed with 
a Leitz Diavert inverted microscope, was obtained. 
The 3rd a/s or 4th y/s passaged material of the 37 samples were 
separately inoculated onto confluent monolayers. One monolayer 
to be used as a control, was inoculated with healthy allantoic 
fluid. Inoculation was performed by first washing the monolayer 
three times with HBSS and then introducing 1 ml of inoculum into 
the flask. Inoculation contact time was 1 h. The inoculum was 
discarded and the monolayer washed three times with HBSS. After 
the final wash, maintenance medium consisting of Eagles MEM 
without FCS was added to the flasks and the flasks incubated at 
37°C for a maximum of 14 days. If no CPE was observed, the flasks 
were freeze-thawed once and the cell suspension centrifuged at 
1000 g for 5 min in a Hereaus Hettich Universal II centrifuge. 
The supernatant was then inoculated onto a new monolayer. This 
procedure was repeated for a minimum of five passages per sample. 
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A slight variation of the method of Williams et al. (1991a) was 
employed in an attempt to adapt the virus, if any, for growth in 
CEF's. This was achieved by separately inoculating a monolayer 
with the sample, and trypsinising the monolayer 3 days later. 
Trypsinisation was performed by first discarding the MEM above 
the monolayer and then washing the monolayer three times with 
HBSS. The monolayer was washed with 0.25% trypsin and allowed to 
stand in contact with 5 ml of the trypsin solution for 60 sec. , 
The trypsin was decanted and the monolayer allowed to stand for 
90 sec. After 90 secs, the cells began disassociating from each 
other. The flask was then gently tapped to release all the cells 
and the trypsin action was stopped with the addition of 10 ml of 
growth medium. After incubation at 37°C for 24 h, the growth 
medium was replaced by maintenance medium. The trypsinisation 
procedure was repeated for a minimum of seven passages. 
Monolayers inoculated with allantoic fluid from healthy non-virus 
inoculated 12-day-old embryonated SPF eggs, were trypsinised as 
described above and used as controls . 
2.2.6. Growth in chicken embryo kidney cell (CEK) monolayers 
Chicken embryo kidney cell monolayers were prepared as for CEF' s, 
using 19-21 day-old SPF embryos or day-old SPF chicks. The 
kidneys were removed from the embryos or chicks and processed as 
for CEF's. Confluency of the monolayers was achieved after 48 
hrs, at which time they were separately inoculated as described 
for CEF monolayers, with the 4th y/s passaged allantoic fluid of 
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the samples. A minimum of three passages in CEK monolayers were 
performed for each sample. Controls consisted of CEK monolayers 
inoculated- with healthy allantoic fluid. 
2.2.7. Growth in Vero cell monolayers 
Vero cells from three different sources were used. Cells were 
obtained from King Edward VIII Hospital (KEH). Onderstepo0rt 
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Veterinary Laboratory (OP), and strain E6 from Highveld 
Biologicals. 
Upon receipt of the cells, the monolayer of cells was washed 
three times with 1M phosphate buffered saline (1M PBS pH 7.2). 
The monolayer was trypsinised by the addition of 5 ml of a 1:1 
mixture of 0.25% trypsin and 0.1 mM EDTA (Highveld Biologicals) . 
The solution was left in contact with the monolayer for 90 secs 
and poured off leaving approximately 0.5 ml on the monolayer. The 
flask with the monolayer was allowed to stand at room temperature 
for approximately 3 min during which time the cells detached from 
the flask. The detached single cells from each flask were 
resuspended in approximately 30 ml of growth medium and aliquots 
of 5 ml dispensed into each of six new 50 cm3 tissue culture 
flasks (Greiner Labortechnik) . 
A confluent monolayer, viewed with a Leitz Diavert inverted 
microscope, developed within 24-48 h. The confluent monolayer was 
maintained with MEM containing no serum. The cell line was 
propagated by trypsinisation of uninoculated monolayers after 
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every 3 -4 days. Confluent monolayers were separately inoculated 
with 3rd y/s passaged allantoic fluid of each sample. A control 
was maintained for each passage by inoculating a monolayer with 
healthy allantoic fluid. Five passages, each lasting 5 days, were 
performed with the sample and control materials. 
The modification of the method of Williams et al. (1991a), used 
to adapt the isolates to CEF's, was also used to qttempt to adapt 
the virus, if any, to Vero cell monolayers. Monolayers were 
separately inoculated with the 3rd y/s material of each sample 
and trypsinised 4 days later. This trypsinisation procedure was 
repeated for a minimum of seven passages, after which normal 
passaging was resumed. The above procedures were used for each 
of the three sources of Vero cells. 
2.2.8. Growth in tracheal organ culture 
Three 19-21 day old SPF chicken embryos were euthanased by 
cervical dislocation and the trachea aseptically removed and 
placed in a Petri dish containing HBSS. Sterile Whatman No. 1 
filter paper was placed on the lid of another Petri dish. The 
trachea was then transferred to this filter paper and 
transversely cut into approximately 1 mm thick rings using a No. 
22 scalpel blade. The tracheal rings were placed into another 
Petri dish containing HBSS. The rings were individually placed 
in sterile 15 ml tissue culture tubes (Greiner Labortechnik) 
containing 1 ml of MEM. 
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The tubes containing the tracheal rings were inserted into a 
roller drum in a 37°C incubator and allowed to rotate at 
approximately 1 rpm for 24 h. The rings were checked for cilial 
activity using a Zeiss Axioskop light microscope. Rings with good 
cilial activity were chosen for inoculation with the 4th y/s 
material of all -37 samples from which virus isolations were 
attempted. Two TOC rings were used for each sample. Two TOC's, 
for use as controls, were inoculated with healthy allantG>ic 
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fluid. Inoculation was performed by first decanting the MEM from 
the tube containing the TOC and replacing it with 0.5 ml of the 
inoculum. After incubation for 1 h, the inoculum was discarded 
and replaced with 1 ml of MEM. 
The rings were scored daily for loss of cilial activity, by 
viewing with a Zeiss Axioskop light microscope. A scoring system 
based on that of Cook, Darbyshire, and Peters (1976) was used. 
A score of 3 indicated a perfectly normal ring with all cilia 
beating whilst slight ciliostasis (10-40%) was recorded as a 
score of 2. A score of 1 indicated 50-80% ciliostasis and a score 
of 0 was reflective of 90-100% ciliostasis. A passage was 
terminated upon ciliostasis or when the combined score of the two 
controls deteriorated to a score of 2. A minimum of three blind 
passages were performed for each isolate before they were 
discarded as negative. 
2.2.9. Titration of the virus 
The titres of the three isolates that were made, were determined 
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in each of the growth systems, except the a/s, by diluting the 
virus in decimal dilutions from 10-2 to 10-6 in nutrient broth for 
eggs, and MEM for monolayers and TOC's, and inoculating the 
standard volume of each dilution via their respective routes 
(eggs, monolayers, and TOC's). Five units of each growth system 
were used per dilution. The infective dose 50% (ID~) of the virus 
in each system was calculated according to a modification of the 
Spearman-Karber method (Villegas and Purchase, .1989) depicted 
below: 
ID~ = 10 L + L1(sum of mortality or pathology - 0.5) /Xml 
L = highest dilution with mortality or pathology 
Ll = difference in consecutive dilutions 
x = volume of inoculum used per egg or monolayer 
2.3. Results 
2.3_1_ Sample material 
Four novel Haemophilis paragallinarium isolates as described by 
Horner, Bishop and Haw (1992), and identified by Dr R Bragg 
(Onderstepoort Veterinary Laboratory) and Mr M.K Govender 
(Rainbow Farms, Pty Ltd), were made from four of the 37 samples. 
E. coli, identified by Mr M_K Govender, was isolated from the 
remaining 33 samples. 
2_3_2. Allantoic sac inoculation 
Seven samples caused severely congested embryos in the 1st a/s 
passage and the HA and SN tests on these samples confirmed the 
presence of Newcastle disease virus (NOV). Three samples caused 
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stunted, curled and clubbed embryos in the 1st a/ s passage. Serum 
neutralisation (SN) tests on these isolates identified the 
isolates as the Massachusetts strain of IBV. All other samples 
caused no embryo mortality or pathology in all 10 a/s passages. 
2.3.3. Yolk sac passage 
There was no embryo mortality or pathology in the ,1st and 2nd y/s 
passages, but in the 3rd passage, 50% of the embryos of three 
samples (sample 4916/91, 652/93 and 711/93) showed pathological 
changes at day 8 pi. Pathology consisted of pale and stunted 
embryos. The liver, kidneys and other internal organs appeared 
normal. By the 4th passage, there was 100% pathology and 80% 
mortality at day 8 pi . At this stage, the dead embryos were 
severely congested (Plate 2.1). There was 100% mortality by day 
6 pi in all subsequent passages of these samples. All other 
samples processed failed to cause any pathology or mortality of 
the embryos. 
2.3.4. Chorio-allantoic sac inoculation 
The 3rd y/s material of sample 4916/91, 652/93 and 711/93 
inoculated onto the CAM, caused 80% embryo mortality by day 6 pi. 
Th~ affected embryos were congested and stunted. Embryos that 
were still alive at this point, were pale and stunted. All the 
internal organs appeared normal . 
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Plate 2.1. Normal (right) and TRTV-like virus-affected 
embryo . Affected embryo appears stunted and 
haemorrhagic . 
2.3.5. Growth in CEF monolayers 
Monolayers inoculated with the 3rd a/s and 4th y/s passaged 
material of all samples, failed to develop any CPE even after 
five passages in this system. However, when monolayers inoculated 
with the 3rd a/s or 4th y/s materials were trypsinised for five 
consecutive passages, a CPE developed on day 2 pi in the 5th 
passage of three samples, samples 4916/91, 652/93 ,and 711/93. The 
f 
CPE, of all three samples, was characterised by the development 
of large syncytia (Plate 2.2). The control monolayer in each 
passage was normal with no CPE. 
2.3.6. Growth in CEK monolayers 
Only three samples, sample 4916/91, 652/93 and 711/93, caused CPE 
in CEK monolayers. In all cases, the CPE occurred in the third 
passage on day 4 pi and was characterised by the presence of a 
few loose cells floating in the medium above the monolayer. The 
number of loose cells did not increase substantially after day 
4 pi or in subsequent passages. There was no evidence of CPE in 
any of the control monolayers. 
2.3.7. Growth in Vero cell monolayers 
There was no detectable CPE in any of the three sources of Vero 
cells after five routine passages. However, after trypsinisation 
of the · monolayers, CPE consisting of large syncytia and 




Typical large syncytia (8) formation in a 
CEF monolayer infected with TRTV-like virus. 
The formation of large syncytia (8) and 
polykaryocytes (P) in a Vero cell monolayer. 
Numerous nuclei (N) occur wi thin a giant 
cell. 
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652/93 and 711/93, on day 2 pi in the 4th passage of the OP and 
E6 strains of Vero cells. No CPE developed, even after 7 
passages, in the KEH Vero cells. 
Once CPE developed, only a further two passages were necessary 
to sufficiently adapt the virus to the cells to enable them to 
cause CPE without further trypsinisation. 
2.3.8. Growth in tracheal organ culture 
Ciliostasis only occurred after the second passage and with only 
three samples; sample 4916/91, 652/93 and 711/93. All other 
samples failed to cause ciliostasis after three blind passages 
and were discarded. Isolate 4916/91 caused 20% ciliostasis (score 
of 2) by day 7 pi during the 2nd passage which increased to 40% 
(score = 1-2) by day 5 pi during the 3rd passage and 70% (score 
= 1) by day 5 in subsequent passages. The amount of ciliostasis 
with this isolate did not increase beyond 70%, even after 15 TOC 
passages. 
Isolate 652/93 caused 50% ciliostasis by day 7 pi in the 2nd TOC 
passage and 100% ciliostasis (score = 0) by day 5 pi in 
subsequent passages. 
Ciliostasis (50%) caused by isolate 711/93 only became evident 
by day 7 pi during the 3rd passage. Subsequent passages caused 
only 70-80% ciliostasis observable by day 5 pi. The degree of 
ciliostasis did not increase beyond 70-80% even after 10 TOC 
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passages. 
2.3.9. Titration of the virus 
The results of the titrations of the three isolates in each 





















Titration results of TRTV-like isqlate 4916/91*in 
various growth systems 




2 10-3 10-4 10-5 10~ 
5/5 5/5 2/5 0/5 0/5 104.6 
5/5 3/5 0/5 0/5 0/5 103.8 
5/5 5/5 0/5 0/5 0/5 104.2 
5/5 0/5 0/5 0/5 0/5 103.2 
5/5 5/5 2/5 0/5 0/5 104.6 
5/5 4/5 0/5 0/5 0/5 103.6 
Titration results of TRTV-like isolate 652/93 in 
various growth systems 
AFFECTED/TOTAL PER DILUTION IDso/ml 
10-2 10-3 10-4 10-5 10~ 
5/5 5/5 5/5 5/5 3/5 106.8 
5/5 5/5 5/5 1/5 0/5 105.4 
5/5 5/5 5/5 5/5 0/5 106.2 
5/5 5/5 5/5 0/5 0/5 105.2 
5/5 5/5 5/5 5/5 0/5 106.2 
5/5 5/5 5/5 0/5 0/5 105.2 
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Table 2.3. Titration results of TRTV-like isolate 711/93 in 




AFFECTED/TOTAL PER DILUTION 
I 
IDso/ml 
I 10-2 10-3 10-4 10-5 10-6 
y/s 5/5 5/5 0/5 0/5 0/5 104.2 
CAM 5/5 3/5 0/5 0/5 0/5 103.8 
CEF 5/5 5/5 3/5 0/5 0/5 104.8 
CEK 5/5 0/5 0/5 0/5 0/5 103.2 
Vero 5/5 5/5 5/5 2/5 0/5 . 105.6 * 
TOC 5/5 3/5 0/5 0/5 0/5 103.8 
2.4. Discussion 
The results demonstrate the difficulty associated with the 
isolation of an avian Pneumovirus from chickens. From a total of 
37 samples processed, only three yielded a Pneumovirus. This 
could be due to several factors, the most important of which 
could be that the sampling may have been done at an advanced 
stage of the disease when the amount of virus in the bird had 
diminished to very low levels. Other researchers have reported 
that the time of sampling is critical for successful Pneumovirus 
isolation (Buys, 1990; Wyeth et al., 1987) . When symptoms in the 
birds are pronounced, it may be very difficult to isolate virus 
(Cook et al., 1991). It may also be difficult to determine the 
correct time for sampling because in many cases, initial 
infection produces few, if any, clinical signs unless secondary 
factors exacerbate the disease (Naylor and Jones, 1993). 
Another factor that may affect the isolation rate, is the 
presence of other pathogens that overgrow the initially poor 
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growing Pneumovirus. It is possible that the NDV positive and IBV 
positive samples could have contained the TRTV-like virus but was 
not detected because it was masked by the more prolific growing 
viruses. Also, the symptoms associated with SHS could have been 
caused by these pathogens in association with adver.se 
environmental factors and innnunosuppressi ve agents. Seven NDV and 
three IBV isolates were made from the 37 samples processed. Also, 
a novel H. paragallinarum, which appears to be callable of causing ,. 
SHS type symptoms in birds, was isolated from four samples. E. 
coli, isolated from most samples, appears to be a secondary 
pathogen introduced after injury by the bird scratching its head 
due to the head swelling and irritation caused by viral 
pathogens. 
The sample material was initially inoculated via the a/s of SPF 
eggs and not directly into the y/s. This was to reduce the risk 
of bacterial contamination. The y/s is rich in nutrients thereby 
facilitating the proliferation of many bacteria. The samples were 
not filtered through a o. 22JL filter since this would have further 
reduced the low level of virus present in the sample. It was 
therefore necessary to inoculate the sample into a system that 
would survive low levels of bacterial contamination. 
Although there was no embryo pathology when isolates 4916/91, 
652/93 and 711/93 were inoculated via the a/s route, the virus 
grew in this system. This was evident when the 1st a/s material 
and the 3rd a/s material were inoculated into the y/s and CEF 
respectively. Both materials caused pathology in these systems, 
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although the 3rd a/s material had to be first adapted to CEF's. 
The three isolates grew well in the y/s, producing a titre of 
104.6/ml for is·olate 4916/91, 106.8/ml for 652/93 and 104.2/ml for 
711/93. Isolate 652/93 was the most prolific growing of the three 
isolates, producing the highest titres in all growth systems. 
There appear to be differences between isolate 652/93 and the 
other two isolates as shown by their varying abilities to grow 
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in various growth systems. It is therefore likely that several 
strains of the virus exist and isolate 652/93 could represent one 
strain whilst isolates 4916/91 and 711/93 could represent another 
strain. Cook et al. (1993) reported differences between the UK 
isolates and those from other countries, but the South African 
isolates were closely related to the UK isolates. 
Although some researchers found that TRTV grew to high titres 
when chicken TOC's were used (Cook and Ellis, 1990), this study 
showed that the titre of the three isolates in this system was 
dependent upon the strain of the virus. Isolate 4916/91 and 
711/93, which have similar characteristics, grew poorly in TOC' s, 
but isolate 652/93 grew to a high titre in this system. However, 
despite the better growth of isolate 652/93 compared to isolates 
4916/91 and 711/93, the titre in TOC's was among the lowest. It 
appears that these strains of avian Pneumovirus differ from those 
of other countries which grow to very high titres in TOC's. There 
may be a geographical difference in strains of the virus, which 
is consistent with the findings of Cook and Ellis (1990). 
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The type of pathology caused by the three isolates in all the 
growth systems, is consistent with that of other .workers (Gough 
et al., 1988b; Naylor and Jones, 1993; Picault et al., 1Q87). The 
level of CPE produced in CEK monolayers could not be increased 
in subsequent passages. However, unlike CEF and Vero cell 
monolayers, the isolates produced pathology in the CEK cell 
monolayer without trypsin treatment . It appears that the isolates 
require less adaptation for chicken epithelial Qells, than for 
" 
chicken fibroblast cells or cells of mammalian origin. It was not 
possible to trypsinise the CEK monolayers because the CEK cells 
in a monolayer cannot withstand the harsh trypsin treatment. 
According to Dr Jane Cook (Intervet UK, 1994 pers. comm.), 
several researchers have found that TRTV could be adapted to grow 
in various cell lines sometimes with trypsin treatment and 
sometimes without. It is possible that the trypsin cleaves 
surface glycoproteins that are necessary for infection, thereby 
facilitating infection, as is the case with NOV (Beard and 
Hanson, 1984) . 
Despite the ease of adaptation of the isolates to CEK monolayers 
compared to CEF and Vero cell monolayers, the isolates, when 
finally adapted for growth in CEF and Vero cells, grew to higher 
titres than in the CEK monolayers. Of all the cell culture 
systems employed, the isolates grew best in the CEF and Vero cell 
monolayers. However, it is preferable to use Vero cell monolayers 
since it is easier to generate them for inoculation than it is 
for any of the avian cell types . 
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The results suggest that the best route for the isolation of 
avian Pneumoviruses is the y/s route. Subsequent propagation can 
be performed via the y/s, CEF and Vero cell routes. 
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CHAPTER 3 
PHYSICAL AND CHEMICAL CHARACTERISATION OF THREE TRTV-LIKE 
ISOLATES 
3.1. Introduction 
There are several direct and indirect methods fo~ the diagnosis 
." 
of virus disease. The direct methods use the clinical specimen 
directly to detect the presence of virus or to demonstrate 
specific changes caused by the virus. However, it is essential 
that the results of the direct methods be confirmed by the 
indirect methods since there may be false positives and negatives 
and the identity of the virus may not be established (Versteeg, 
1985) . 
Most methods are based on the fact that many viruses cause 
characteristic changes in the cells of the inoculated or infected 
host. These cause the production of infectious virus particles 
in host cells, secretions and excretions. The host usually 
responds to the infection by the production of antibodies 
specific for the virus (Hawkes, 1979) . 
The present criteria for the classification of animal viruses are 
based on the physical and chemical characteristics of the virus. 
After the initial isolation and subsequent propagation of the 
virus, it is essential to determine the type of virus isolated . 
Since there are seven families of deoxyribonucleic acid (DNA) 
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containing animal viruses and 16 families of ribonucleic acid 
(RNA) containing animal viruses, it is important to determine to 
which of the two groups the virus belongs (Lukert, 1989). Other 
tests to determine whether the virus possesses an envelope, its 
susceptibility to adversely high temperatures and its ability to 
agglutinate red blood cells (RBC's), are also important 
characteristics for classification. 
Microscopic examination of stained cell cultures for inclusion 
bodies and other pathological changes, is a rapid method of 
obtaining an indication of the group of virus involved. Serology 
is also of importance, especially in retrospectively defining the 
incidence of disease with the virus isolate obtained. One could 
also inoculate the purified virus into SPF animals and monitor 
the animal serologically for substantial increases in antibody 
titres. This would provide circumstantial evidence as to the 
identity of the virus (Hawkes, 1979). Serological assays cormnonly 
used, include enzyme linked irmnunosorbent assays (ELISA), serum 
neutralisation (SN) , haemagglutination (HA) and haemagglutination 
inhibition (HI). 
Characterisation of chicken TRTV-like isolates 4916/91, 652/93 
and 711/93 using some of the above techniques, were attempted, 
and the results are presented here. Relatively new technological 
advances for viral diagnosis based on molecular biology, will be 
discussed in other Chapters. 
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3.2. Materials and Methods 
3.2.1. Haemagglutination 
All eggs inoculated with samples 4916/91, 652/93 and 711/93, were 
tested for haemagglutinating activity (HA) at the end of each 
passage using the method described by Villegas (1987). 
The test was performed by removing a small volu~e of clarified 
• 
allantoic fluid with a sterile disposable Pasteur pipette and 
placing approximately two drops on a white tile. An equal volume 
of a 10% suspension of REC's, collected from the brachial wing 
vein of SPF chickens into Alsever's solution (Appendix, recipe 
1) and washed three times with phosphate buffered saline (PBS pH 
7.0), was added to the allantoic fluid. The plate was gently 
swirled by hand for 1 min to mix the allantoic fluid and RBC's. 
A positive control consisting of NDV-containing allantoic fluid 
and a negative control consisting of healthy uninoculated SPF 
allantoic fluid, were used for each set of HA tests. A positive 
HA test was identified by the agglutination of RBC's which appear 
"sandy" . 
3.2.2. Heat stability 
The 4th y/s A/F of the three isolates, 4916/91, 652/93 and 
711/93, were serially diluted in ten fold dilutions from 10-3 to 
10-7 and separately inoculated into the y/s of 6-day-old SPF 
eggs. The A/F from the lowest dilution with pathological changes 
were harvested, diluted to 10-3 , and re-inoculated into the y/s 
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of SPF eggs. This purified 6th y/s A/F was used in further tests 
and as seed material for vaccine production. 
Approximately 1.5 ml of the 6th y/s allantoic fluid of each of 
the three isolates, 4916/91, 652/93 and 711/93, was placed into 
two separate 2 rnl thin-walled glass screw-top vials and one vial 
of each placed ina water bath at a temperature of 56°C for 1 h. 
The remaining vials were kept at 4°C until requi~ed. After 1 hr, 
the heat treated vials were immediately transferred to a beaker 
containing ice. Serial ten- fold dilutions of the heat treated and 
non-heat treated samples were made in nutrient broth and the 10-1 
to 10-4 dilutions of the heat treated samples and the 10-3 to 10-6 
dilutions of the control samples were inoculated into the y/s of 
6-day-old SPF eggs . Five eggs were used for each dilution. The 
eggs were incubated at 37°C for seven days or until mortality of 
the embryos. 
After seven days, the eggs were opened, examined for pathological 
effects and the titre of the heat treated and non-heat treated 
samples determined as described earlier. A heat labile and a heat 
resistant control sample comprising the H120 IB vaccine virus 
(IBV) (TAD Pharmazeutisches) and a chicken embryo lethal orphan 
(CELO) virus (Rainbow Farms Laboratory) respectively, were 
included in the test and treated identically to the test samples. 
The titres of the purified 6th y/s allantoic fluids of isolates 
4916/91, 652/93 and 711/93, freshly harvested, at 4°C for 24 and 
72 h, at -20°C for 3 and 28 days, and at -7QoC and in liquid 
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nitrogen for 6 months, were determined by exposure of the 
isolates to these temperatures for the stipulated time. The 
samples were inoculated into eggs as described earlier, and the 
titres calculated. 
3.2.3. Chloroform sensitivity 
The protocol for this test was similar to tl1p.t of Villegas 
(1987) . 
Two milliliters of the 6th y/s allantoic fluid of isolates 
4916/91, 652/93 and 711/93 were separately aliquoted into two 
sterile Bijou bottles each and 0.2 ml of chloroform added to one 
set of the duplicates . The untreated samples were kept at 4°C 
until required. The chloroform treated samples were vortexed for 
10 min, with the bottles kept in an ice bath between mixes. The 
treated samples were centrifuged at approximately 1500 g for 30 
min in a Hereaus Hettich Universal II centrifuge. Without 
disturbing the precipitate, the upper clear layer was transferred 
into a sterile Bijou bottle with a sterile Pasteur pipette. The 
bottle was left opened in a laminar flow hood for 10 min to allow 
traces of chloroform to evaporate . Serial 10-1 and 10-2 dilutions 
of the treated and untreated samples were made in nutrient broth 
and separately inoculated into the y/s of SPF eggs as described 
earlier. A chloroform-sensitive and a resistant control sample, 
comprising the TAD H120 IBV and CELO virus respectively, were used 
as controls and treated identically to the test samples. 
54 
3.2.4. Nucleic acid determination 
Nucleic acid determination was performed according to the method 
described by Lukert (1989) and Villegas (1987). Preformed CEF 
monolayers in 50 cm3 tissue culture flasks (Greiner Labortechnik) 
were separately inoculated with the 6th y/s A/F of isolates 
4916/91, 652/93 and 711/93. After adaptation qf the isolates to 
CEF cells, CEF monolayers were separately inoculated with the ith ,. 
CEF passage of each isolate at dilutions of 10-3 to 10-6 and also 
with reference strains of the CELO virus and with the 10-6 to 10-9 
dilutions of the Hitchner strain of NDV (TAD 
Pharmazeutisches). After an incubation time of 45 min at 37°C, 
the inoculum was discarded and maintenance medium containing 
50p.g/ml of 5-iodo-2'-deoxyuridine (IDU) (Sigma Chemicals) was 
added. These virus samples were also inoculated onto CEF's using 
regular maintenance medium without IDU. Five replicates per 
dilution were used for each sample . 
The titre of each isolate, in the presence and absence of IDU, 
was calculated according to the modified method of Spearman-
Karber (Villegas and Purchase, 1989). 
3 . 2.5. Serum neutralisation 
Antisera to TRTV, 4916/91, 652/93, 711/93 and IBV were produced 
in approximately 6-week-old SPF white leghorn chickens by 
separately inoculating each of five birds with 0.5 ml of TRTV 
(Pittman-Moore vaccine virus), the 6th y/s A/F of each of the 
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three isolates, and with IBV vaccine virus (TAD Pharmazeutisches) 
respectively, directly into the infraorbital sinus. The birds 
were bled pre-inoculation and two weeks post-inoculation via the 
brachial wing vein. If the ELISA antibody titre againstTRTV for 
the TRTV, 4916/91, 652/93, and 711/93 isolate inoculated birds, 
and IBV for the IBV inoculated birds, shifted from a negative 
value pre-inoculation to a highly positive value (~ ELISA kit 
positive control) 4 wks post-inoculation, tpe birds w~re 
sacrificed and the serum collected from the blood. 
The sera were clarified by centrifugation at 2000 g in a Hearaeus 
Hettich Universal II centrifuge and heated at 56°C for 1 h. The 
inactivated sera were filtered through a 0.22~ Sterivex filter 
(Millipore) . These sera were tested by D.N Bhoora (Rainbow Farms 
Laboratory), using haemagglutination inhibition for antibodies 
to NDV, by ELISA for antibodies to IBV, reovirus, infectious 
bursal disease virus (IBDV) (Delta Bioproducts) , TRTV 
(Pathasure), and by the rapid serum plate agglutination test 
(RSPA) for antibodies to Mycoplasma gallisepticum (MG) and 
Mycoplasma synovia (MS). The serum was only used for the serum 
neutralisation test when found to be monospecific for TRTV . 
The alpha neutralisation procedure was used (Beard, 1989). This 
procedure involved the use of serial dilutions of virus mixed 
with a standard dilution of serum. The TRTV monospecific serum 
was diluted 1:10 in nutrient broth . The 6th y/s A/F of the three 
isolates were separately used as antigen for the neutralisation 
tests . Serial dilutions of the ant i gens (10-1 to 10-7 ) were made in 
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nutrient broth and 0.7 ml of the 10-4 to 10-7 dilutions separately 
placed into sterile vials containing 0.7 ml nutrient broth. To 
another set of four vials was separately added 0.7 ml of the 10-2 
to 10-s dilution of antigen and 0.7 ml of the diluted TRTV serum. 
These viruses and virus-serum complexes were allowed to react at 
room temperature for approximately 45 min and 0.2 ml inoculated 
into each of five SPF eggs per dilution. A negative anci a 
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positive control, comprising the TAD Hl20 IBV and the Pittman-
Moore TRT vaccine virus respectively, were included in the test 
and treated as described above. The eggs were opened 7 days post-
inoculation and mortality and pathology recorded. The titre of 
the viruses and their neutralisation indices were calculated. The 
indices were calculated by subtracting the titre of the serum-
virus complex from the titre of the respective virus. 
A cross-neutralisation test was also performed using the Pittman-
Moore TRT vaccine virus and the monospecific anti.sera of the 
three isolates. The test was performed as described above. 
3.2.6. Enzyme linked immunosorbent assay 
Approximately 0.5 ml of the 6th y/s A/F of each of the three 
isolates, 4916/91, 652/93 and 711/93, were separately inoculated 
intra-sinusly into each of three white leghorn SPF chickens 
housed in isolators. Positive and negative controls consisted of 
SPF birds inoculated with the Pittman-Moore TRT vaccine virus and 
the TAD H120 IBV respectively. 
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The birds were bled before inoculation and 14 days post-
inoculation from the brachial wing vein. The serum was collected 
from the blood and analysed by ELISA, using the avian 
rhinotracheitis ELISA kit (Pathasure) . The method was performed 
according to the kit specifications described below. 
Using a Beckman Accu-Prep 221 system, 50 ~l of the kit positive 
and negative control sera wer~. separately pipetted into two wells ,. 
each of the 96 well TRTV-coated microwell assay plate. The test 
serum samples were first diluted in a sterile microwell plate by 
pipetting 5 ~l of each serum sample into a well (three serum 
samples per isolate), using a clean pipette tip for each sample, 
and then adding 200 ~l of the kit sample diluent into each of 
these wells. The contents of each well were mixed by aspirating 
and discharging several times with a 50 ~l 8-channel Titertek 
pipette. After the pre-dilution, 50 ~l of the test samples were 
transferred with the 8-channel Titertek pipette into the TRTV-
coated ELISA plate wells . The plate was covered with a clean lid 
and allowed to incubate for 30 min at room temperature. 
After the incubation, the contents of the plate were discarded 
and the plate blotted with absorbent paper towel . The wells were 
washed five times with distilled water using an EL403H microplate 
Autowasher (Bio Tek Instruments) . After the final wash, the plate 
was blotted onto paper towel and 50 ~l of conjugate reagent added 
to each well. The plate was covered with a lid and allowed to 
incubate for 30 min at room temperature . The contents were 
discarded and the plate blotted wi th paper towel. The wells were 
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washed five times and blotted as described earlier. After this 
step, 100 ~l of the kit substrate reagent was quickly added to 
each well and the plate covered and allowed to incubate for 10 
min at room temperature. 
After the 10 min incubation, 100 ·~l of the kit stopping reagent 
was added to each well with an 8-channel Titertek micropipette. 
The contents of the wells were then agitated with the aid of a 
micro-orbital shaker (Bellco Biotechnology) . 
An EL308 microplate reader (Bio Tek Instruments), was blanked on 
air and the absorbance of each well measured at 450nm. The 
results were calculated by determining the sample (S) to mean 
positive control (P) ratio multiplied by 100 ie. sip X 100 
According to the kit specifications, the test was valid only if 
the mean positive to negative control ratio was above 6. Samples 
were deemed positive for TRTV antibodies if the Sip ratio X 100 
was greater than 30. Samples with a figure less than 30 were 
diagnosed as negative for antibodies against TRTV . 
3.2.7 . Haematoxylin and eosin staining of monolayers 
The 4th Vero cell passage of each of the three isolates was 
serially diluted from 10-4 to 10-7 and separately inoculated onto 
preformed Vero cell monolayers . The lowest dilution with CPE 4 
days pi, was diluted to 10~ and re-inoculated onto Vero cell 
monolayers. This purified 6th Vero cell adapted passage of each 
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of the three isolates (4916/91, 652/93 and 711/93), was used for 
the inoculation of Vero cell monolayers for the haematoxylin and 
eosin staining test. The inoculated and uninoculated control 
monolayers were subsequently stained by the haematoxylin and 
eosin (H and E) staining method. Monolayers were grown on sterile 
coverslips placed in disposable 60mm tissue culture dishes 
(Greiner Labortechnik) . 
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The coverslips with the inoculated monolayers were stained two 
days after inoculation. The Hand E staining method used was 
similar to that of Villegas (1987). The coverslips were washed 
with PBS (pH 7.0) and the cells fixed with Bouins fixative for 
1 h. The coverslips were rinsed in 100% ethanol and transferred 
to 70% ethanol for 5 min, washed under slowly running tap water 
for 5 min and stained with Harris' haematoxylin containing 4% 
glacial acetic acid for 5-10 min. After haematoxylin staining, 
the coverslips were briefly washed under tap water and 
differentiated with two dips in acid alcohol (0 . 5% HCI in 70% 
alcohol). To stop differentiation, they were immediately washed 
under running tap water for 20 min. 
The coverslips were counter-stained with a water soluble eosin-
phloxine solution (1: 1) for 30 sec and the cells on the 
coverslips dehydrated by dipping once each in a graded alcohol 
series (70%, 96%, 100%) . The coverslips were placed in 100% 
alcohol for a further 30 sec and left in xylene until ready to 
fix onto a slide with DePeX mounting medium (BDH Chemicals). 
After Hand E staining, the monolayers were viewed with a Zeiss 
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All passages of the three isolates, isolates 4916/91, 652/93 and 
711/93, were found to be free of haemagglutinating activity.~ 
3.3.2. Heat stability 
All three isolates, as well as the Hl20 rBV, were completely 
inactivated by exposure to 56°C for 1h. However, the CELO virus 
ti tre was virtually unaltered by the heating. Table 3.1 shows the 
results obtained with the test and control samples. 
The titres of the isolates after exposure to various temperatures 
for varying periods of time, are shown in Table 3.2. There was 
no effect on the titres of the isolates after storage at -70°C 
and liquid nitrogen for 6 months. There was a drop in the titre 
of each isolate when stored at -20°C for 28 days but little 
effect on the titres when the isolates were stored at this 
temperature for 3 days. There was a slight drop in the titres of 
the isolates when stored at 4°C for 24 h, but the titres dropped 
more when stored at this temperature for 72 h, especially 
isolates 4916/91 and 652/93. 
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Table 3.1. Titres of the controls and three TRTV-like 
isolates exposed to 56°C for 1h. 
I SAMPLE I TREATMENT I TITRE (EIDso/rnl) I 
4916/91 control 104.6 
4916/91 56°C 1 h 0 
652/93 control 106.8 
652/93 56°C 1 h 0 
711/93 control 104.2 
'" 711/93 56°C 1h 0 
Hl20 IBV control 106.2 
Hl20 IBV 56°C 1h 0 
CELO virus control 106.6 
CELO virus 56°C 1h 106.2 
Table 3.2. Titre of TRTV-like isolates 4916/91, 652/93 and 
711/93 after various exposure times to different 
temperatures. 
TEMPERATURE TIME 4916/91· 652/93· 711/93· 
4°C 24 h 104.2 106.6 104.0 
4°C 72 h 102.6 104.8 103.8 
-20°C 3 days 104.4 106.6 104.2 
-20°C 28 days 103.8 105.6 103.6 
-70°C 6 months 104.6 106.8 104.2 
Liq. N2 6 months 104.6 106.8 104.2 
control fresh 104.6 106.8 104.2 
• EID50/ml of respective isolate 
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3.3.3. Chloroform sensitivity 
The chloroform treated samples of all three isolates failed to 
cause any infection when the 10-1 and 10-2 dilutions were 
inoculated into .SPF eggs. However, there was 100% mortality when 
the 10-1 and 10-2 dilutions of the untreated test samples were 
inoculated into SPF. eggs. The chloroform sensitive H120 lBV also 
failed to cause effects in SPF eggs when treated w.ith chloroform . .. 
The chloroform resistant CELO virus was not affected by 
chloroform treatment and caused 100% mortality in SPF eggs at the 
10-1 and 10-2 dilution when inoculated with the treated and 
untreated samples. 
3.3.4. Nucleic acid determination 
There was no difference in the titre of the three isolates 
(4916/91, 652/93 and 711/93) as well as NDV, in the presence or 
absence of lDU. However, the titre of the positive control 
sample, CELO virus, dropped from 107.2 TClDso/ml to 103.6 TClDso/ml. 
The results are shown in Table 3 .3. 
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Table 3.3. Results of the nucleic acid determination test of 
three TRTV-like isolates 
I SAMPLE I TREATMENT I TITRE (TCIOso/ml) I 
4916/91 untreated 104.2 
4916/91 IOU treated 104.2 
652/93 untreated 106.2 
652/93 IOU treated 106.2 
711/93 untreated 104.8 
711/93 Ihu treated 104.8 
NDV untreated 109.2 
NDV IOU treated 109.0 
CELO virus untreated 107.2 
CELO virus IOU treated 103.6 
3.3.5. Serum neutralisation 
The titres of the isolates in the absence of TRTV specific 
antibodies and when reacted with TRTV specific antiserum for 45 








Resul ts of the serum neutralisation tests of 
three TRTV-like isolates and controls 
VIRUS TITRE NEUTRALISATION NEUTRALISATION 
(EIDso/ml) TITRE (EIDso/ml) INDEX 
104.6 10°·9 3.7 
106.8 101.1 5.7 
104.2 10°·9 3.3 
106.2 >104.5 <1. 7 
106.6 101.3 5.3 
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Table 3.5. Results of the cross-neutralisation test using 
the TRTV and monospecific antisera to isolates 
4916/91, 652/93 and 711/93 
SERA NEUTRALISATION NEUTRALISATION 
TITRE ( EIDso/ml) INDEX 
TRTV 101.3 5.3 
4916/91 102.5 4.1 
652/93 101.5 5.1 
711/93 • 102.5 
. 
4.1 
IBV 104.9 1.7 
I TRTV TITRE (EIDso) = 106.6/ml I 
The three isolates, 4916/91, 652/93 and 711/93, were all 
neutralised to some extent by the TRTV specific antiserum and the 
TRTV was also strongly neutralised by the 4916/91, 652/93 and 
711/93 antisera (Table 3.5) . The 652/93 antiserum neutralised the 
TRTV more strongly than the other two isolates. The positive 
controls were strongly neutralised whereas the negative IBV 
control antigen and antiserum was not neutralised by the TRTV 
specific antisera or virus respectively. 
3.3.6. Enzyme linked immunosorbent assay 
All the birds were found to be negative for antibodies against 
TRTV before inoculation. However, serum samples from birds 
inoculated with the three isolates and the Pittman-Moore TRTV, 
were found to have very high levels of antibodies against TRTV. 
Serum from birds inoculated with the TAD IBV, remained negative 
2 wks post-inoculation. The results are shown in Table 3.6 below. 
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The optical density (OD) and SiP ratio X 100 of the kits positive 
and negative controls were 671, 100 and lOS, 16 respectively. The 
positive: negative control ratio was 6.4. A value below six, 








TRTV ELISA results with isolates 4916/91, 652/93 
and 711/93 
PRE-INOCULATION POST-INOCULATION • .. 
OD sip X 100 OD Sip X 100 
127 19 684 102 
138 21 731 109 
121 18 611 91 
134 20 644 96 
138 21 168 25 
3.3.7. Haematoxylin and eosin staining of monolayers 
All the inoculated monolayers displayed a similar type of CPE 
visualised by the Hand E staining. Apart from the occurrence of 
syncytia, there were eosinophilic inclusions in the cytoplasm of 
the infected cells (Plate 3.1). The uninoculated control 
monolayer showed no signs of CPE (Plate 3.2). 
3.4. Discussion 
The results of the physico-chemical tests were similar for the 
three isolates (4916/91, 652/93 and 711/93), indicative of the 
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Plate 3.1 . 
Plate 3.2. 
Vero cell monolayer stained with haematoxylin and 
eosin. The syncytia (s) and inclusions (i) are 
clearly visible. Numerous nuclei (n) can be 
observed within a syncytium. 
Healthy uninoculated Vero cell monolayer. Note 
the absence of syncytia and inclusions. (n = 
nucleus) 

possible relatedness between them . 
The HA tests with the isolates were negative, suggesting that the 
isolates do not contain haemagglutinin in th~ir membrane. A 
negative HA test excludes viruses that do possess haemagglutinin 
ego NDV and avian influenza (Alexander, 1989). 
The isolates were found to be heat labile since they were . . 
inactivated when exposed to a temperature of 56°C for 1 h. Most 
viruses that possess an outer membrane around the nucleocapsid 
are inactivated by prolonged exposure to this temperature which 
denatures the membrane. This also indicates that the virus 
requires the membrane for infection. Further evidence for the 
presence of a membrane around the isolates, is the fact that they 
were completely inactivated after treatment with chloroform. 
Chloroform is a lipid solvent that destroys lipoprotein 
membranes. The sensitivity of a virus to lipid solvents therefore 
indicates whether it has a lipoprotein envelope or not (Lukert, 
1989) . 
The isolates were found to be stable for a long period of time 
at temperatures of about -70°C or lower. The titre of the 
isolates did not drop when stored at -70°C or in liquid nitrogen 
(Nz)· However, when stored at 4°C for longer than 24 h, there was 
a drop in the titre of the isolates. Prolonged exposure to a 
temperature of -20°C also caused a drop in the titre of the 
isolates. These results suggest that the isolates are relatively 
fragile and if storage for a period exceeding 3 days is required, 
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then they should be stored at a temperature of -70°C or lower. 
The titre of the isolates was unaltered by IDU treatment, 
indicative of the fact that the isolates contain a genome of RNA 
(Wyeth and Alexander, 1989). IDU is a thymidine analog and an 
inhibitor of DNA replication (Lukert, 1989). The DNA-containing 
CELO virus positive control was significantly reduced in titre 
by IDU treatment whilst the RNA-containing NDV n~gative control 
was virtually unaltered by IDU treatment. 
All three isolates were significantly neutralised by TRTV 
specific antisera and the TRTV was significantly neutralised by 
antisera against each of the three .isolates, especially 652/93, 
which suggests a close relationship between the isolates and with 
TRTV. Neutralisation tests with specific antisera are usually 
accurate and useful in identifying unknown viruses and 
differentiating between serotypes of a virus (Lukert, 1989). The 
reason for the lower neutralisation indices of isolate 4916/91 
and 711/93 compared to that of 652/93, may be due to the lower 
titres of the former and because they are probably not as 
immunogenic as isolate 652/93 . 
The results of the ELISA tests indicate a high degree of 
serological relatedness between the three isolates and TRTV. 
Since the commercial TRTV ELISA kit was able to detect antibodies 
against the three isolates, it was not necessary to develop 
specific ELISA kits for each of the three isolates. The ELISA Sip 
ratios of isolates 4916/91 and 652/93 were higher than that of 
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the positive control. The difference in ELISA results amongst 
the three isolates could be due to a difference in the ability 
of the isolates to replicate, as well as the amount of virus 
initially present in the inoculum. Isolate 652/93 which grows 
prolifically and to a significantly higher titre than that of the 
other two isolates, also produced the highest antibody response 
against TRTV in SPF birds. 
All three isolates caused CPE comprising giant cells or syncytia 
and the production of eosinophilic cytoplasmic inclusions. This 
type of CPE is a characteristic of the Pneumoviruses ego 
respiratory syncytial virus (RSV) and TRTV (Buys et al., 1989a,b; 
Naylor and Jones, 1993; Parrott, Kim, Brandt, Beem, Richardson, 
Gerin, and Chanock, 1979). 
The results sugg~st that the three isolates, although possessing 
different abilities to grow in laboratory host systems, are 
remarkably similar and possibly strains of the same serotype. 
Furthermore, the serological evidence indicates that the isolates 
are similar to TRTV. It is therefore suggested that the three 
isolates are enveloped RNA viruses and possibly strains of the 
same serotype as the Pittman-Moore vaccine TRTV. This theory must 
be substantiated by electron microscopy and molecular biological 
techniques such as SDS-PAGE, western blotting, the polymerase 




ELECTRON MICROSCOPY OF CHICKEN TRTV-LIKE VIRUS AND TRTV-
LIKE VIRUS-INFECTED TISSUES 
4.1. Introduction 
The electron microscope (EM) is one of the mos~ useful single 
tools available to virologists, but it is also an extremely 
expensive instrument which requires qualified and experienced 
technicians for its efficient operation and maintenance 
(Versteeg, 1985). When available, the EM can be of inunense 
diagnostic value and may be used as the first step towards virus 
diagnosis (Hill, 1984). Since several new human and animal 
pathogens were recognised for the first time by this technique, 
electron microscopy has been used as a routine screening for 
viruses, especially when less intensive methods were not within 
reach (Versteeg, 1985). 
The diagnosis made by electron microscopy is morphological. 
However, since viruses from a group have basically the same 
morphology, they cannot be typed with the EM. With known viruses, 
the EM can be used to examine detailed virus substructure, to 
study various aspects of virus-cell interactions, and to examine 
the localisation of virus development in the host. 
Buys et ale (1989a) and Giraud et ale (1987), using the EM, 
observed accumulations of virus nucleoprotein on the plasma 
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membrane of TRTV-infected Vero cells. The accumulations later 
budded through the plasma membrane. Apart from these studies, 
there are no records of other electron microscopical work on 
TRTV-infected tissues. No electron microscopy has been performed 
on the localisation and virus development in TOC's. However, 
there are numerous reports on TRTV and chicken isolates of a 
TRTV-like virus particle morphology. 
Results of electron microscopy on isolate 4916/91, 652/93 and 
711/93 infective allantoic fluid to determine virus morphology, 
and on infected TOC's and Vero cells to study virus development, 
are presented in this Chapter. 
4.2. Materials and Method 
4.2.1. Treatment of infective allantoic fluid for the EM 
The allantoic fluid from embryos separately inoculated via the 
y/s route with the 6th y/s passage of isolates 4916/91, 652/93 
and 711/93, were harvested 4 days post-inoculation. The allantoic 
fluid was then treated for electron microscopy according to the 
method of Gough and Collins (1989). 
The allantoic fluid was centrifuged at approximately 3000 g for 
10 min in a Hereaus Hettich Universal II centrifuge to remove red 
blood cells and debris. The fluid was then centrifuged at 70000g 
for 60 min in a 80rvall RC288 centrifuge using a 8-20 rotor. The 
pellet was resuspended in 0.5 ml of sterile deionised water and 
placed on a 15 ml step gradient comprising 12.5 ml 30% (w/w) 
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sucrose and 2.5 ml 55% (w/w) sucrose. After centrifugation at 
56500g for 60 min in a Sorvall RC28S centrifuge using a S-20 
rotor, the band at the interface was removed with a syringe 
fitted with a 21 gauge hypodermic needle which was bent 
horizontally at the end. This fraction was diluted with PBS (pH 
7.0) and pelleted at 70000g for 60 min. The resultant pellet was 
resuspended in O. 5 ml O. 01M Tri s - HCI buf f er (pH 7. 0). Heal thy 
allantoic fluid from uninoculated SPF eggs of ~he same age.as 
that of the test samples, was treated in the same manner as the 
test samples. However, there was no band at the interface of the 
gradients of the healthy control sample. Therefore, the fluid at 
the general location of the band was removed and further 
processed. 
One drop of the purified suspension was placed on formvar coated 
copper grids, negatively stained for 2 min with 2% 
phosphotungstic acid (PTA, pH 6.0), and viewed with a Jeol 100CX 
transmission electron microscope (TEM) . 
4.2.2. Preparation of infected Vero cells and TOC's for EM 
TOCs with good cilial activity were prepared from 19-21 day~ld 
SPF chicken embryos and separately inoculated with the 5th y/s 
material of isolates 4916/91, 652/93 and 711/93. A few TOC's were 
also inoculated with healthy allantoic fluid. After 2 days, the 
TOC's were placed in 6% glutaraldehyde in O. 05M sodium cacodylate 
buffer for fixation until ready for subsequent processing. 
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Confluent layers of healthy Vero cells were separately inoculated 
with healthy allantoic fluid and with the 7th Vero cell passaged 
material of isolates 4916/91, 652/93 and 711/93. The medium above 
the monolayers was discarded 2 days pi and replaced with a small 
volume of 6% glutaraldehyde in 0.05M sodium cacodylate buffer 
which completely covered the monolayer. The monolayers were 
stored at 4°C in this fixative until ready for further 
processing. 
The glutaraldehyde fixed samples were washed twice for 30 min 
each in 0.05M sodium cacodylate buffer, post-fixed in 2% osmium 
tetroxide for 2 h followed by two 30-min washes in buffer. The 
samples were then block-stained in 2% uranyl acetate for 30 min 
followed by two 30-min washes with double distilled water. 
The samples were dehydrated in a graded ethanol series ranging 
from 10-100% in increasing steps of 10%. The samples were 
submersed in each ethanol concentration for 10 min and the 100% 
dehydration step was repeated three times. The samples were then 
washed in two 30-min changes of propylene oxide and embedded in 
Spurr's resin according to the following embedding formulation 
recommended by Spurr (1969): 
ERL 4206 .................................. 10g 
DER 736 .................................. 6g 
NSA (nonenyl succinic anhydride) ......... 26g 
S-l (dimethylaminoethanol) .............. 0.4g 





75% absolute alcohol ... . ..... 2 h 
50% absolute alcohol ......... 2 h 
75% Spurrs 25% absolute alcohol .. .. ..... 2 h 
100% Spurrs ............ .. ......... . . . ... overnight 
The samples in 100% Spurrs resin were poured into labelled 
embedding dishes and polymerised in an oven at 70~C for 16 h. Xhe 
samples were cut out of the mould and mounted on labelled perspex 
stubs. The blocks were trimmed with a glass knife on a Reichert 
ultramicrotome. Ultrathin sections of the specimens were cut and 
three sections picked up on each 200 mesh copper grid, stained 
with 2% uranyl acetate for 10 min followed by lead citrate for 
a further 10 min, and viewed with a Jeol 100CX transmission 
electron microscope. 
4.3. Results 
Since the EM results obtained with isolates 4916/91, 652/93 and 
711/93 were similar, only the results obtained with isolate 
652/93, are presented . 
4 . 3.1. EM of infective allantoic fluid 
Electron microscopy of 6th y/s passage allantoic fluid of all 
isolates, revealed the presence of highly pleomorphic virus-like 
particles (VLP's) approximately 100-300 nm in diameter with a 
fringe of spikes approximately 12 nm in length (Plate 4.1). 
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However, although there were often numerous VLP's present in a 
field, the spikes were not always clearly visible (Plate 4.2) . 
In some preparations of allantoic fluid, structures resembling 
helical nucleocapsids with the typical "herringbone" type 
structure of . approximately 15 nm in diameter, was observed 
extruding from the VLP's (Plates 4.3 and 4.4). A coiled 
nucleocapsid-like structure was also observed within a VLP in 
Plate 4.2. No VLP's or nucleocapsids were observed .in 
preparations made from healthy allantoic fluid. 
4.3.2. EM of sections of infected Toe's and Vero cells 
Various developing forms of VLP's were observed in sections of 
Toe's. Plate 4.5 shows the presence of developing VLP's in a 
vesicle. Electron dense accumulations of viral nucleoprotein-like 
material were observed close to the cell membrane (Plates 4.6, 
4.7 and 4.8). Plate 4.8 shows a nucleocapsid-like structure with 
electron dense material located beneath the cell membrane which 
appears to be altered. Fine structures resembling spikes were 
vaguely discernable on the outer surface of the plasma membrane 
as shown in Plates 4.7 and 4.8. The development of electron dense 
filamentous and pleomorphic nucleoprotein-like material were also 
observed in a vesicle-like structure (Plate 4.9). All such 
accumulations were located in the cytoplasm of the tracheal 
epithelial cells. 
The development of VLP's in Vero cells was found to be similar 
to that in Toe's. Numerous developing nucleocapsid-like 
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structures were observed in vesicular-like structures in the 
cytoplasm of Vero cells (Plates 4.10-4.13) . Electron dense 
nucleoprotein accumulations, similar to that of infected TOC's, 
were observed in vesicle-like structures (Plate 4.14 and 4.15) . 
Plate 4.15 shows a well defined nucleoprotein-like accumulation 
in the process of differentiation . Electron dense accumulations 
close to the plasma membrane, in the process of budding, are 
shown in Plate 4.16. Each accumulation of nucleoprotein may f0rm 
a separate VLP. Four such accumulations are depicted in Plate 
4.16. There were no accumulations of nucleoprotein and a marked 
lack of vesicles in healthy TOC and Vero cell sections. Vesicles 
that were observed in healthy material were always devoid of any 
distinctive material. 
4.4. Discussion 
The EM results on infective allantoic fluid were consistent with 
the findings of other workers for TRTV (Buys et al., 1989a,b; 
Collins and Gough, 1988; Gough and Collins, 1989; Picault et al., 
1987). They found the agents associated with TRT and SHS to be 
highly pleomorphic virus particles with diameters ranging from 
40-800 nm possessing a fringe of approximately 13nm long spikes. 
The diameter of the internal nucleocapsid was approximately 14 
nm and had a "herringbone" type appearance. The VLP'S observed 
in EM preparations of infective allantoic fluid in this study, 
were approximately 100-300 nm in diameter with the spikes 
approximately 12 nm in length. The helical nucleocapsid was 




Pleomorphic virus-like particles (VLP) with a 
fringe of spikes (8) 
Numerous pleomorphic VLP's. The fringe of spikes 
is not well defined. The coiled nucleocapsid-like 
structure (N) is vaguely visible inside a VLP. 
O.2tJm 4.1 
Plate 4 . 3 and 4.4. Helical nucleocapsid (N) approximately 
15 nm in diameter from disrupted VLPs. 
0.12 Po!!!- 4.4 
Plate 4.5. 
Plate 4.6. 
possible nucleocapsids (N) of developing VLPs in 
a vesicle (V) of a tracheal epithelial cell. The 
cilia (C) are visible. 
Viral nucleoprotein-like material (NP) close to 
the cell membrane (CM) of a tracheal epithelial 
cell. 

Plate 4.7 and 4 . 8. Electron dense nucleoprotein-like 
accumulations (NP) just beneath the cell 
membrane of a tracheal epithelial cell that 
appears to be altered (A) in areas . 
Structures resembling spikes (8) are vaguely 
discernable in some areas of the outer 




Electron-dense viral nucleoprotein-like material 
(NP) in a vesicle of a tracheal epithelial cell. 
Possible viral nucleocapsid (N) in the process of 
development in a vesicle of a Vero cell. 

Plate 4.11 and 4.12. Developing viral nucleocapsid-like (N) 
structures in vesicles of Vero cells . 

Plate 4.13. 
Plate 4 . 14. 
possible viral nucleocapsids (N) in the process 
of development in a vesicle of a Vero cell. 
Electron-dense nucleoprotein-like accumulations 
(NP) in vesicles of a Vero cell. 

Plate 4 . 15. 
Plate 4.16. 
Accumulations of nucleoprotein-like material (NP) 
in the process of differentiation in a vesicle of 
a Vero cell . 
Electron-dense accumulations of viral 
nucleoprotein-l i ke material (NP) in the process 
of budding from the cell membrane (eM) of a Vero 
cell. Each accumulation probably results in a 
VLP. 
O.2 pm 4.16 
smaller than 100 nm, depicted in Plate 4.2, which were fragmented 
particles caused during preparation for EM. 
The results obtained in TOC and Vero cells · were identical, 
suggesting that the process of VLP development and maturation is 
similar in both systems. It appears that virus-like nucleoprotein 
may accumulate in vesicles where virus assembly may occur and 
these vesicles move toward the plasma membrane wpere maturation 
and budding of the VLP's occur. Also, accumulations of 
nucleoprotein-like material occurred close to the cell plasma 
membrane and appeared to form a possible nucleocapsid as 
described by Fraser and Martin (1978) for measles virus. Virus-
like particle specified spikes are then probably inserted into 
the plasma membrane (Plate 4.8) . The mature VLP then buds from 
the cell plasma membrane which contains spikes, incorporating 
this cell membrane as its own . Plate 4.8 shows a possible VLP in 
the process of budding from a tracheal epithelial cell. These 
findings are similar to those of Buys et al . (1989a) and Giraud 
et al. (1987) for TRTV in Vero cells . These results are also a 
characteristic of another Pneumovirus, RSV, which has highly 
pleomorphic virions ranging in diameters between 90-860 nm with 
an internal nucleocapsid 14 nm in diameter (Parrott et al., 
1979) . 
The smaller diameter of the nucleocapsid differentiates these 
isolates from those of NDV, a Paramyxovirus, which has a wider 
helical nucleoprotein component 18 nm in diameter (Chanock, 
1979). The influenza viruses are also pleomorphic, but are 
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generally spherical . with an approximate diameter of 100 nm, 
surface spikes 8-10 nm long, and a nucleoprotein component 
approximately 9 nm in diameter (Dowdle, Kendal, and Noble, 1979). 
The results obtained here are similar to features associated with 
RSV and TRTV both of which ~re Pneumoviruses. The EM differences 
between TRTV and isolates 4916/91, 652/93 and 711/93, are 
indistinguishable. It is therefore probable that isolates 
4916/91, 652/93 and 711/93 are similar to RSV a~d TRTV and are 




SOS-PAGE AND WESTERN BLOTTING OF THREE TRTV-LIKE ISOLATES 
5.1. Introduction 
Advances in molecular biology and immunology have provided 
pathologists with powerful tool!? to enhance morphologic and 
clinical laboratory diagnoses. The application of J:.his technology 
to pathology represents the transfer of recent basic research 
tools into the laboratory (Fenoglio-Preiser and Willman, 1987). 
Electrophoresis in polyacrylamide gels in the presence of the 
anionic detergent sodium dodecyl sulphate (SOS), has proven to 
be a useful tool for the separation of proteins and the 
determination of their molecular weights (Sigma Chemical Company, 
1988). SOS-polyacrylamide gel electrophoresis (SOS-PAGE) can 
therefore greatly assist in the identification and classification 
of pathogens. 
SOS-PAGE is normally performed with a discontinuous buffer system 
where the buffer in the reservoir is of a different pH and ionic 
strength to that used to cast the gel. A reducing agent, heat and 
SOS are used to dissociate proteins in a sample before loading 
onto a gel. The polypeptides bind SOS and attain a negative 
charge. The amount of SOS bound by the polypeptide is 
proportional to the molecular weight of the polypeptide, 
resulting in the complex migrating through the gel in accordance 
with the size of the polypeptide (Sambrook, Fritsch and Maniatis, 
79 
1989) . The electric current applied between the electrodes of the 
gel apparatus causes the charged SOS-polypeptide complexes to 
move along with the moving boundary in the gel. The SOS-
polypeptide complexes move through the resolving gel and are 
separated according to size by sieving . The effective range of 
separation of SOS-polyacrylamide gels depends on the 
concentration of polyacrylamide used to cast the gel and on the 
amount of cross-linking. The sieving properties,of the gel are 
determined by the size of the pores (Sambrook et al., 1989). 
The molecular weight of a given protein can be determined by 
comparing its electrophoretic mobility (~) with known protein 
markers. A linear relationship is obtained if the logarithms of 
the molecular weights of the protein markers are plotted against 
their respective electrophoretic mobility (Sigma Chemical 
Company, 1988) . 
Many researchers have performed 80S-PAGE on TRTV (Cavanagh and 
Barrett, 1988; Collins and Gough , 1988; Gough and Collins, 1989; 
Ling and Pringle, 1988) and although their results are largely 
similar, there are some differences which have been explained as 
being caused by differences in the SOS-PAGE protocols used and 
not to strain differences . 
Western blotting involves the electrophoretic transfer of 
proteins from the gel to a solid support such as nitrocellulose 
paper . This paper is then probed with antibodies that react 
specifically with antigenic epitopes displayed by the target . 
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protein. Western blotting can therefore be used to identify 
specific proteins in complex mixtures of proteins and to indicate 
immunogenic relatedness between different strains of a virus 
(Sambrook et al., 1989). 
This Chapter describes the SD8-PAGE and western blotting results 
obtained with three TRTV-like isolates, 4916/91, 652/93 and 
711/93. 
5.2. Materials and Method 
5.2.1. Preparation of samples for SDS-PAGE 
The 5th y/s allantoic fluid of isolates 4916/91, 652/93 and 
711/93 were each harvested from SPF eggs and centrifuged in a 
Heraeus Hettich Universal II centrifuge at approximately 3000 g 
for 10 min. The supernatant of each sample was recentrifuged 
using a 80rvall 8-20 rotor at 70000 g for 1 h in a Sorvall RC28S 
centrifuge. The resulting pellet was resuspended in 1 ml of 
sterile distilled water and layered onto a 15 ml 30-55% (12.5 ml 
and 2.5 ml respectively) stepped sucrose gradient. The sucrose 
gradients were centrifuged at 56500 g for 1 h in the 80rvall 8-20 
rotor. The band at the interface of the gradient was removed, 
diluted with distilled water to 15 ml, and centrifuged as before 
at 56500 g for 1 h. The resulting pellet was resuspended in 0.5 
ml of sterile distilled water and used as sample for SDS-PAGE and 
subsequent western blots. Allantoic fluid from healthy 13-day-old 
embryonated SPF eggs was harvested and treated identically to 
that of the three isolates. 
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Just prior to .SDS-PAGE, 50 ~l of each purified sample was added 
to an equal volume of SDS gel loading buffer (Appendix, recipe 
2) and heated to 100°C for 3 min. 
5.2.2. SDS-PAGE 
The method used for SDS-PAGE was according to that of Sambrook 
et al. (1989). A 12% running gel and a 5% stacking gel were cast 
, 
according to the formulation in Table 5.1. 
Table 5.1. The formulation for the preparation of the 
stacking and running SDS-polyacrylamide gels. 
INGREDIENT STACKING GEL RUNNING GEL 
(ml) (ml) 
water 3.3 2.7 
30% acrylamide mix@ 4.0 0.67 
1.5 M Tris (pH 8.8) 2.5 -
1 M Tris (pH 6.8) - 0.5 
10% SDS 0 . 1 0.04 
10% Ammonium persulphate 0.1 0.04 
TEMED· 0.004 0.004 
@ Solution of 29% (w/v) acrylamide and 1% (w/v) N,N'-
methylenebisacrylamide in deionised water. 
• N,N,N' ,N'-tetramethylethylenediamine. 
The glass plates for gel casting were assembled and the freshly 
prepared running gel mixture introduced between them wi th the aid 
of a syringe and 21 gauge needle to approximately 2 cm from the 
top of the plates. With the aid of a Pasteur pipette, isobutanol 
was overlayed on the gel to prevent oxygen from diffusing into 
the gel and inhibiting polyrnerisation. After polyrnerisation of 
the running gel, the overlay was poured off and the top of the 
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gel washed with distilled water. The water was drained and the 
stacking gel mixture poured on top of the running gel. 
Irrunediately thereafter, a clean teflon comb with 10 "teeth" and 
of the same thickness as the spacers between the glass plates, 
was inserted into the stacking gel solution without trapping any 
air bubbles. After polymerisation, the teflon comb was carefully 
removed and the wells created were washed with distilled water. 
The gel was then mounted in the electrophoresis apparatus and 
Tris-glycine electrophoresis buffer (Appendix, recipe 3) added 
to the top and bottom buffer reservoirs. 
Approximately 50 III of each sample for electrophoresis was 
separately loaded into the bottom of the well with the aid of a 
micropipette. WeIll was loaded with MW-SDS-70 (Sigma) molecular 
weight markers, well 2 with heal thy control material and well 3,4 
and 5 with 4916/91, 652/93 and 711/93 material respectively. SDS-
gel loading buffer was loaded into unused wells. Two such gels 
were loaded identically and run together in the same apparatus. 
The electrophoresis apparatus was connected to a Consort E702 
power pack and run at 180 volts for approximately 2 h or until 
the bromophenol blue dye front reached the bottom of the running 
gel. 
One of the two identical gels was removed from between the glass 
plates for Coomassie brilliant blue (CBB) staining. Approximately 
0.25g of CBB R-250 was dissolved in 90 ml of a solution of 
methanol:water (1:1 v/v) and 10 ml glacial acetic acid. The 
solution was filtered through Whatman No.1 filter paper and the 
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gel immersed in this solution with gentle agitation on a micro-
orbital shaker for 24 h at room temperature. The stain was 
decanted and the gel destained by soaking in a solution of 
methanol:water (1:1 v/v) with 10% acetic acid on a micro-orbital 
shaker. The destain solution was regularly changed at 2 h 
intervals. After 8 h of destaining, the gel was photographed with 
a FCR 10 polaroid camera. 
The ~ values of all the protein bands were determined by 
measuring the distance of the protein band from the top of the 
running gel and dividing this by the distance of the dye front. 
A standard graph was drawn by plotting the log of the molecular 
weight of the protein markers (lane 1) on the y-axis and their 
~ valus on the x-axis. The molecular weights of all other 
protein bands (lanes 2-5) were determined from this standard 
graph. 
5.2.3. Western blotting 
The unstained SDS polyacrylamide gel was used for western 
blotting according to the method of Sambrook et al. (1989). A 
piece of Hybond-C nitrocellulose paper (Amersham), corresponding 
to the size of the gel, was cut. The blotting apparatus, 
manufactured and supplied by South African Scientific Products, 
was assembled. The nitrocellulose paper was placed against one 
side of the gel and the gel and nitrocellulose paper were 
sandwiched between two Whatman 3M filter papers cut to the size 
of the gel. A porous pad of sponge was placed on either side of 
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the sandwich. A gauze support was clipped together on either side 
of the sandwich with teflon clips to hold the sandwich in place. 
The sandwich was placed in the electrotransfer unit so that the 
gel faced the negative electrode and the nitrocellulose paper the 
positive electrode. Refrigerated transfer buffer (Appendix, 
recipe 4) was added to the buffer chamber to a level just below 
the electrodes. A current of 200 rnA was applied to the sandwich 
for 16 hrs with a Consort E702 power pack. The sandwich was 
removed and the nitrocellulose paper carefully removed and 
transferred to a clean 3M Whatman filter paper. The 
nitrocellulose paper was allowed to dry at room temperature for 
1 h. 
The nitrocellulose paper was submerged in a tray of deionised 
water for 5 min and transferred to a working solution of Ponceau 
S stain for 10 min with gentle agitation on a micro-orbital 









The working solution of Ponceau S was prepared by diluting the 
stock tenfold with distilled water. The Ponceau S stained 
nitrocellulose paper was washed several times in distilled water. 
The stained protein bands of the molecular weight markers were 
marked with waterproof ink. The nitrocellulose paper was then 
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placed in a container and covered with a blocking solution, 
consisting of a solution of 5% non-fat dried milk powder in 1M 
PBS (pH 7.0), for 1 h at room temperature on a micro-orbital 
shaker. 
The nitrocellulose paper was washed twice with 1M PBS (pH 7.0) 
for 5 min each. The primary antibody solution, prepared by adding 
100 ~l of high titre TRTV monospecific antisera. (refer Chapter 
3) to 10 ml 1M PBS (pH7.0), was incubated with the blot for 24 
h at 37°C. The blot was washed with PBS (4 X 5 min), incubated (2 
h, RT) with 10 ml of anti-chicken horseradish peroxidase enzyme 
conjugate (Sigma) (1:2000 dilution in PBS, pH 7.0) and again 
washed (4 X 5 min) with PBS. 
Just prior to developing the blot, 0 . 1 ml of a 4-chloro-1-naphtol 
(Promega) stock solution was added to 10 ml of 50 mM Tris buffer 
(pH 7.6). The solution was filtered through Whatman 3M filter 
paper. Ten ~l of a 30% hydrogen peroxide solution was added and 
the blot was incubated (30 min, RT), with gentle agitation on a 
micro-orbital shaker. The reaction was stopped by decanting the 
substrate solution and rinsing the blot with the PBS solution for 
10 min. 
The TRTV-specific antigenic proteins of the three TRTV-like 
isolates were identified on the blot and their molecular weights 
determined from the standard graph . 
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5.3. Results 
5.3.1. SDS-PAGE analysis of the proteins of the three TRTV-
like isolates 
Plate 5.1 .shows the result obtained after eBB staining of the 
SDS-PAGE gel. The molecular weights of the protein bands in the 
control (lane 2) and test samples (lane 3-5) were determined from 
the standard graph (Fig. 5.1). Table 5.2 depicts the molecular 
, 
weights of the various bands obtained from each sample. 
Since the results obtained with all three TRTV-like isolates were 
identical, only those of 4916/91 are shown in Table 5.2. 
5.3.2. Western blot analysis of the immunogenic proteins of 
the three TRTV-like isolates using TRTV-monospecific 
antisera 
Two bands of polypeptides of molecular weights approximately 83 
kDa and 53 kDa (Plate 5.2) were observed in the developed blot 
of samples 4916/91, 652/93 and 711/93. No bands were observed in 
the blot of the healthy control material. 
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Plate 5.1. SDS-PAGE results obtained with isolates 
4916/91, 652/93 and 711/93. Lane 1 = 
molecular weight markers; Lane 2 = healthy 
allantoic fluid; Lanes 3 '" , 4 and 5 were 
loaded with 4916/91, 652/93 and 711/93 
infected allantoic fluid respectively. 
Plate 5.2. Western blot with isolates 4916/91, 652/93 
and 711/93 using TRTV-specific antisera. 
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Table 5.2. The ~ values and resultant molecular weig~ts (~) 
of the protein bands of the 4916/91 lsolate 
obtained using the standard graph 
k CONTROL k 4916/91 I I Mr(kDa) I Mr (kDa) 
- - 0.03 200 
0.06 190 0.06 190 
0.16 150 0.16 150 




- - 0.32 83 
0.37 74 0.37 74 
- - 0.4 65 
0.42 61 0.42 61 
- - 0.466 53 
0.51 47 0.51, 47 
- - 0.56 40 
- - 0.6 37 
- - 0.69 28 
0.72 25 0.72 25 
- - 0.82 19 
- - 0.89 15 
0.93 13 0.93 13 
5.4. Discussion 
According to Naylor and Jones (1993) several researchers have 
reported on the polypeptide composition of TRTV based on SDS-
PAGE results. Most have reported detecting seven viral 
polypeptides of molecular weights 200 kDa, 82-84 kDa, 68 kDa, 
38-43 kDa, 35-40 kDa, 30-35 kDa and 19-22 kDa. The 68 kDa 
polypeptide could dissociate into a 53-54 kDa and a 14-15 kDa 
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polypeptide (Cavanagh and Barrett, 1988). Cavanagh and Barrett 
(1988) found the 82-84 kDa and the 53-54 kDa polypeptides to 
be glycosylated. According to them, three polypeptides 
distinguish TRTV from Paramyxoviruses and Morbilliviruses and 
-
group it with the Pneumovirus. The nucleocapsid protein (38-43 
kDa) and the P-protein (35-40 kDa) of TRTV were found to be 
much smaller in size whilst the 22 kDa protein was not found 
in the other two genera. 
The results obtained with the three TRTV-like isolates 
(4916/91, 652/93 and 711/93), were very similar to those 
obtained by Cavanagh and Barrett (1988), Collins and Gough 
(1988), Gough and Collins (1989) and Ling and Pringle (1988). 
Nine viral polypeptides were detected in this study with 
molecular weights corresponding to those obtained for TRTV. 
The 83 kDa band detected corresponds to the 82-84 kDa band of 
TRTV, the 53 kDa and 15 kDa bands correspond to the 
dissociated 68 kDa band of TRTV which results in two bands of 
53-54 kDa and 14-15 kDa . The 40 kDa, 37 kDa, 28 kDa and 19 kDa 
proteins are similar to the 38-43 kDa, 35-40 kDa, 30-35 kDa 
and 19-22 kDa TRTV polypeptides respectively. 
The slight differences in molecular weights between a few of 
the TRTV polypeptides and those of the three TRTV-like 
isolates are probably due to differences in the gel running 
conditions and the plotting of the standard curve. 
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The western blot analysis of the SOS-PAGE gel, revealed the 
presence of two stained bands of molecular weights 83 kDa and 
53 kDa. Protein bands will only develop on a western blot if 
the primary antibody used in the analysis contains sufficient 
antibodies to react with the antigen on the blotted 
nitrocellulose paper. Therefore, with the use of specific 
antisera, one could use the western blot to determine 
relatedness between isolates. Since there were s.tained bands. 
on the western blot of the three TRTV-like isolates and none 
on that of the control sample, it would appear that there is a 
close relatedness between TRTV and the three isolates. It is 
also likely that the TRTV-like isolates are strains of TRTV. 
The SOS-PAGE and western blot analysis of 4916/91, 652/93 and 
711/93 support this suggestion. However, in order to firmly 
establish the relatedness between TRTV and the three TRTV-like 
isolates, it is essential that a DNA probe against TRTV be 
developed and tested against these isolates. A positive result 
would provide conclusive evidence of the close relatedness 
between TRTV and the TRTV-like isolates. 
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CHAPTER 6 
THE CONSTRUCTION AND USE OF A TRTV DNA PROBE AGAINST THREE 
TRTV-LIKE ISOLATES 
6.1. Introduction 
The ability to achieve a rapid, accurate diagnosis of a pathogen , 
is fundamental to maintaining good programmes to monitor health 
and disease in poultry flocks (Murtaugh, 1993). Current methods 
of laboratory diagnosis of infectious diseases are based on 
isolation of the agent, or serological methods. Clinical signs 
alone cannot be used to diagnose the causal organism since many 
can produce similar diseases (Andreasen, Jackwood and Hilt, 
1991) . Often, many passages of a virus in laboratory host systems 
are required before it becomes adapted for growth in these 
systems. This often makes the isolation of viruses a lengthy 
process. The process is labour-intensive and expensive, 
, 
especially considering the fact that two to three passages are 
required before the isolation attempt can be aborted as being 
negative for virus (Kwon, Jackwood, Brown and Hilt, 1993). 
Alternative diagnostic methods such as detection of increasing 
antibody titres and fluorescent antibody tests, also have 
disadvantages such as non-specificity, insensitivity or delayed 
diagnosis. A sensitive, specific and rapid means of diagnosis is 
desirable (Andreasen et al., 1991) . 
Recent advances in molecular biology and recombinant DNA 
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technology have provided new opportunities for improving the 
effectiveness and productivity of disease diagnosis. This 
provides the ability to identify disease agents rapidly and 
accurately by their molecular structure rather than by indirect 
measurements based on what they do in cell culture, animals or 
embryonated eggs (Murtaugh, 1993). 
The polymerase chain reaction (peR) is an in vitro method for the 
. . 
enzymatic synthesis of selected pieces of DNA or RNA sequences, 
specific for each type of organism, using two oligonucleotide 
primers that hybridise to opposite strands and flank the region 
of interest in the target DNA (Saiki, 1989). In peR, DNA 
polymerase is incubated together with primers, deoxynucleotide 
triphosphates (dNTP) and the sample DNA. If DNA from the target 
species is present, the bases in the primers will pair with the 
complementary bases in the sample DNA. To perform peR on RNA, it 
has to be initially transcribed into DNA using a reverse 
transcriptase enzyme. This DNA (cDNA) is then used as the target 
DNA in the peR reaction. The enzyme machinery will then extend 
the chain by adding complementary bases (Murtaugh, 1993). 
peR is a three-step procedure of template DNA denaturation to 
separate the two strands of DNA, primer annealing to the template 
and the extension of the annealed primers by the DNA polymerase. 
This constitutes one cycle of peR. Because the primer extension 
products synthesised in one cycle can serve as a template in the 
next, the number of target DNA copies approximately doubles at 
every cycle. Thus, 20 cycles of peR yields about a million-fold 
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amplification (Jackwood, Kwon and Hilt, 1992). 
The selection oft.imes, temperatures and number of cycles for PCR 
depends on a number of factors (Taylor, 1991) . Incubation times 
are normally kept as short as possible to reduce the overall 
cycling times and to minimise the risk of non-specific 
amplification. The number of cycles also depends on the abundance 
of target DNA and t~e efficiency of the PCR (Saiki, 1989). The 
annealing temperature chosen for a PCR depends on the length and 
composition of the primers (Prof . E . Rybicki, University of Cape 
Town, 1993 pers. comm.). 
Extraction of RNA from material can be performed by the 
guanidinium thiocyanate extraction procedure that inactivates 
RNases and the RNA is then purified by organic extraction and 
ethanol precipitation (Sambrook et al . , 1989), or by the use of 
Proteinase K and SDS for tissue disruption, followed by organic 
extraction of the RNA (Jackwood et al., 1992). After 
transcription of the RNA and PCR, the PCR product is purified and 
then labelled with a molecule that can be easily detected (Kwon 
et al., 1993). The specific base sequence of this labelled probe 
enables it to bind to a specific complementary region of a 
micr90rganism's nucleic acid. This makes the test specific for 
the target organism (Andreasen et al., 1991). 
The use of PCR and specific oligonucleotide probes in routine 
microbiological screening, is an area of great potential and has 
been used to detect many infectious diseases (Peake, 1989). 
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Jing, Cook, Brown, Shaw and Cavanagh (1993) detected TRTV in 
turkeys using the PCR. Turkeys were inoculated with virulent 
strains of TRTV and tracheal swabs were taken from the inoculated 
birds every 2-3 days pi and RNA extracted from them. A reverse 
transcription (RT) reaction was performed on the RNA using a 
primer, designated PCRF.1st, complementary to the 3' end of the 
fusion protein mRNA. This cDNA was then used in a PCR with an 
upstream primer designated F .GRH to generate a 541 base pair (hp) , 
product. To further enhance the result and to exclude non-
specific reactions, a hemi-nested PCR was performed with PCRF .1st 
and another primer designated AN17, using the product of the 1st 
PCR as the sample for this second PCR. This yielded a 175 bp 
product. 
This Chapter describes the synthesis of a TRTV and 652/93 isolate 
probe using the primers described by Jing et al. (1993). The 
652/93 probe will be evaluated as a routine diagnostic tool for 
virus detection. The TRTV probe was used to confirm the identity 
of three TRTV-like isolates and the 652/93 probe to detect the 
presence of the 652/93 isolate at regular intervals pi in 
tracheal swabs of birds inoculated with this isolate. 
6.2. Materials and methods 
6.2.1. Extraction of RNA from allantoic fluid 
Allantoic fluid from SPF eggs separately inoculated with isolates 
4916/91, 652/93, 711/93, Pittman- Moore TRT vaccine virus, IBV 
(TAD) and healthy A/F, were separately harvested 6 days pi and 
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the procedure of Jackwood et al. (1992) for the extraction of RNA 
from IBV-infected A/F, was used for the extraction of RNA from 
the allantoic fluid of the six samples. 
To 438 ~l of A/F in a 1.5 ml sterile microfuge tube, was added 
50 ~l of 20% SDS and 12.5 ~l of a 20 mg/ml Proteinase K solution 
(Sigma). The mixture was incubated at 50°C for 5 min and cqoled 
for 20 min at 20°C. An equal volume of electrophoresis grade 
buffered phenol (10mM Tris pH 7 . 5, 1mM EDTA) (Sigma) was added 
to the solution and thoroughly mixed. This mixture was 
centrifuged for 2 min at 12500 g in a microfuge (Hawksley) and 
the aqueous phase retained. This procedure was repeated twice. 
Thereafter, an equal volume of a chloroform : isoamyl alcohol 
mixture (24:1) was added to the aqueous phase and treated as for 
the phenol extraction. This step was repeated once. 
Precipitation of RNA was performed by adding 0.1 volume (vol) of 
3M sodium acetate (pH 5.0) and 2.5 vol cold 95% ethanol and 
incubating at -20°C for 24 h. The mixture was then centrifuged 
at 12500 g for 30 min in a microfuge. The supernatant was 
discarded and the often invisible pellet resuspended in 6 ~l of 
diethyl pyrocarbonate (DEPC)-treated sterile water. The RNA was 
then transcribed into cDNA by reverse transcriptase. 
6.2.2. Primer synthesis 
Primers used in this study were synthesised by Oligo Express (UK) 
according to the sequence of Jing et al. (1993) for TRTV. The 
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primers were complementary to the PCRF. 1st, F. GRH and AN17 of the 
fusion protein (F) rnRNA of TRTV . The sequences of the primers are 
shown below: 
PCRF.1st: 5'-AAATAACTTAACTGACATAAGCCAT-3' 





Oligonucleotide primer TRT1 was complementary to nucleotides 1612 
to 1636 at the 3' end of the F rnRNA, whilst oligonucleotide TRT2 
corresponded to nucleotides 1096 to 1116 of the F rnRNA. 
Oligonucleotide TRT3 corresponded to nucleotides 1462 to 1481 of 
the F rnRNA (Jing et al., 1993). 
6.2.3. Reverse transcription of RNA 
Reverse transcription (RT) was performed according to the method 
of Sarnbrook et al. (1989) using the avian myeloblastosis virus 
(AMV) reverse transcriptase (Boehringer) . The RT reaction mixture 
was prepared according to the method shown in Table 6.1 . 
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Table 6.1. Ingredients used in the RT reaction 
INGREDIENT VOLUME 
5 X AMV-RT incubation buffer (Boehringer) 4JLl 
Sterile DEPC-treated water 6JLl 
RNAsin (40units/ml) (Pharmacia) 2JLl 
Primer TRT1 (320 JLg/ml) 2JLl 
dNTP mix (20mM) (Boehringer) lJLl 
AMV-RT (40 units/JLl) (Boehringer) 1JLl . 
Sample RNA , 4JLl 
Total reaction volume 20JLl 
The above mixture was incubated at 25°C for 10 min and then at 
42°C for 60 min in a thermal cycler (Hybaid). 
6.2.4. The polymerase chain reaction (PCR) 
The product of the RT reaction of samples 4916/91, 652/93, 
711/93, TRTV, IBV and healthy material produced by AMV-RT, was 
used as template in the PCR reaction as described by Jing et al. 
(1993). The PCR was performed in the same tube as the RT 
reaction. The reaction mixture used is shown in Table 6.2 with 
the reagents added to the tube in the order prescribed in the 
table. The mixture was incubated in a thermal cycler (Hybaid) at 
94°C for 1 min, then at 52°C for 2 min followed by 72°C for 3 
min. This constituted one PCR cycle . Thirty five such cycles were 
performed. 
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Table 6.2. Quantity of ingredients used for the PCR 
INGREDIENTS VOLUME 
Sterile DEPC-treated water 48 III 
dNTP mix (20mM) (Boehringer) 2 III 
Primer TRT1 (320 Ilg/ml) 2 III 
Primer TRT2 (400 Ilg/ml) 2 III 
10 X PCR buffer (Appendix 5) 4 III 
Tag DNA polymerase (2 units) (AB) 2 III . • 
Sterile mineral oil overlay 30 III 
Template DNA (RT tube contents) 20 III 
Total reaction volume 80 III 
A second hemi-nested PCR was performed using 4 III of the product 
of the 1st PCR as template with primers TRT1 and TRT3. The 
reaction conditions were similar to the 1st PCR conditions 
described above, except that the volume of sterile water was 
increased to 64 III to compensate for the reduced volume of 
template DNA (4 Ill), and the TRT2 primer was substituted with 
primer TRT3 . The thermocycler settings and the number of PCR 
cycles were as for the 1st PCR . 
6.2.5. Agarose gel electrophoresis 
The PCR products were resolved by electrophoresis in 2% agarose 
gels using a Mini-Horizontal Electrophoresis Unit (Fisher 
Biotech) connected to a Consort E702 power pack. The gel was 
prepared by melting 0.8g agarose in 40 ml of Tris-acetate-EDTA 
(TAE) buffer (pH 8 . 0) (Appendix, recipe 6). The gel mixture was 
cooled to approximately 50°C and 2 III of a 10 mg/ml ethidium 
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bromide solution added to the mixture. The gel mixture was poured 
into the gel casting tray with the ' "comb" in place. 
After solidification of the gel, the comb was carefully removed 
and the gel transferred to the electrophoresis apparatus. TAE 
electrophoresis buffer (pH 8. 0) was poured into the 
electrophoresis apparatus buffer chamber to a level of 
approximately 2 cm above the gel surface. 
1 JlI of molecular markers consisting of ¢X174 DNA RAE III 
fragments (Promega), were mixed with 13 JlI sterile water and 3JlI 
agarose gel loading buffer (Appendix, recipe 7), and loaded into 
well No.1 of the gel. Fifteen JlI of each PCR sample was mixed 
with 3 JlI of agarose gel loading buffer and individually loaded 
into separate wells of the gel. Well 2 was loaded with 4916/91 
PCR product, well 3 with 652/93 PCR product, well 4 with 711/93 
PCR product, well 5 with TRTV PCR product, well 6 with IBV PCR 
product and well 7 with PCR product obtained with healthy A/F. 
All agarose gels were loaded in this sequence. 
Electrophoresis was performed at 100 rnA for 1 h. After 
electrophoresis, the gel was viewed with a Fotodyne uv 
Transilluminator and photographed with a FCR 10 Polaroid Camera 
using Polaroid 667 instant pack film. 
6.2.6. Purification of 175 bp DNA fragment 
The Magic PCR Prep DNA Purification kit (Promega) was used to 
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clean-up the 175 bp TRTV and isolate 652/93 DNA fragments 
produced by the hemi-nested peR with primers TRT1 and TRT3. 
The oil overlay used for the peR (Table 6.2) was removed from the 
175 bp peR product and 100JLl of the kit buffer placed in a 
sterile 1.5 ml microfuge tube. Sixty JLl of PCR sample were also 
placed in this tube and briefly mixed by vortexing. One ml of 
well mixed kit resin was dispensed in the tube and briefly 
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vortexed 3 times over a period of 1 min. Thereafter, the plunger 
was removed from a sterile 3 ml syringe and a kit microcolumn 
fitted onto the tip of the syringe . The resin-sample mixture was 
poured into the syringe. The syringe plunger was replaced and the 
resin slowly forced into the microcolumn. The fluid discharged 
from the column was discarded . 
The microcolumn was detached from the syringe, the plunger 
removed and the microcolumn reattached to the syringe. Two ml of 
an 80% propan-2-ol solution was introduced into the syringe and 
the plunger replaced. The liquid was gently forced through the 
column. The column was removed from the syringe and placed in a 
new sterile 1.5 ml microcentrifuge tube. This was centrifuged in 
a Hawksley microcentrifuge for 20 sec at 12500 g. The column was 
placed in another sterile 1 . 5 ml microcentrifuge tube and 50 JLl 
of sterile distilled water added to it . This was allowed to stand 
at room temperature for 1 min followed by centrifugation at 
12500 g for 20 sec in a microfuge . The fluid discharged into the 
microcentrifuge tube contained the clean 175 bp DNA fragment 
which was stored at 4°C until ready for labelling with 
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digoxygenin (DIG) (Boehringer). 
6.2.7. Labelling of 175 bp DNA fragment with DIG 
The DIG Labelling and Detection Kit from Boehringer was used for 
the labelling of the 175 bp DNA fragments of TRTV and the 652/93 
isolate. 
The protocol used was as described in the Boehringer Kit insert. 
The DNA fragment was denatured at 95°C for 10 min in a thermal 
cycler (Hybaid) and immediately chilled in an ice-bath 
thereafter. The following ingredients were then mixed together 
in a sterile 1.5 ml microcentrifuge tube: 
5 III denatured 175 bp DNA fragment 
2 III dNTP labelling mix (Kit reagent) 
2 III hexanucleotide mix (Kit reagent) 
10 III sterile distilled water 
1 III Klenow enzyme (Kit reagent) 
The mixture was briefly centrifuged in a microfuge and incubated 
at 37°C for 2 h. The reaction was stopped by the addition of 2 
III 0.2 M EDTA (pH 8.0). The labelled 175 bp probe was 
precipitated with 2.5 III 4 M lithium chloride (LiCl) and 75 III 
chilled 95% ethanol. The solution was thoroughly mixed and 
allowed to stand at -70°C for 30 min. The mixture was centrifuged 
at 12500 g for 10 min and the pellet washed with chilled 95% 
ethanol. The resuspended mixture was again centrifuged at 12500g 
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for 10 min. The supernatant was discarded and the excess ethanol 
allowed to evaporate. The dried pellet was dissolved in 50 ~l 
Tris-EDTA (TE) buffer (1M Tris-HCl, pH 8.0; O.lM EDTA) (Sigma) 
and stored at 4°C until required for use. 
6.2.8. Evaluation of DIG labelled probe 
Three groups of 10 4-week-old SPF birds were housed in separate , 
isolators and one group inoculated via the eyedrop method with 
0.2 ml of the 5th y/s passaged 652/93 isolate containing 106.2 
EIDso/rnl. Another group was inoculated with 103.4 EIDso/rnl of IBV 
(TAD) and the third group was the uninoculated control group. 
Tracheal swabs were taken from these birds daily up to 21 days 
pi. RNA was extracted from these swabs according to the method 
of Sambrook et al. (1989). 
Swabs were shaken in 0.5 ml guanidinium isothiocyanate (GITC) 
extraction solution (Appendix, recipe 8) in a 1.5 ml microfuge 
tube. The tubes were microfuged at 12500 g for 30 min. The 
supernatant was discarded and the pellet resuspended in 0.5 ml 
extraction buffer containing 1 ~l of a 20 ~g/~l glycogen 
solution. To this solution was added 50 ~l of a 2 M sodium 
acetate (pH 4.1) solution, 0.5 ml O.lM citrate buffer (pH 4.3) 
saturated phenol (Sigma), and 0.1 ml of a 49: 1 mixture of 
chloroform isoamyl alcohol. The mixture was vortexed and 
microfuged at 12500 g for 5 min. The aqueous phase was recovered 
and mixed with 2.5 vols of cold 95% ethanol. This solution was 
stored at -20°C overnight and microfuged at 12500 g for 30 min. 
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The pellet was resuspended in 10 ~l TE buffer (pH 8.0). The RT 
reaction and PCR with primers TRT1 and TRT2 were performed on 
these samples as previously described. The PCR products were 
probed with the 175 bp 652/93 isolate DIG-labelled probe. 
The RT-PCR products of 4916/91, 652/93, 711/93, TRTV, IBV, and 
healthy material from A/F-extracted RNA, were also probed with 
the 652/93-isolate and TRTV DIG-labelled probes .. 
6.2.9. Blotting procedure for DIG-labelled probe 
The Boehringer blotting and probing procedure, as described in 
the DIG DNA Labelling and Detection Kit insert, was used. 
One ~l of each PCR sample product was dot blotted onto nylon 
membrane (Amersham), baked at 80°C for 30 min and UV cross-linked 
for 30 secs on a UV transilluminator (Fotodyne). Thereafter, the 
blot was placed in hybridising buffer (Appendix, recipe 9) for 
1 h at 68°C. The labelled probe (652/93 or TRTV) was denatured 
at 95°C for 10 min and diluted to 5 ~l/ml of hybridising buffer. 
The blot was incubated with the diluted probe for 2 h at 68°C and 
washed twice for 5 min each at 68°C with 2 X SSC buffer (pH 7.0) 
(Appendix, recipe 10). Two 15 min washes were performed with 0.1 
X SSC buffer followed by one 1 min wash with buffer 1 (Appendix, 
recipe 12) and one 30 min wash with buffer 2 (Appendix, recipe 
13). These washes were performed at 680C. 
The Boehringer DIG DNA Labelling and Detection Kit anti-DIG 
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reagent was diluted 1:5000 in buffer 2 and the blot incubated 
with it for 30 min at 37°C followed by two 15 min washes with 
buffer 1. The blot was then washed for 2 min with buffer 3 
(Appendix, recipe 14) . 
Just prior to use, colour-substrate solution was prepared by 
mixing 22.5 ~l nitroblue tetrazolium (NET) (Boehringer) with 17 
~l 5-bromo-4-chloro-3-indolyl phosphate (Boehripger) and 5.ml . 
buffer 3. The blot was incubated with this substrate at 37°C for 
2 h. The reaction was stopped by washing the blot with TE buffer 
(pH 8 . 0) for 5 min. 
Each blot contained negative and posi ti ve control samples. 
Negative control samples consisted of PCR product of IBV and 
healthy A/F material whilst the positive control sample consisted 
of the 652/93 or TRTV 175 bp DNA fragment, complementary to the 
probe being used. 
6.3. Results 
6.3 . 1. Agarose gel electrophoresis of PCR products 
The results of the agarose gel electrophoresis of the PCR 
products using primers TRT1 and TRT2, are shown in Plate 6.1. The 
size of the DNA bands obtained in the test sample lanes were 
determined from the standard graph (Fig. 6.1). Table 6.3 depicts 
the size of the ¢X174 DNA marker fragments and their ~ values 
as well as the ~ values and sizes of the fragments obtained with 
652/93. Since 4916/91, 652/93, 711/93 and TRTV all yielded 
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identical results, only those for 652/93 are shown in Table 6.3. 
A band of approximately 541 bp in size was visualised in the 
sample lanes containing 4916/91, 652/93, 711/93 and TRTV PCR 
product. No such band was detected in the IBV and heal thy 
material PCR product lanes. 
Agarose gel electrophoresis results of PCR product obtained with 
primers TRT1 and TRT3, are shown in Plate 6 .. 2. A band. of 
approximately 175 bp in length was detected in the same lanes as 
for the 541 bp bands reported above. No bands were detected in 
the IBV and healthy material PCR product lanes. 
Table 6.3 . The ~ values and sizes obtained after 
electrophoresis of TRTV and TRTV-like isolate PCR 
products in a 2% agarose gel using primers TRT1 
+ TRT2 and TRT1 and TRT3 with ¢X174 DNA fragments 
as markers . 
¢X174 DNA MARKERS 652/93 PCR PRODUCT 
SIZE (bp) ~ ~ SIZE (bp) 
1353 0 . 50 0 . 90 175 













peR product of TRTV and TRTV-like isolates using 
primers TRT1 and TRT2 electrophoresed in 2% 
agarose gel. Lane 1 = ¢X174 DNA markers; lane 2 
= Isolate 4916/91 peR product; lane 3 = Isolate 
652/93 peR product; lane 4 = Isolate 711/93 peR 
product; lane 5 = TRTV peR product; lane 6 = IBV 
peR product; lane 7 = healthy A/F peR product. 
peR product of TRTV and TRTV-like isolates using 
primers TRT1 and TRT3 electrophoresed in 2% 
agarose gel. Lanes loaded as for Plate 6.1. 
DNA probe blots of peR product using the 652/93 
probe (6.3a) and the TRTV probe (6.3b). Dot 1 = 
4916/91; 2 = 652/93; 3 = 711/93; 4 = TRTV; 5 = 
po~itive control; 6 = IBV; 7 = healthy 
unlnoculated A/F. 6.3(c) is the DNA probe blot 
using the 652/93 probe on swabs taken from 
652/93-inoculated birds from day 1 to day 21 
after inoculation. Dot 22 = swabs from IBV-
inoculated birds; 23 = healthy uninoculated 
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6.3.2. DNA-probe blots 
The results of the probing of peR samples with the 175 bp DIG-
labelled TRTV and 652/93 isolate probes, are shown in Plates 
6 . 3 a, band c . . 
The 4916/91, 652/93, 711/93 and TRTV peR products from A/F, 
yielded positive pr,obe results with both the 'IRTV and 652(93 
isolate probes (Plates 6. 3a and 6. 3b respectively). The peR 
products of RNA extracted from IBV infected A/F and healthy A/F, 
did not hybridise to either probe. Positive 652/93 isolate probe 
results were obtained for the peR products of tracheal swab 
samples up to 19 days pi as shown in Plate 6.3c. The peR product 
of swabs taken from healthy birds and birds inoculated with IBV, 
did not hybridise with the 652/93 isolate probe and therefore 
yielded negative probe results. 
6.4. Discussion 
Every organism has a unique genetic composition which 
distinguishes it from other organisms. The principles of nucleic 
acid probes are based on this phenomenon. Numerous nucleic acid 
probes are currently in use for the diagnosis of infectious 
organisms and genetic disorders (Roberts, Montandon, Green and 
Bentley, 1991). 
According to Jing et al. (1993), the 541 bp band obtained with 
primers TRT1 and TRT2 are specific for TRTV and can be used for 
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the diagnosis of TRTV. Using the RT-PCR, the 541 bp band was 
detected by agarose gel electrophoresis using A/F separately 
infected with isolates 4916/91, 652/93, 711/93 and TRTV. This 
band was not detected with healthy A/F or IBV infected A/F, 
thereby demonstrating the specificity of the primers for TRTV or 
TRTV-like isolates. However, non-specific reactions have been 
reported to occur in some PCR's (Kwok and Higuchi, 1989). 
Therefore, to further validate the results, the hemi-nested peR 
with primers TRT1 and TRT3 was performed using the product of the 
1st PCR as sample template. This generated a 175 bp product 
specific for TRTV. The 175 bp fragment occurs inside the 541 bp 
fragment thereby eliminating the risk of non-specific priming. 
Hence, the presence of a 175 bp band after PCR with primer sets 
TRT1 and TRT2 followed by TRT1 and TRT3, is indicative of the 
presence of TRTV (Jing et al., 1993). 
Although the 175 bp band visualised in the agarose gels is 
specific for TRTV, to show that it is of the same sequence as 
TRTV, a DNA probe was developed by labelling the 175 bp fragment 
produced from 652/93 isolate and TRTV extracted RNA, with DIG. 
If a sample DNA contained the same sequence of nucleotide bases 
as the specific 175 bp fragment, then the 175 bp labelled probe 
will hybridise to this fragment producing a colour reaction when 
the probe-blot is developed. 
A/F samples of isolates 4916/91, 652/93, 711/93 and TRTV 
hybridised to the TRTV probe and yielded positive results. TRTV-
infected A/F was used as the positive control and IBV-infected 
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A/F as the negative control. These results confirm the identity 
of 4916/91, 652/93 and 711/93 as chicken isolates of TRTV. The 
ter.m avian rhinotracheitis virus (ARTV) is therefore used to 
distinguish the chicken isolates from the turkey isolates of 
rhinotracheitis virus. 
The obvious benefit of an infectious disease nucleic acid probe 
is to detect the presence of a virus in the field early in the 
disease outbreak, thereby enabling the early treatment of the 
disease. The 652/93 isolate probe was therefore evaluated in a 
controlled laboratory study by infecting birds with the chicken 
isolate of TRTV (652/93 isolate), and tracheal swabbing these 
birds daily for up to 21 days pi. The probe was able to detect 
the virus for 19 days pi, suggesting that the virus persists in 
the bird, although at low levels, for 19 days after infection. 
The reason for the inability to isolate virus from birds beyond 
6 days pi, could be due to the low titres at which the virus 
persists in the birds. These results are consistent with the 
findings of Jing et al. (1993) who were able to detect TRTV in 
turkeys for 17-19 days pi. 
These results are encouraging in that the probe could be used for 
the field detection of ARTV infection. This has far reaching 
implications with regard to disease diagnosis. Conventional virus 
isolations for the diagnosis of ARTV are time consuming and 
difficult. A successful ARTV isolation from field material would 
take a minimum of 2 weeks to grow the virus and a further 2 weeks 
for identification purposes. The result of the virus isolation 
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attempt would therefore only be available a month after the 
sample was taken. The cost of the isolation and subsequent tests 
are enormous since SPF eggs with a cost of approximately RB.OO 
per egg, are used for virus isolation attempts. Also, the virus 
can only be isolated from fresh field material for a maximum of 
7 days pi (Cook et al., 1991; Naylor, Al-Ankari, Al-Afaleq, 
Bradbury and Jones, 1992). 
The detection of ARTV from tracheal swabs by RT-PCR followed by 
the DNA probe hybridisation assay, would take only 2 days or a 
maximum of 3 days if the hemi-nested PCR was performed. The RT-
PCR-probe assay can detect minute quantities of ARTV for a long 
period of time (19 days) without the need for other confirmatory 
tests to identify the pathogen, since the RT-PCR-probe assay is 
specific (Jing et al., 1993). The advantages of the RT-PCR-probe 
system over the conventional methods of isolation, are therefore 
obvious. 
The results presented in this Chapter confirm that the three 
isolates, 4916/91, 652/93 and 711/93, are chicken strains of 
TRTV. However, the probe could not distinguish between the 
chicken and turkey strains of the virus due to their close 
relatedness and the fact that the TRTV primers used were derived 
from sequences of the nucleic acid common to TRTV and ARTV. 
Sequencing of the ARTV genome is required to determine 
differences, if any, between the TRTV and ARTV genomes. 
109 
CHAPTER 7 
PRODUCTION OF A VACCINE AGAINST A TRTV-LIKE VIRUS 
7.1. Introduction 
Disease of animals occurs when the animal's body defences are 
impaired and the severity of the disease is determined by the , 
degree of impairment. Diseases caused by infectious agents may 
be complex and dependent upon the characteristics of the host and 
infectious agent. Whether an infectious agent is capable of 
causing disease, depends on a number of factors such ' as the 
virulence of the agent, its route of entry into the host, 
environmental factors, genetic susceptibility and immunological 
status of the host, and the presence of other infectious agents. 
Some organisms exist as strains of different virulence. Velogenic 
strains of an organism may overcome the hosts' natural resistance 
and cause severe disease and mortality. Mesogenic strains may 
cause moderate disease with little mortality whilst lentogenic 
strains normally cause very slight or no reaction in healthy 
hosts. The lentogenic strains may be used as potential vaccines. 
However, some strains may not cause disease on their own but 
predispose the host to infection by other infectious agents which 
may then cause disease. Also, adverse environmental conditions 
and stress of birds, may result in strains that are normally 
considered nonpathogenic, causing disease (Zander, 1984) . 
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Vaccination of flocks of cormnercially reared birds, is very 
useful in the control of most viral disease outbreaks. 
Theoretically, the ideal viral vaccines are those manufactured 
with live avirulent strains since they normally stimulate the 
irmnunising mechanisms in a similar way to the natural infection, 
although less intensively, and also because live vaccines are 
easily mass applied thus making them less labour intensive than 
vaccination with inactivated vaccines (Zanella and Marchi, 1982) . 
Also, the age of application of live vaccines could be easily 
maneuvered to accormnodate changes in vaccination prograrmnes, 
whereas inactivated vaccines, for practical reasons, would have 
to be applied at 1 day of age. 
The method of live vaccine application is very important. 
Vaccination of day-old chicks can be performed by the "eye-drop" 
method where a drop of reconstituted vaccine is introduced onto 
the eye, or by spray vaccinating where the vaccine is 
reconstituted in a volume of deionised water and sprayed over the 
chicks. Birds older than one day of age, can be spray vaccinated 
or the vaccine may be administered via the drinking water. 
However, according to Dr Philip Box (Pittman-Moore Ltd UK, 1992 
pers. cormn.), avian Pneumoviruses should not be administered via 
the drinking water since these viruses are rapidly inactivated 
in chlorinated water. Different vaccines work well at different 
ages. The time and frequency of application depend on conditions 
prevalent in the area. 
Several cormnercial vaccine manufacturers have marketed attenuated 
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TRTV vaccines for use in turkeys and chickens. However, all these 
vaccines comprise viruses isolated from turkeys. None of the 
vaccines consist of a virus isolated from chickens. The method 
of large scale production of the vaccine differs from one 
manufacturer to the next . Some use chicken eggs as the medium for 
vaccine production (Box, 1989), whilst others use Vero cells 
(Ivaz Vaccine Manufacturers Italy, 1993 pers. cornm.). Williams 
et al. (1991ai b) produced a TRTV vaccine in V~ro cells which 
provided protection to susceptible turkey poults from challenge 
with a virulent virus, whilst Cook and Ellis (1990), used 
alternate passaging between TOC's and chicken eggs to 
sufficiently attenuate a TRTV for use as a potential vaccine. 
Vaccines against any disease must be pure, effective, stable, 
economically applicable and must not constitute a danger to the 
health of the vaccinates (Lensing, 1973). The vaccine must 
therefore be subjected to extensive bacteriological and 
mycological tests and must contain no microorganism other than 
the vaccine microorganism. The vaccine has to contain a suitable 
number of infective virus particles capable of causing a 
seroconversion in birds and offering protection against virulent 
virus. Also, there should be a demonstrable benefit in vaccinates 
compared to non-vaccinated birds . 
In this Chapter, the selection of an isolate , derived from 
chickens, for use as a vaccine and further testing in laboratory 
and field trials to evaluate its efficacy, are described. The 
stability of the attenuation and the purity of the vaccine was 
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also tested. 
7 . 2. Materials and Methods 
7.2.1. Selection of an isolate for use in a vaccine 
The purified 6th y/s A/F of each of the three isolates, 4916/91, 
652/93 and 711/93, were separately inoculated in SPF chick TOC's 
and at the first sign of ciliostasis, the fluid WqS harvested and 
inoculated into the y/s of 6-day-old embryonated SPF chicken 
eggs. After 6 days, the A/F was harvested and re-inoculated into 
TOC' s. This alternate passaging between TOC's and eggs was 
performed for 10 passages. This is similar to the method of Cook 
and Ellis (1990) where they used TOC-a/s passaging. This 
procedure of TOC-a/s passaging was also performed. 
Approximately 0 . 5 ml of the 10th TOC-y/s passaged A/F, yolk, and 
homogenised CAMs, the 10th TOC-a/s passaged A/F, the 5th Vero 
cell passaged material, and the 5th CEF passaged fluid of all 
three isolates, were separately inoculated intrasinusly or by the 
eyedrop method, in 4-week-old SPF birds housed in isolators. The 
birds were bled before inoculation and 14 days post-inoculation 
from the brachial wing vein. The sera were tested for antibodies 
against TRTVwith the Pathasure avian rhinotracheitis ELISA kit. 
The EID~ or TCID~ of the isolates in each system, except the 10th 
TOC-y/s passaged material, was not determined as this was done 
previously and discussed in Chapter 3. 
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7.2.2. Stability of the attenuation 
The 11th TOC-y/s passaged isolate of 652/93, was given an 
additional passage via the y/s route and then a total of 0.5 ml 
of this A/Fwas inoculated intrasinusly, orally, and via the eye 
drop method, into a total of 10 day-old SPF chicks which were 
then housed in an isolator. Six days post-inoculation, the 
trachea and turbinates were harvested from the 10 chicks, 
homogenised in 6 rn1 of PBS, centrifuged at 3000 g in a Heraeus 
Hettich Universal II centrifuge to sediment the debris, and the 
supernatant was inoculated into a further 10 day-old SPF 
chickens. This procedure was repeated for five passages. After 
the final passage, 50% of the birds were kept for 12 days post-
inoculation. Birds in each passage were observed daily for 
symptoms of infection. 
After the 5th passage, the trachea and turbinates were removed 
from 50% of the birds, processed as described earlier, and the 
supernatant used for virus isolation attempts as described in 
Chapter 2. Upon isolation of virus, a serum neutralisation test 
was performed on the isolate using monospecific antisera against 
the 652/93 isolate. The entire procedure was repeated with 4-
week-old SPF chickens. 
7.2.3. Vaccine production 
For various reasons discussed later in this Chapter, isolate 
652/93 was selected as the candidate for use as a vaccine. The 
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10th TOC-y/s passaged material was used as the master seed for 
vaccine production. The working seed for vaccine production 
consisted of an additional passage of the master seed. Six-day-
old embryonated SPF chicken eggs were inoculated via the y/s with 
o .2 ml of a 10-2 dilution of the working seed. The eggs were 
chilled at 4°C for 24 hrs when the first signs of embryo 
mortality of a proportion of the embryos (15-20%) were observed. 
The A/F, yolk fluid, and CAM were then harvested. The A/F and 
yolk were combined and clarified by centrifugation at 6000 g for 
15 min in a Sorval GSA rotor using a Sorval RC28S centrifuge. The 
supernatant was decanted through sterile muslin cloth into a 
sterile collection vessel kept on ice. The CAMs were homogenised 
in a half volume of PBS (pH7.2) and centrifuged at 6000 g as 
before. The supernatant was filtered through sterile muslin cloth 
into the vessel containing the clarified allantoic and yolk . 
fluids. Two ml of a penicillin / streptomycin solution containing 
25000 units/ml and 25000 ug/ml respectively (Bio Whittaker), were 
added to each litre of supernatant. This material constituted the 
vaccine which was dispensed into 5 ml cryogenic vials and stored 
at -70°C until released for use. 
A vial of the freshly dispensed vaccine as well as a vial of 
vaccine stored at -70°C for 7 days, were titrated in the y/s of 
6-day-old embryonated SPF eggs as previously described. 
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7.2.4. Sterility tests 
Sterility tests were performed by inoculating thioglycollate and 
Freys broth with O. 5 ml of the vaccine and the vaccine was 
streaked onto blood agar, nutrient agar and sabaroud agar. The 
Freys broth was incubated at 37°C for 10 days whilst the 
remaining agars and broth were incubated at 37°C for 48 hand 
then visually inspected for growth of microorga~isms. • 
7.2.5. Purity test 
Monospecific antiserum against the 652/93 isolate was reacted 
with an equal volume of vaccine in a serum neutralisation test 
as described in Chapter 3. The test was carried out in the y/s 
of 6-day-old embryonated SPF chicken eggs. 
7.2.6. Safety 
Each of 10 1-day-old and 10 4-week-old SPF chickens, housed 
separately in isolators, were inoculated intranasally and by the 
ocular route with a total of 0.5 ml of vaccine. The birds were 
observed daily for 28 days for mortality, and symptoms of 
infection such as rhinitis, sinusitis, swollen he.ads, and 
snicking. 
7.2.7. Serological tests for extraneous viruses 
Ten 4-week-old SPF chickens, housed in an isolator, were 
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inoculated intrasinusly, intramuscularly and by the ocular route 
with a total 1 ml of vaccine. This inoculation was repeated at 
10 days of age. The birds were kept in the isolators for a period 
of 4 wks post-inoculation. Serum was drawn from these birds 
before inoculation and at 4 wks post-inoculation for the 
detection of antibodies against IBV, NOV, IBDV, reovirus, avian 
encephalomyelitis virus (AEV) , M. gallisepticum (MG) , M. synovia 
(MS) and TRTV as shown in Table 7.1. The table als,o indicates the 











·Rapid Serum Plate Agglutination 
Tests employed to detect antibodies against 
various diseases in SPF chickens inoculated with 
the 652/93 isolate vaccine. 
I TEST EMPLOYED I SOURCE I 
ELISA Delta Biologicals 
ELISA Delta Biologicals 
ELISA Delta Biologicals 
ELISA Idexx 




7.2.8. Evaluation of the efficacy of the vaccine in 
laboratory trials 
Ten day-old SPF chicks were each inoculated by the eye drop 
method with a bird dose of vaccine (103.6 EIDso/bird) . A further 10 
14-day-old SPF chicks were inoculated intranasally with 0.2 ml 
of the 3rd y/s A/F of isolate 652/93. Another group of 10 day-old 
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SPF chicks were inoculated via the eye drop method with a bird 
dose of vaccine and challenged 14 days later by intranasal 
instillation of 0.2 ml of the 3rd y/s A/F of isolate 652/93. The 
fourth group of day-old SPF chicks were inoculated via the eye 
drop method with 0.2 ml of PBS only. All groups of birds were 
housed under similar conditions in separate isolators for the 
duration of the experiment. The chicks were observed daily for 
symptoms of infection or vaccine reaction. 
Twenty day-old SPF chicks, housed in an isolator, were each 
vaccinated with one bird dose of vaccine via the eye drop method. 
After 14 days, 10 birds were removed from the isolator and placed 
in another isolator. The remaining 10 birds in the first isolator 
were re-vaccinated with a bird dose of vaccine via the eye drop 
method and maintained in the isolator for a further 14 days. 
Another group of 10 SPF birds, maintained in an isolator, were 
vaccinated only at 14 days of age with a bird dose of the 
vaccine. Ten day-old SPF chicks were maintained in an isolator 
for 28 days without any vaccination. All groups of birds were 
bled at 14 and 28 days of age. Serum for determination of the 
TRTV antibody status at day-old was obtained by sacrificing 10 
day-old SPF chicks. TRTV ELISA, using the Pathasure avian 
rhinotracheitis kit, was performed on all the serum samples. 
7.2.9. Evaluation of the efficacy of the vaccine in field 
trials 
A trial was conducted at a broiler site using the 652/93 vaccine. 
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The site consisted of four subsites designated A, B, C, and D. 
Each subsite, except for A which had six houses, possessed four 
houses. Chicks to be placed at subsite A were vaccinated at one 
day of age by the eye drop method. Chicks placed at subsite B 
were vaccinated at one day of age by the eye drop method and at 
14 days of age by the spray method. Chicks placed at subsite C 
were vaccinated only at 14 days of age whilst chicks at subsite 
D were not vaccinated with the 652/93 vaccin~. All day-"ld 
vaccinations were performed at the hatchery. All other 
vaccinations were identical for each group. Thirty thousand birds 
were placed in each house. 
Twenty-five chicks from each subsite were sacrificed at day-old 
for serum and twenty-five birds were bled fortnightly from the 
brachial wing vein thereafter. The sera were tested for the 
presence of antibodies against NDV by the HI test, M. 
gallisepticum and M. synovia by the RSPA test, and IBV and TRTV 
by the Delta ELISA and the Pathasure ELISA systems respectively. 
A proportion of the sick and dead birds from each subsite were 
examined by a Rainbow Farms Veterinarian (Dr. M. J Versfeld). 
Samples for virus isolation attempts and bacteriology were taken 
when necessary. The trial was terminated when the birds were 35 
days of age since a large proportion of the birds were 
slaughtered as grillers at this age. The serology, mortality and 




7.3.1. Selection of an isolate for vaccine production 
The titres of the 10th TOC-y/s passaged A/F of the three isolates 
are shown in Table 7.2. The 652/93 isolate 10th TOC-y/s passaged 
A/F had the highest EID~/ml. The SPF birds inoculated 
intrasinusly with the 10th TOC-y/s passaged 652/93 isolate A/F, 
produced the highest level of seroconversion against TRTV. The , 
similiarly passaged 4916/91 and 711/93 isolates, also caused 
seroconversion in SPF birds but at a lower level than that of the 
652/93 isolate. The Vero cell passaged material of all three 
isolates caused a much reduced level of seroconversion than the 
TOC-y/S passaged material whilst the CEF material produced no 
seroconversion. The TOC-a/s passaged material of all the three 
isolates inoculated intrasinusly, produced only slight 
seroconversion in SPF birds with the highest level produced by 
the 652/93 isolate. The results of the intrasinus inoculation of 
SPF birds with the various materials are depicted in Table 7.3. 
Only the TOC-y/s passaged 652/93 isolate caused a good 
seroconversion in SPF chicks when inoculated via the eye drop 
method. All the other passaged material caused negligible or no 
seroconversion in SPF birds inoculated via the eye drop method. 
The results are depicted in Table 7.3. The yolk material and 
homogenised CAMs of the TOC-y/s passaged material of all three 
isolates caused a good seroconversion in SPF birds when 
inoculated intrasinusly. However, this seroconversion was 
drastically reduced when the same samples were inoculated via the 
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eye drop method. Nonetheless, the, 652/93 material consistently 
produced higher titres of antibodies against TRTV, than any of 
the other isolates. The results are presented in Table 7.4. 
Table 7.2. The titres of the 10th TOC-y/s passaged A/F of 
the three TRTV-like isolates 
I ISOLATE I TITRE (EIDso/ml) I 
4916/91 . 104.6 
652/93 106.6 
. 
• . . 
711/93 104.2 
Table 7.3. Seroconversion results obtained before and after 
intrasinus and eye drop inoculation of SPF 
chickens with various passages of the three TRTV-
like isolates 
ISOLATE INTRASINUS EYE DROP 
PRE· POST· PRE· POST· 
4916/91 10th TOC-y/s 21 92 22 36 
4916/91 10th TOC-a/s 17 42 24 30 
4916/91 5th CEF 20 23 21 20 
4916/91 5th Vero 20 42 15 28 
652/93 10th TOC-y/s 22 104 24 69 
652/93 10th TOC-a/s 18 66 24 38 
652/93 5th CEF 25 26 18 25 
652/93 5th Vero 24 78 20 31 
711/93 10th TOC-y/s 22 90 18 37 
711/93 10th TOC-a/s 21 39 22 32 
711/93 5th CEF 20 25 20 18 
711/93 5th Vero 18 52 26 29 
• = ELISA index value pre-inoculation or post-inoculation 
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Table 7.4. Seroconversion results obtained before and after 
intrasinus and eyedrop inoculation of SPF 
chickens with the CAMs and yolk of the three 
TRTV-like isolates 
ISOLATE INTRASINUS EYE DROP 
PRE· POST· PRE· POST· 
4916/91 yolk 24 78 21 32 
4916/91 CAM 16 90 23 33 
652/93 yolk 19 90 24 39 
96 18 48 
•. 
652/93 CAM , 18 
711/93 yolk 22 72 26 29 
711/93 CAM 24 82 19 31 
.= ELISA index value pre-inoculation or post-inoculation 
7.3.2. Stability of the attenuation 
There were no signs of infection i~ both groups of chickens, the 
group inoculated at day-old and that inoculated at 4 wks of age, 
in all the 5 bird-bird passages. Virus was isola~ed from both 
groups of chickens after the 5th' passage and they were both 
neutralised with the 652/93 isolate monospecific antisera by the 
serum neutralisation test. 
7.3.3. Vaccine production 
Eggs inoculated with the working seed were chilled 6 days post-
inoculation when the first signs of embryo mortality occurred. 
Approximately 20% of the embryos were dead at this stage with the 
remaining embryos showing signs of stunting. Approximately 25 ml 
of a combination of A/F, yolk and homogenised CAMs was obtained 
122 
from each SPF egg inoculated with the 652/93 vaccine isolate. The 
titre of the final blend of vaccine before and after freezing at 
-70°C, was 106.6 E1Dso/ml and 106.5 E1Dso/ml respectively. 
7.3.4. Sterility tests 
There was no growth of microorganisms in any of the agars or 
broths. • 
7.3.5. Purity tests 
The vaccine virus was neutralised by monospecific antisera 
against the 652/93 isolate. The neutralisation index was 5.7. 
7.3.6. Safety 
None of the birds in the two groups, the day-old inoculated and 
4-week-old inoculated groups, showed any signs of infection. The 
birds appeared healthy throughout the duration of the experiment. 
7.3.7. Serological tests for extraneous viruses 
Except for TRTV, the SPF birds inoculated with the vaccine were 
serologically negative for the presence of antibodies against the 
various organisms tested. There was a dramatic increase in 
antibodies against TRTV in the inoculated birds. Table 7.5 shows 
the differrence in antibody titres before and after inoculation 
with the vaccine. 
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Table 7.5. Antibody levels of SPF birds against various 
diseases before and after vaccination with the 
652/93 vaccine 
ORGANISM ANTIBODY TITRES· 
PRE-INOCULATION POST-INOCULATION 
IBV 80 82 
IBDV 72 68 
Reovirus 72 70 
AEV 14 16 . 
NOV 0 0 
MG -ve -ve 
MS -ve -ve 
TRTV 20 109 
• = TRTV ELISA index values 
7.3.8. Evaluation of the efficacy of the vaccine in 
laboratory trials 
The day-old chicks vaccinated with one bird dose of vaccine, 
, showed no symptoms of infection or any vaccine reaction for the 
entire duration of the trial . However, the group of chicks 
inoculated intranasally with the 3rd y/s A/F of isolate 652/93 
caused a slight sinusitis 3 days post-inoculation in 40% of the 
chicks. This symptom lasted only for 1 day and the chicks 
appeared to have fully recovered by the following day. 
Neither the group of chicks vaccinated at day-old and then 
challenged at 14 days of age with the 3rd y/s A/F of isolate 
652/93, nor the control group inoculated with PBS, showed any 
symptoms of disease for the duration of the experiment. 
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The serological results of the 20 day-old SPF chicks vaccinated 
at day-old, at day-old plus 14 days, and only at 14 days of age 
are depicted in Table 7.6. The chicks seroconverted from a 
negative TRTV ELISA index value at day-old, to a value indicating 
a large amount of TRTV antibodies at 14 days of age. The level 
of antibodies increased to a higher value by 28 days of age. The 
group vaccinated only at day-old had a slightly lower TRTV ELISA 
index value at 28 days of age. The group vaccinated only at'14 
• 
days of age had a similar ELISA index value as the group 
vaccinated only at day-old. The control group of birds showed 
virtually no shift in their day-old, 14 day- and 28 day-TRTV 
antibody titres 
Table 7.6. TRTV ELISA results of chicks vaccinated with the 
652/93 vaccine at day-old, day-old and 14 days, 
and at 14 days only 
VACCINATION TRTV ELISA INDEX VALUE 
AGE 
DAY-OLD 14 DAYS 28 DAYS 
day-old 18 36 44 
day-old + 14 days 18 36 48 
14 days 18 20 42 
non-vaccinated 18 21 20 
7 . 3 . 9. Evaluation of the efficacy of the vaccine in field trials 
The average mass of the birds from each subsite at various ages, 
are shown in Table 7.7 below. The average mass of the birds at 
35 days of age at all the vaccinated sites was higher than that 
of the unvaccinated control site. Also, the mass of the birds at 
all sites was higher than the Rainbow Farms inhouse standard mass 
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of birds at that age. No statistical analysis was performed on 
these figures since due to the lack of manpower, only one house 
on each subsite was weighed. The serology results of the birds 
in each subsite are shown in Table 7.8. Subsite B had an elevated 
NOV HI titre at 35 days whilst the IBV ELISA titre of subsite C 
at this age was higher than that of the other subsites. The TRTV 
.ELISA titres of all subsites, except C which was lower, were 
similar. All subsites were positive for antibod.ies against·M . 
• 
gallisepticum, but negative for antibodies against M. synovia. 
Table 7.9 shows the daily mortality of birds in each house at the 
various subsites. The average mortality at subsites A (6.09%) and 
B (6.28%) was lower than that at C (7.37%) and D (7.26%). 
However, using the "Minitab Statistical Software" package, a 
oneway analysis of variance was performed ("t" test). It was 
found that at the 95% confidence limit, there were no significant 
differences between the treatments. Fig. 7.1 graphically depicts 
the average daily mortality of subsites A, B, C and D. 
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Average mass of birds at various ages from 
subsites A, B, C and D 
STANDARD AND AVERAGE MASS AT SUBSITES (g) 
STD A B C D 
221 236 233 235 233 
335 358 357 359 352 
449 479 481 486 479 
610 662 672 674 648 
751 808 812 820. 795 • 
1095 1169 1173 1173 1148 
1300 1377 1384 1386 136 
Serology results of vaccinated and unvaccinated 
birds from subsites A, B, C and D at fortnightly 
intervals 
TRT ELISA IBV ELISA NDV HI 
14 28 35 0 14 28 35 0 14 28 35 
33 37 65 118 54 80 100 5 2 2 2 
32 38 65 120 60 90 80 6 2 3 6 
28 26 37 118 72 102 140 5 3 3 2 
28 30 35 110 56 80 77 5 2 3 3 
The Veterinarian did not take samples for viral or bacterial 
isolation attempts from any of the subsites, as he felt that it 
was not justified. Also, he did not note any major disease 
problems during post-mortem examination of dead and live birds 
from each subsite. The cause of death was non-specific. 
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Several groups have licensed live attenuated TRTV vaccines for 
use against virulent TRTV in turkeys. The vaccines are not 
indicated for use in chickens . All of these vaccines consist of 
isolates made from turkeys (Pitman-Moore Ltd, UK; Ivaz Vaccine 
Manufacturers, Italy; Intervet, Holland). Some groups have used 
Vero cell propagated virus (Williams et al., 1991&) whilst others 
employ SPF chicken eggs (Pitman-Moore Ltd, UK). In this study, 
various routes of propagation of three TRTV-like isolates were 
tested for their suitability as a live chicken derived vaccine. 
Alternation between Toc-y/s passaging was attempted as a method 
to attenuate the isolates without significantly altering them. 
This Toc-y/s passaging is similar to the method employed by Cook 
and Ellis (1990) where they used TOC-a/s passaging to attenuate 
their TRTV isolate without drastically affecting its 
irnrnunogenicity. According to them, this worked well as a vaccine, 
but there were always clinical signs of infection following 
vaccination of turkeys. 
From the results, it is evident that the best candidate for a 
live vaccine was the 10th TOC-y/s passaged 652/93 isolate. This 
isolate had the highest titre when passaged via this system and 
also induced the highest antibody response against TRTV in SPF 
birds. The TOC-a/s passaged A/F did not stimulate the same high 
level of antibodies against TRTV . This is contrary to the results 
of Cook and Ellis (1990) who obtained very good seroconversion 
with their TOC-a/s material . This could be due to slight 
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differences between the two isolates caused by differences in 
their isolation and propagation. This view was also expressed by 
Cook et al. (1993a) to explain differences between isolates from --
different geographical areas. 
The Vero cell passaged material of all three isolates caused a 
much reduced level of seroconversion against TRTV compared to the 
TOC-y/S material. This was unexpected since the~e was a severe 
CPE in the Vero cell monolayer and other workers obtained good 
seroconversion with Vero cell propagated isolates (Gaudry, 1991j 
Williams et al., 1991ajb). The isolates were probably modified 
to some extent by the Vero cell passaging, resulting in a loss 
of immunogenicity. 
The CEF passaged material of all three isolates failed to cause 
seroconversion against TRTV in SPF birds . This is consistent with 
the findings of Williams et al . (1991a). The reason for this 
phenomenon could be that the infected cell membrane, which is 
used by the virus to form its outer envelope, was not 
significantly altered by the viral glycoproteins. 
The homogenised CAM's and yolk of the TOC-y/s passaged material 
also caused good seroconversion when inoculated intrasinusly in 
SPF birds, but the level of seroconversion was sharply reduced 
when the same samples were inoculated via the eye drop method. 
This drop was not unexpected since direct introduction of 
inoculum into the sinus will have a greater impact than 
introduction via the eye. However, the 652/93 TOC-y/s passaged 
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A/F inoculated via the eye drop method, caused a good 
seroconversion in SPF birds although lower than the intrasinus 
inoculation. Since the 652/93 isolate TOC-y/s passaged material 
consistently produced better results than the other isolates, it 
was chosen as the candidate for the vaccine. The 652/93 isolate 
10th TOC-y/s A/F, CAM and yolk were harvested and blended 
together for use as the vaccine since all three had high titres 
of virus and were able to induce significant antibody response 
against TRTV in SPF birds. 
Before approval of a vaccine for use, it has to be shown to be 
free of contaminants, safe and effective . The purity and 
sterility tests showed that the vaccine was free of any 
contaminating bacteria, virus, fungi, or mycoplasmas. The vaccine 
was serologically demonstrated to be negative for antibodies 
against IBV, IBDV, reovirus, AEV, NDV, M. gallisepticum and M. 
synovia . The stability of the attenuated virus was demonstrated 
by bird to bird passaging in day-old as well as 4-week-old SPF 
chickens. The isolate did not revert to pathogenicity and cause 
any symptoms of infection in any of the chickens. The virus was 
also re-isolated from both groups of birds, demonstrating the 
presence and viability of the virus in the inoculum. 
There was a negligible drop in vaccine virus titre after storage 
at -70°C for 7 days. The vaccine could therefore be stored at 
this temperature prior to use. Titration results of Chapter 3 
show that the virus could be stored for more than 6 months at 
this temperature without loss of titre. This makes storage of 
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large amounts of vaccine convenient in the absence of a freeze 
drier. Freeze drying is also more time consuming, and a small 
freeze drier cannot handle millions of doses of vaccine. The best 
option is therefore to store the vaccine at -70°C after 
manufacture and transport in liquid nitrogen to the hatchery for 
application. 
Based on the titre of the vaccine which was 1.06.6EIDso /ml, and 
since 1 ml of vaccine is normally reconstituted into 30 ml of 
vaccine diluent which is sufficient to vaccinate 1000 birds, one 
bird dose of vacqine would therefore contain 103.6EIDso/ml. 
However, this dosage must be shown to be effective and able to 
cause seroconversion and protection in vaccinates. This was 
demonstrated in laboratory trials where vaccinated birds 
seroconverted against the TRTV and showed no symptoms of 
infection when challenged 14 days post-vaccination with the 3rd 
y/s A/F of isolate 652/93. There was a transient sinusitis in 40% 
of the unvaccinated chicks challenged with this isolate. The 
sinusitis was of a very short duration and only in a few chicks. 
This suggests that in the field situation, the severity of the 
disease is dependent upon other predisposing factors such as 
adverse environmental conditions, the presence of other pathogens 
which may be the primary or secondary organism in a disease 
outbreak, and. poor flock management. Specific pathogen-free 
chicks vaccinated at day-old and again at 14 days of age, had the 
highest seroconversion against TRTV, whilst the groups vaccinated 
at day-old or 14 days, had lower seroconversions than the double 
vaccination, but similar to each other. The results of the 
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laboratory trials suggest that two vaccinations at day-old and 
14 days of age may offer the best protection against the virulent 
virus. 
The results of vaccination studies undertaken in the laboratory 
do not always correlate with the results obtained in the field. 
This was found to be especially true for TRTV by a major vaccine 
manufacturer in France (Gaudry, 1991) . 
The broiler vaccination trial conducted with the 652/93 vaccine 
showed that the best results were achieved with birds vaccinated 
at day-old or at day-old and again at 14 days of age . The average 
mortality of birds at the subsite vaccinated at day-old, was 
6.09%, whilst that given the double vaccination was 6 . 28%. 
However, statistically, these differences were not significant. 
There was little difference in the percentage mortality between 
the subsite vaccinated at 14 days of age only and the 
unvaccinated control subsite . However, there was one house on 
subsite C (14 day vaccination) , which had an extremely high 
mortality that elevated the average percentage mortality for the 
subsite. It is extremely difficult to measure small benefits 
derived from a vaccine in the field, when other predisposing 
factors are present. 
The elevated mortality could have been due to several factors. 
This particular house had elevated mortality from the day of 
chick placement which suggests that the chicks placed in this 
house were of poor quality compared to the other houses. Also, 
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subsite C had an elevated IBV antibody titre at 35 days of age 
with elevated mortality occurring between 29-35 days. This 
suggests that there may have been an IBV infection which could 
have contributed to the increased mortality. The TRTV and NDV 
antibody titres were not very high, suggesting the absence of 
infection with these viruses. 
Fig. 7.1 illustrates two major phases of morta~ity at all the 
subsites. The first phase occurred between 13-16 days of age and 
the second phase occurred between 27-35 days of age and was of 
a longer duration. The first phase may be due to the culling or 
death of the poor quality chicks that had been placed on the 
farm. The second phase of mortality may have been due to disease 
outbreak and the increased competition for food and water between 
birds, with the sick and weaker birds unable to compete, 
resulting in an increase in mortality. The disease could have 
been caused by NDV at subsite B and by IBV at subsite C since 
there were increased titres of the respective antibodies. 
The cause of the second phase of mortality at subsite A and D is 
not clearly evident. However, the elevated TRTV titre at the 
unvaccinated subsite D, could suggest that TRTV may have been 
responsible. However, the TRTV antibody titres were also elevated 
at subsites A and B. Although subsites A and B were vaccinated 
with the 652/93 vaccine, there was little serological response 
following day-old vaccination. It is therefore unlikely that the 
elevated TRTV antibody titres at A and B were due to the vaccine 
although the vaccine may have protected the birds from the field 
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virus and resulted in the higher 35-day TRTV antibody titres at 
these two vaccinated sites. 
Al though one cannot determine precisely the nature or 
circumstances responsible for the high late mortality, it is 
believed that no single factor is responsible, but a combination 
of factors including environmental factors, management of the 
flock and farm, and disease. In field trials, the best method· to 
evaluate the efficacy of the vaccination, is by comparing the 
performance of vaccinated and unvaccinated birds. This is the 
only reliable method when serological results cannot be 
extrapolated to determine vaccination efficacy. 
The average mass of 35-day-old birds at subsite C was the highest 
with the mass at subsite B only 2 grams lower. The mass at 
subsite A was 9 grams lower than C but the average mass of birds 
at the unvaccinated control subsite was much lower at 19 grams 
below that of C. However, the bird mass of all the subsites was 
above the in-house standard mass of birds aged 35 days. Based on 
the mortality figures (although not statistically significant) 
and the average mass of birds at each subsite, it would appear 
that day-old or day-old plus 14 day vaccination would yield the 
best broiler performance results. 
Serologically, there was hardly any response to the vaccine 14 
days after day-old application. This has also been the experience 
of other workers. Gaudry (1991) found that although there was 
good seroconversion in birds vaccinated with their TRTV vaccine 
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in laboratory trials, there was often no seroconversion when the 
same vaccine was used in field trials and when seroconversion did . 
occur, it was very low. It is possible that other vaccines 
administered before, after, or together with the 652/93 vaccine, 
could inhibit the birds response to this vaccine. Also, it is 
possible that maternal antibodies present in broiler chicks, 
drastically affect the seroconversion results. However, although 
the serological res~onse may be inhibited, the vaccinated birds 
appeared to perform better than the unvaccinated birds. 
The localised irrununity induced by the vaccine may be more 
important in the protection against the virulent virus, than 
circulating irrununity. This view was also expressed by Cook et al. 
(1989b). They found the serological response of turkey poults 
with maternal antibodies to be poor with many poults showing no 
detectable serum antibody response. They were, however, protected 
against challenge with virulent TRTV, indicating that humoral 
antibody may not be a good indication of protection against 
infection. They believed that local or cellular irrununity was more 
important in resistance against TRTV infection. It would appear 
that the isolates used in their vaccine and in the 652/93 
vaccine, are capable of significantly inducing the cellular 
irrununity to provide protection against infection with these field 
isolates. 
Based on the results obtained, it is evident that the 652/93 
vaccine provides adequate protection against the field virus and 
results in improved bird performance. A 1% reduction in mortality 
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results in enormous savings for a large commercial chicken 
producer. It is therefore essential that effective vaccination 
against disease and proper management procedures be introduced 
wherever possible. Vaccination on its own is unlikely to have a 
maj or impact in the control of a disease, but implemented 
together with adequate biosecurity, proper hygiene and 
management, can contribute to the containment and eventual 
eradication of most diseases. 
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GENERAL DISCUSSION 
It is now accepted that the virus responsible for TRT is also 
involved in SHS of chickens. Many researchers have isolated TRTV-
like viruses from turkeys and chickens and shown that some of the 
symptoms of TRT and SHS could be reproduced in turkeys and 
chickens respectively although the symptoms in chickens were 
often mild compared to the symptoms produced in kurkeys. 
Most of the research has concentrated on the turkey disease 
rather than its chicken counterpart. The main reason for this is 
the difficulty involved in the isolation of these viruses from 
chickens and the apparently more severe disease in turkeys. 
However, although the disease appears to be more severe in 
turkeys, the chicken disease may be equally, or more devastating 
since there may be numerous other factors involved in the disease 
such as complications with other chicken viruses, secondary 
bacterial infections, high stocking density, and other management 
factors. Turkeys are not usually stocked at the high stocking 
density of chickens. 
A phenomenon evident in this study was the inability to achieve 
a successful TRTV-like virus isolation from chickens if the time 
of sampling and the choice of birds for sampling were incorrect. 
It was essential that birds with sinusitis in the early stages 
of the disease be "hand-picked" for sampling. Samples from birds 
in the more pronounced or latter stages of the disease yielded 
negative isolation results. This was also reported by other 
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workers (Naylor and Jones, 1993). This short isolation period is 
indicative of the short duration of the disease and the time of 
peak virus concentration in the birds. 
After consultation with Dr S.S. Buys (Early Bird), sinus exudate 
and sinus washings from birds in the early stages of sinusitis 
were used for isolation. The three ARTV isolates obtained were 
made from these samples. The use of other material, ego trachea, , 
lungs and tracheal swabs, failed to yield any ARTV isolates 
(resul ts not presented) . This could be because the virus does not 
grow to very high titres in these tissues. The failure to isolate 
the virus from the lungs is not unexpected, since it has been 
established by many researchers that TRTV and TRTV-like viruses 
of chickens, cause upper respiratory tract infections. However, 
the inability to isolate ARTV from the trachea and tracheal 
swabs, was unexpected since the virus is reported to cause 
tracheitis and other workers (Picault et al.,198?) have isolated 
the virus from this tissue. It is possible that the time of 
sampling may not have been during the period of maximum virus 
titre in the trachea. 
To confirm the identity of the three ARTV isolates and to show 
their similarity to TRTV, various physicochemical tests were 
performed. The virus was shown to be enveloped, heat labile, and 
non-haemagglutinating. Electron microscopy showed it to be 
pleomorphic with diameters ranging between 100-300nm and the 
membrane covered with a fringe of approximately 12 nm long 
spikes . Also, a helical internal nucleocapsid component 
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approximately 15nm in diameter, was observed. The IUDR test 
demonstrated that the genome of the isolates consisted of RNA. 
All these morphological and chemical findings are consistent with 
characteristics of members of the Pneumovirus genus. 
The culture characteristics of the ARTV isolates were similar to 
those of TRTV. The serological tests also suggest that the 
isolates are closely related to TRTV. In fact, the isolates could 
not be distinguished from TRTV serologically. Monoclonal antibody 
studies may demonstrate serological differences between these 
isolates and TRTV. This work is currently being performed by Dr 
J.K.A Cook (Intervet, UK). 
The determination of an organism's identity is contained in its 
genetic material. Unequivocal evidence of an organism's identity 
can therefore be obtained by analysis or comparison of its 
genetic material to that of other related organisms. There exists 
at present only one commercially available avian disease DNA 
probe. This probe is manufactured by Idexx (USA) for the 
detection of M. gallisepticum. Jing et al. (1993) used PCR to 
detect TRTV in samples but their detection was based on the 
presence of a 541 or 175 bp DNA fragment in agarose gels. 
Although these bands are specific for TRTV using the TRT1 and 
TRT2 primers or the TRT1 and TRT3 primers respectively, 
hybridisation of the 175 bp TRTV-specific DNA probe to this 541 
bp band provides absolute proof as to the identity of the 
isolate. The results of this study show that the three ARTV 
isolates are chicken strains of TRTV. Further molecular 
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characterisation of the three isolates involving sequencing of 
the genomes, is in progress at the laboratory of Dr A.J. Easton 
(University of Warwick, UK). 
Although the DNA probes synthesised for TRTV and ARTV utilised 
the primers described by Jing et ale (1993), this is the first 
TRTV or ARTV DNA probe for routine qiagnostic use. This enables 
a rapid, sensitive and accurate diagnosis of a virus that would 
, 
otherwise take weeks to identify. PCR and probe technology have 
revolutionised routine virus identification. 
The successful control of a disease can be achieved by suitable 
biosecurity measures, good disinfection, effective vaccination 
and proper management. There are currently no commercially 
available vaccines derived from chicken isolates of TRTV (ARTV). 
Commercial chicken producers wishing to vaccinate their flocks 
against ARTV, have to use the TRTV vaccine which is available 
from many commercial vaccine manufacturers. Al though this vaccine 
has been effective for the protection of turkeys against TRT, no 
benefit could be demonstrated in broiler chickens (D.K. Thomson, 
Rainbow Farms, 1993 · pers. comm.). It was believed that an 
autogenous chicken-isolate derived vaccine would provide better 
results. According to the results presented in Chapter 7, there 
appeared to be a small benefit to chickens vaccinated with this 
chiCken-derived ARTV vaccine. However, the benefit was not 
statistically significant. It is extremely difficult to measure 
small benefits afforded by a vaccine in field trials when other 
environmental and disease factors have a much more pronounced 
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effect on the vaccinates. The vaccination trials were repeated 
at the same sites on numerous occasions but the results were 
severely distorted by the occurrence of virulent NDV which has 
subsequently become endemic in the Natal and Transvaal regions. 
According to Shane (1992, 1993), SHS is a complicated disease 
with a host of .factors contributing to its severity. This has 
also been observed at Rainbow Farms (Dr A.J. Morley, Rainbow 
Farms, 1993 pers. corom.). ARTV is believed to be the primary 
organism responsible for SHS, but due to the damage caused to the 
sinuses and the upper respiratory tract, other opportunistic 
pathogens like E. coli, exacerbate the disease. This is possibly 
the reason why only mild symptoms of the disease could be 
reproduced under laboratory conditions. It is therefore obvious 
that to achieve effective control of ARTV in broilers, steps 
should be taken to maintain a relatively "clean" environment and 
to institute effective ARTV vaccination at 1 day of age and again 
at 14 days of age. Strict biosecurity measures should also be 
instituted. These procedures should result in effective ARTV 
control. 
This study provides unequivocal proof for the presence of strains 
of TRTV in chickens and possible control measures using 
autogenous chicken derived TRTV vaccines. This is the first 
report of the use of a chicken derived TRTV vaccine for the 
control of SHS. This is also the first report of a TRTV/ARTV DNA 




1). Alsever's solution 
20.5 g dextrose 
2) . 
4.2 g sodium chloride 
0.55 g citric acid 
8.0 g sodium citrate 
1000 ml distilled water 
SOS-gel loading buffer 
50 mM Tris.HCl (pH 6.8) 
100 mM dithiothreitol 
2 % SOS 
0.1 % bromophenol blue 
10 % glycerol 
3). Tris-glycine electrophoresis buffer 
25 mM Tris 
250 mM glycine (pH 8.3) 
0.1 % SOS 
4). Transfer buffer 
39 mM glycine 
48 mM Tris 
0.037 % SOS 
20 % methanol 
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5) . 10 X PCR buffer 
500 mM KCl 
200 mM Tris 
20 mM MgClz 
0.1 % gelatin 
0.1 % triton-X 100 
6). Tris-acetate EDTA (TAE) buffer (50 X) (pH 8 .. 0) 
242 g Tris 
57.1 ml glacial acetic acid 
1000 ml distilled water 
7). Agarose gel loading buffer 
4 g sucrose 
10 ml distilled water 
0.025 g bromophenol blue 
8). Guanidinium isothiocyanate (GITC) extraction buffer 
250 g GITC 
17.6 ml 0.75 M sodium citrate (pH 7.0) 
26.4 ml 10% N-lauryl sarcosinate 
293 ml DEPC-treated water 
before use, add 360 ~l mercaptoethanol / 50 ml of above 
solution. 
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9). Hybridising buffer 
4ml 20 X SSC 
2 ml blocking stock solution 
2 ~l N-laurylsarcosine 
1 ~l SDS 
10). 20 X SSC buffer (pH 7.0) 
175.32 9 sodium chloride 
88.23 9 sodium citrate 
1000 ml distilled water 
11). Blocking stock solution 
10 9 blocking reagent powder 
100 ml buffer 1 
12). Buffer 1 (pH 7.5) 
11.61 9 maleic acid 
8.77 9 sodium chloride 
1000 ml distilled water 
13). Buffer 2 
Blocking stock solution diluted 1:10 in buffer 1 
14). Buffer 3 (pH 9.5) 
12.14 g Tris 
5.84 9 sodium chloride 
10 . 1 7 9 MgC12 
1000 ml distilled water 
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FIG 1: Typical Kudoa thyrsites spore 
FIG 2: Accumulation of Kudoa thyrsites spores within muscle bundle 
home and laid on a cold stone floor before preparation for cook-
ing. On returning to the fish 20 hours later, extensive muscle 
degeneration was apparent, the fish resembling a ' bag of bones' . 
The fish was submitted to the MAFF Veterinary Investigation 
Centre at Penrith for further examination. 
Muscle smears were made on to glass slides and agar-coated 
slides, while samples of muscle were fixed in 10 per cent buffered 
formalin and histological sections cut and stained with haema-
toxylin and eosin and Giemsa. Numerous myxosporean spores 
were seen on direct smear. These conformed with published 
descriptions of K thyrsites, showing four pyriform polar capsules 
arranged tetrahedrally. One polar capsule was larger than the 
remaining three, their apices met centrally and the overall spore 
shape was stellate (Figs 1 and 2). 
Myxosporean spores were also readily detected in histological 
sections both within and between muscle fibres. There was little 
or no associated inflammatory reaction and no evidence of pseu-
docyst formation, encapsulation or pigment reaction (Fig 3). This 
is in marked contrast to fish such as Pacific hake, Merluccius pro-
ductus, which develops a focal, chronic inflammatory response 
that ultimately destroys the parasite (Morado and Sparks 1986). 
The lack of inflammatory reaction noted in salmonids is 
thought to allow the parasite to continue multiplying within the 
flesh of the fish . K thyrsites is presumed to excrete histiolytic 
enzymes which diffuse into the surround.ing muscle. Whether 
these enzymes are released in response to the death of the host in 
order to facilitate spore release from infection sites, or whether 
they are excreted continuously but removed by vascular perfusion 
in the live fish is not clear. 
The method of transmission of Kudoa species between fish 
hosts is unknown. It appears to be a strictly fish parasite, carrying 
no known human health risk. No drugs are commercially available 
to treat Kudoa infections. 
It is likely that salmonid species represent aberrant hosts. 
However, its potential significance for salmon farming in both 
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FIG 3: Diagrams of antero-pos-
terior and lateral views of Kudoa 
thyrsites spores (bar = 5 !-lm). 
(Reprinted from Langdon [1991] 
Myoliquefaction post mortem 
('miIky flesh') due to Kudoa thyr-
sites (Gilchrist) (Myxosporea: 
MuJtivalvulida) in mahi mahi, 
Coryphaena hippurus L) 
Ireland and Scotland due to the unappealing appearance and poor 
quality flesh of the resultant product must not be underestimated. 
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Isolation of an avian pneumovirus-
like agent from broiler breeder 
chickens in South Africa 
S. B. Maharaj, D . K. Thomson, J. V. da Graca 
Veterinary Record (1994) 134, 525-526 
'1 
TURKEY rhinotracheitis (TRT) is an acute upper respiratory tract 
infection of poultry (Collins and others 1986). Concurrent with 
the appearance of TRT in turkeys, a disease condition known as 
swollen head syndrome, was observed in chickens worldwide 
(Buys and others 1989). Several researchers isolated a non-
haemagglutinating myxo-like virus from turkeys with TRT which 
was named TRT virus (TRTV) (Naylor and Jones 1993). A TRTV-
like virus was subsequently isolated from chickens with swollen 
head syndrome (picault and others 1987, Buys and others 1989). 
The aetiological agent of TRT is believed to be a pneumovirus 
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TABLE 1: ELISA results of the two affected flocks, and SPF birds inocu-
lated with yolk sac material, before and after challenge 




* Days after infection 
ELISA index value 







t SPF birds inoculated with third yolk sac material 
200nm 
FIG 1: Pleomorphic virus-like particle with a fringe of spikes 
of the Paramyxoviridae family (Collins and Gough 1988). This is 
the first report on the isolation of a TRTV-like agent from broiler 
breeders with sinusitis and swollen head syndrome in South 
Africa. 
During August 1991 , two adult broiler breeder flocks, housed 
in close proximity to one another in the Natal midlands, exhibited 
acu. sinusitis and periorbital swelling. Approximately 10 per cent 
of the flock exhibited signs, while egg production declined 
between 5 and 10 per cent over a two-week period. During the 
early stages of the disease, virus isolation was attempted by 
killing five affected birds and aseptically removing the infraorbital 
sinus fluid with a syringe. The sinuses were then washed with 
cold tryptose phosphate broth containing antibiotics. 
The antibody status of the two affected flocks, flocks 1 and 2, 
against TRTV just before the appearance of clinical signs, as deter-
mined by ELISA (pathasure, Cambridge), was negative, while sera 
drawn 14 and 21 days after infection revealed a significant rise in 
antibodies against TRTV (Table I). 
Sinus fluids were pooled into a single vial and clarified by 
centrifugation. The material was then inoculated into the allantoic 
sac of nine-day-old embryonated specific pathogen free (SPF) 
eggs.Jhe allantoic.-fluid-.Was~harvested seven days after inocula-
tion and then inoculated via the yoLk sac of six-day-old embry-
onated SPF eggs, and also on to Vero cell mono layers. No evi-
dence of virus activity was detected in the first allantoic sac and 
first yolk sac passages. However, embryo mortality occurred nine 
days after inoculation in the third yolk sac passage. Affected 
embryos were congested, stunted and oedematous. After two Vero 
cell passages, a few loose cells were observed floating in the 
media. Loose floating cells were also observed when chicken 
embryo kidney cells were inoculated with third passage Vero cell 
material. The third Vero cell passage material was also inoculated 
into the yolk sac of SPF eggs, causing congestion and stunting of 
the embryos. 
The third yolk sac passage material was inoculated into the 
sinus of three four-week-old SPF birds housed in an isolator. The 
birds were bled before inoculation and 10 days after inoculation. 
None . of the in?culated birds displayed any clinical signs of 
mfectlOn. The blfds seroconverted from a negative ELISA value 
pre-inoculation, to a highly positive value LO days after 
inoculation (Table I). 
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Electron microscopy of sixth yolk sac passage allantoic fluid, 
revealed the presence of a few highly pleomorphic virus-like par-
ticles (Fig 1) 112 to 297 nm in diameter with a fringe of spikes 
approximately 12 om in length. The isolate did not agglutinate 
chicken red blood cells and was completely inactivated at 56°C 
for one hour and by chloroform. The isolate differed from that of 
Buys and others (1989), in that it failed to produce clinical signs 
of infection in SPF birds. This could be due to it being a non-
pathogenic strain or to the lack of secondary pathogenic organ-
isms. 
The characteristics of this virus suggests that it could be related 
to TRTV which has already been classified as a pneumovirus. 
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Abstracts 
Expiration of hydrogen by cats given 
xylose orally 
THE mean rate of expiration of hydrogen by 11 healthy cats after the 
oral administration of 0'75 g/kg xylose was 0'18 mllhour and was lit-
tle different from the rate before the administration of the xylose. In 
contrast, the rate of expiration of hydrogen by five cats with chronic 
diarrhoea and/or vomiting was much higher before the administration 
of the same dose of xylose, and in four of them increased consider-
ably after its administration, indicating some degree of failure of 
absorption of carbohydrate. One of the sick cats had a hiatus hernia 
and three had inflammatory bowel disease; large numbers of 
Clostridium species were isolated from samples of small intestinal 
fluid taken from all the sick cats, but from only one of the eight 
healthy cats sampled. However, it was not possible to decide whether 
a specific bacterial pathogen was responsible for the increased expira-
tion of hydrogen by the sick cats. 
MUIR, P., GRUFFYDD-JONES, T. J., CRIPPS, P. J., PAPASOULIOTIS, K. & 
BROWN, P. 1. (1994) Journal of Small Animal Practice 35, 86 
Treatment of endotoxin-induced 
mastitis with isotonic or hypertonic 
sodium chloride 
EIGHT lactating Holstein cows received 1 mg endotoxin by intramam-
mary infusion into the left fore quarter. Four hours later each cow 
received either isotonic (Is) 0·9 per cent sodium chloride at 5 ml/kg 
bodyweight (n=4) or hypertonic (HS) 7·0 per cent sodium chloride, 
5 ml/kg (n=4). This model closely rnirnicked naturally acquired 
Gram-negative bacterial mastitis, causing a consistent inflammatory 
reaction ill the udder and a severe, transient shock syndrome which 
resolved in two days. Plasma volume decreased at three hours after 
inoculation, and expanded consistently both in HS and IS treated cows at 
six (peak values), 12, 24 and 48 hours after endotoxin infusion. Serum 
protein and haematocrit values decreased. Neither haemoglobinuria nor 
haematuna was observed. In contrast to other studies using an intra-
venous endotoxin induction model, serum activity of hepatic and mus-
cle-specific enzymes was unchanged or decreased in this model. 
Azotaernia, increased serum urea nitrogen or creatinine concentration 
was lacking. 
TYLER, J. W., WELLES, E. G., ERSKINE, R. 1., LIN, H.-C., WILLIAMS, M. A., 
SPANO, 1. S., GASLIN, T. & McCLURE, K. A. (1994) American Journal of 
Veterinary Research 55, 278 
